id	sid	tid	token	lemma	pos
cuesj-706	1	1	tx_1	tx_1	PROPN
cuesj-706	1	2	~	~	X
cuesj-706	1	3	abs	ab	NOUN
cuesj-706	1	4	:	:	PUNCT
cuesj-706	1	5	at	at	ADP
cuesj-706	1	6	/	/	SYM
cuesj-706	1	7	add	add	VERB
cuesj-706	1	8	:	:	PUNCT
cuesj-706	1	9	tx_2	tx_2	PROPN
cuesj-706	1	10	~	~	NOUN
cuesj-706	1	11	abs	ab	NOUN
cuesj-706	1	12	:	:	PUNCT
cuesj-706	1	13	at	at	ADP
cuesj-706	1	14	57	57	NUM
cuesj-706	1	15	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-706	1	16	cuesj	cuesj	ADJ
cuesj-706	1	17	2022	2022	NUM
cuesj-706	1	18	,	,	PUNCT
cuesj-706	1	19	6	6	NUM
cuesj-706	1	20	(	(	PUNCT
cuesj-706	1	21	2	2	NUM
cuesj-706	1	22	):	):	PUNCT
cuesj-706	1	23	57	57	NUM
cuesj-706	1	24	-	-	SYM
cuesj-706	1	25	61	61	NUM
cuesj-706	1	26	research	research	NOUN
cuesj-706	1	27	article	article	NOUN
cuesj-706	1	28	serum	serum	VERB
cuesj-706	1	29	fibroblast	fibroblast	ADJ
cuesj-706	1	30	growth	growth	NOUN
cuesj-706	1	31	factors	factor	NOUN
cuesj-706	1	32	23	23	NUM
cuesj-706	1	33	,	,	PUNCT
cuesj-706	1	34	chemerin	chemerin	NOUN
cuesj-706	1	35	,	,	PUNCT
cuesj-706	1	36	and	and	CCONJ
cuesj-706	1	37	vitamin	vitamin	NOUN
cuesj-706	1	38	d	d	PROPN
cuesj-706	1	39	levels	level	NOUN
cuesj-706	1	40	in	in	ADP
cuesj-706	1	41	patients	patient	NOUN
cuesj-706	1	42	with	with	ADP
cuesj-706	1	43	psoriasis	psoriasis	NOUN
cuesj-706	1	44	shatha	shatha	NOUN
cuesj-706	1	45	n.	n.	PROPN
cuesj-706	1	46	tawfeeq1	tawfeeq1	PROPN
cuesj-706	1	47	,	,	PUNCT
cuesj-706	1	48	moayad	moayad	PROPN
cuesj-706	1	49	m.	m.	NOUN
cuesj-706	1	50	al	al	PROPN
cuesj-706	1	51	anzy2	anzy2	PROPN
cuesj-706	1	52	,	,	PUNCT
cuesj-706	1	53	entedhar	entedhar	PROPN
cuesj-706	1	54	r.	r.	PROPN
cuesj-706	1	55	sarhat3	sarhat3	PROPN
cuesj-706	2	1	1department	1department	NUM
cuesj-706	2	2	of	of	ADP
cuesj-706	2	3	medical	medical	ADJ
cuesj-706	2	4	microbiology	microbiology	NOUN
cuesj-706	2	5	,	,	PUNCT
cuesj-706	2	6	cihan	cihan	VERB
cuesj-706	2	7	university	university	NOUN
cuesj-706	2	8	-	-	PUNCT
cuesj-706	2	9	erbil	erbil	PROPN
cuesj-706	2	10	,	,	PUNCT
cuesj-706	2	11	kurdistan	kurdistan	PROPN
cuesj-706	2	12	region	region	NOUN
cuesj-706	2	13	,	,	PUNCT
cuesj-706	2	14	iraq	iraq	PROPN
cuesj-706	2	15	,	,	PUNCT
cuesj-706	2	16	2department	2department	NUM
cuesj-706	2	17	of	of	ADP
cuesj-706	2	18	pharmaceutical	pharmaceutical	NOUN
cuesj-706	2	19	sciences	science	NOUN
cuesj-706	2	20	,	,	PUNCT
cuesj-706	2	21	tikrit	tikrit	NOUN
cuesj-706	2	22	university	university	NOUN
cuesj-706	2	23	,	,	PUNCT
cuesj-706	2	24	tikrit	tikrit	NOUN
cuesj-706	2	25	,	,	PUNCT
cuesj-706	2	26	iraq	iraq	PROPN
cuesj-706	2	27	,	,	PUNCT
cuesj-706	2	28	3department	3department	NUM
cuesj-706	2	29	of	of	ADP
cuesj-706	2	30	basic	basic	ADJ
cuesj-706	2	31	science	science	NOUN
cuesj-706	2	32	,	,	PUNCT
cuesj-706	2	33	faculty	faculty	NOUN
cuesj-706	2	34	of	of	ADP
cuesj-706	2	35	medicine	medicine	NOUN
cuesj-706	2	36	,	,	PUNCT
cuesj-706	2	37	tikrit	tikrit	NOUN
cuesj-706	2	38	university	university	NOUN
cuesj-706	2	39	,	,	PUNCT
cuesj-706	2	40	tikrit	tikrit	NOUN
cuesj-706	2	41	,	,	PUNCT
cuesj-706	2	42	iraq	iraq	PROPN
cuesj-706	2	43	abstract	abstract	NOUN
cuesj-706	2	44	the	the	DET
cuesj-706	2	45	aim	aim	NOUN
cuesj-706	2	46	of	of	ADP
cuesj-706	2	47	the	the	DET
cuesj-706	2	48	study	study	NOUN
cuesj-706	2	49	was	be	AUX
cuesj-706	2	50	to	to	PART
cuesj-706	2	51	compare	compare	VERB
cuesj-706	2	52	the	the	DET
cuesj-706	2	53	levels	level	NOUN
cuesj-706	2	54	of	of	ADP
cuesj-706	2	55	fibroblast	fibroblast	ADJ
cuesj-706	2	56	growth	growth	NOUN
cuesj-706	2	57	factor	factor	NOUN
cuesj-706	2	58	23	23	NUM
cuesj-706	2	59	(	(	PUNCT
cuesj-706	2	60	fgf23	fgf23	NOUN
cuesj-706	2	61	)	)	PUNCT
cuesj-706	2	62	and	and	CCONJ
cuesj-706	2	63	chemerin	chemerin	NOUN
cuesj-706	2	64	,	,	PUNCT
cuesj-706	2	65	as	as	ADV
cuesj-706	2	66	well	well	ADV
cuesj-706	2	67	as	as	ADP
cuesj-706	2	68	vitamin	vitamin	NOUN
cuesj-706	2	69	d	d	NOUN
cuesj-706	2	70	in	in	ADP
cuesj-706	2	71	psoriasis	psoriasis	NOUN
cuesj-706	2	72	sufferers	sufferer	NOUN
cuesj-706	2	73	and	and	CCONJ
cuesj-706	2	74	healthy	healthy	ADJ
cuesj-706	2	75	controls	control	NOUN
cuesj-706	2	76	.	.	PUNCT
cuesj-706	3	1	from	from	ADP
cuesj-706	3	2	2021	2021	NUM
cuesj-706	3	3	to	to	ADP
cuesj-706	3	4	2022	2022	NUM
cuesj-706	3	5	,	,	PUNCT
cuesj-706	3	6	ninety	ninety	NUM
cuesj-706	3	7	subjects	subject	NOUN
cuesj-706	3	8	were	be	AUX
cuesj-706	3	9	studied	study	VERB
cuesj-706	3	10	.	.	PUNCT
cuesj-706	4	1	the	the	DET
cuesj-706	4	2	study	study	NOUN
cuesj-706	4	3	comprised	comprise	VERB
cuesj-706	4	4	45	45	NUM
cuesj-706	4	5	individuals	individual	NOUN
cuesj-706	4	6	with	with	ADP
cuesj-706	4	7	psoriasis	psoriasis	NOUN
cuesj-706	4	8	and	and	CCONJ
cuesj-706	4	9	45	45	NUM
cuesj-706	4	10	healthy	healthy	ADJ
cuesj-706	4	11	controls	control	NOUN
cuesj-706	4	12	.	.	PUNCT
cuesj-706	5	1	serum	serum	NOUN
cuesj-706	5	2	fasting	fast	VERB
cuesj-706	5	3	fgf23	fgf23	PROPN
cuesj-706	5	4	and	and	CCONJ
cuesj-706	5	5	chemerin	chemerin	NOUN
cuesj-706	5	6	levels	level	NOUN
cuesj-706	5	7	of	of	ADP
cuesj-706	5	8	the	the	DET
cuesj-706	5	9	study	study	NOUN
cuesj-706	5	10	group	group	NOUN
cuesj-706	5	11	were	be	AUX
cuesj-706	5	12	examined	examine	VERB
cuesj-706	5	13	by	by	ADP
cuesj-706	5	14	sandwich	sandwich	NOUN
cuesj-706	5	15	enzyme	enzyme	NOUN
cuesj-706	5	16	-	-	PUNCT
cuesj-706	5	17	linked	link	VERB
cuesj-706	5	18	immunosorbent	immunosorbent	NOUN
cuesj-706	5	19	assay	assay	ADV
cuesj-706	5	20	.	.	PUNCT
cuesj-706	6	1	the	the	DET
cuesj-706	6	2	results	result	NOUN
cuesj-706	6	3	demonstrate	demonstrate	VERB
cuesj-706	6	4	that	that	SCONJ
cuesj-706	6	5	the	the	DET
cuesj-706	6	6	mean	mean	NOUN
cuesj-706	6	7	serum	serum	PROPN
cuesj-706	6	8	fgf23	fgf23	PROPN
cuesj-706	6	9	and	and	CCONJ
cuesj-706	6	10	chemerin	chemerin	NOUN
cuesj-706	6	11	quantities	quantity	NOUN
cuesj-706	6	12	in	in	ADP
cuesj-706	6	13	psoriasis	psoriasis	NOUN
cuesj-706	6	14	patients	patient	NOUN
cuesj-706	6	15	were	be	AUX
cuesj-706	6	16	greater	great	ADJ
cuesj-706	6	17	than	than	ADP
cuesj-706	6	18	in	in	ADP
cuesj-706	6	19	controls	control	NOUN
cuesj-706	6	20	,	,	PUNCT
cuesj-706	6	21	with	with	ADP
cuesj-706	6	22	a	a	DET
cuesj-706	6	23	statistically	statistically	ADV
cuesj-706	6	24	significant	significant	ADJ
cuesj-706	6	25	.	.	PUNCT
cuesj-706	7	1	patients	patient	NOUN
cuesj-706	7	2	with	with	ADP
cuesj-706	7	3	psoriasis	psoriasis	NOUN
cuesj-706	7	4	,	,	PUNCT
cuesj-706	7	5	on	on	ADP
cuesj-706	7	6	the	the	DET
cuesj-706	7	7	other	other	ADJ
cuesj-706	7	8	hand	hand	NOUN
cuesj-706	7	9	,	,	PUNCT
cuesj-706	7	10	had	have	VERB
cuesj-706	7	11	considerably	considerably	ADV
cuesj-706	7	12	lower	low	ADJ
cuesj-706	7	13	blood	blood	NOUN
cuesj-706	7	14	vitamin	vitamin	NOUN
cuesj-706	7	15	d	d	NOUN
cuesj-706	7	16	levels	level	NOUN
cuesj-706	7	17	than	than	ADP
cuesj-706	7	18	healthy	healthy	ADJ
cuesj-706	7	19	controls	control	NOUN
cuesj-706	7	20	.	.	PUNCT
cuesj-706	8	1	these	these	DET
cuesj-706	8	2	findings	finding	NOUN
cuesj-706	8	3	demonstrate	demonstrate	VERB
cuesj-706	8	4	that	that	SCONJ
cuesj-706	8	5	psoriatic	psoriatic	ADJ
cuesj-706	8	6	patients	patient	NOUN
cuesj-706	8	7	have	have	VERB
cuesj-706	8	8	lower	low	ADJ
cuesj-706	8	9	vitamin	vitamin	NOUN
cuesj-706	8	10	d	d	NOUN
cuesj-706	8	11	levels	level	NOUN
cuesj-706	8	12	than	than	ADP
cuesj-706	8	13	healthy	healthy	ADJ
cuesj-706	8	14	controls	control	NOUN
cuesj-706	8	15	,	,	PUNCT
cuesj-706	8	16	and	and	CCONJ
cuesj-706	8	17	they	they	PRON
cuesj-706	8	18	add	add	VERB
cuesj-706	8	19	to	to	ADP
cuesj-706	8	20	the	the	DET
cuesj-706	8	21	growing	grow	VERB
cuesj-706	8	22	body	body	NOUN
cuesj-706	8	23	of	of	ADP
cuesj-706	8	24	data	datum	NOUN
cuesj-706	8	25	linking	link	VERB
cuesj-706	8	26	fgf23	fgf23	NOUN
cuesj-706	8	27	,	,	PUNCT
cuesj-706	8	28	chemerin	chemerin	NOUN
cuesj-706	8	29	vitamin	vitamin	NOUN
cuesj-706	8	30	d	d	NOUN
cuesj-706	8	31	levels	level	NOUN
cuesj-706	8	32	,	,	PUNCT
cuesj-706	8	33	and	and	CCONJ
cuesj-706	8	34	the	the	DET
cuesj-706	8	35	course	course	NOUN
cuesj-706	8	36	of	of	ADP
cuesj-706	8	37	psoriasis	psoriasis	NOUN
cuesj-706	8	38	.	.	PUNCT
cuesj-706	9	1	keywords	keyword	NOUN
cuesj-706	9	2	:	:	PUNCT
cuesj-706	9	3	serum	serum	NOUN
cuesj-706	9	4	fibroblast	fibroblast	NOUN
cuesj-706	9	5	,	,	PUNCT
cuesj-706	9	6	psoriasis	psoriasis	NOUN
cuesj-706	9	7	,	,	PUNCT
cuesj-706	9	8	fibroblast	fibroblast	ADJ
cuesj-706	9	9	growth	growth	NOUN
cuesj-706	9	10	factor	factor	NOUN
cuesj-706	9	11	23	23	NUM
cuesj-706	9	12	,	,	PUNCT
cuesj-706	9	13	chemerin	chemerin	NOUN
cuesj-706	9	14	,	,	PUNCT
cuesj-706	9	15	1,25	1,25	NUM
cuesj-706	9	16	(	(	PUNCT
cuesj-706	9	17	oh)2d	oh)2d	NUM
cuesj-706	9	18	introduction	introduction	NOUN
cuesj-706	9	19	psoriasis	psoriasis	NOUN
cuesj-706	9	20	is	be	AUX
cuesj-706	9	21	now	now	ADV
cuesj-706	9	22	recognized	recognize	VERB
cuesj-706	9	23	as	as	ADP
cuesj-706	9	24	a	a	DET
cuesj-706	9	25	chronic	chronic	NOUN
cuesj-706	9	26	immunemediated	immunemediate	VERB
cuesj-706	9	27	inflammatory	inflammatory	ADJ
cuesj-706	9	28	dermatosis	dermatosis	NOUN
cuesj-706	9	29	with	with	ADP
cuesj-706	9	30	an	an	DET
cuesj-706	9	31	unknown	unknown	ADJ
cuesj-706	9	32	etiology	etiology	NOUN
cuesj-706	9	33	.	.	PUNCT
cuesj-706	10	1	it	it	PRON
cuesj-706	10	2	is	be	AUX
cuesj-706	10	3	caused	cause	VERB
cuesj-706	10	4	by	by	ADP
cuesj-706	10	5	a	a	DET
cuesj-706	10	6	variety	variety	NOUN
cuesj-706	10	7	of	of	ADP
cuesj-706	10	8	external	external	ADJ
cuesj-706	10	9	and	and	CCONJ
cuesj-706	10	10	endogenous	endogenous	ADJ
cuesj-706	10	11	causes	cause	NOUN
cuesj-706	10	12	,	,	PUNCT
cuesj-706	10	13	related	relate	VERB
cuesj-706	10	14	with	with	ADP
cuesj-706	10	15	a	a	DET
cuesj-706	10	16	range	range	NOUN
cuesj-706	10	17	of	of	ADP
cuesj-706	10	18	biochemical	biochemical	ADJ
cuesj-706	10	19	and	and	CCONJ
cuesj-706	10	20	immunological	immunological	ADJ
cuesj-706	10	21	abnormalities,[1	abnormalities,[1	ADV
cuesj-706	10	22	]	]	PUNCT
cuesj-706	10	23	affecting	affect	VERB
cuesj-706	10	24	approximately	approximately	ADV
cuesj-706	10	25	2	2	NUM
cuesj-706	10	26	%	%	NOUN
cuesj-706	10	27	of	of	ADP
cuesj-706	10	28	the	the	DET
cuesj-706	10	29	global	global	ADJ
cuesj-706	10	30	population.[2	population.[2	NOUN
cuesj-706	10	31	]	]	PUNCT
cuesj-706	10	32	despite	despite	SCONJ
cuesj-706	10	33	the	the	DET
cuesj-706	10	34	fact	fact	NOUN
cuesj-706	10	35	that	that	SCONJ
cuesj-706	10	36	it	it	PRON
cuesj-706	10	37	does	do	AUX
cuesj-706	10	38	not	not	PART
cuesj-706	10	39	affect	affect	VERB
cuesj-706	10	40	just	just	ADV
cuesj-706	10	41	one	one	NUM
cuesj-706	10	42	tissue	tissue	NOUN
cuesj-706	10	43	,	,	PUNCT
cuesj-706	10	44	it	it	PRON
cuesj-706	10	45	is	be	AUX
cuesj-706	10	46	linked	link	VERB
cuesj-706	10	47	to	to	ADP
cuesj-706	10	48	autoimmune	autoimmune	ADJ
cuesj-706	10	49	reactions	reaction	NOUN
cuesj-706	10	50	all	all	ADV
cuesj-706	10	51	over	over	ADP
cuesj-706	10	52	the	the	DET
cuesj-706	10	53	body	body	NOUN
cuesj-706	10	54	.	.	PUNCT
cuesj-706	11	1	sharply	sharply	ADV
cuesj-706	11	2	defined	define	VERB
cuesj-706	11	3	dull	dull	ADJ
cuesj-706	11	4	red	red	ADJ
cuesj-706	11	5	spots	spot	NOUN
cuesj-706	11	6	with	with	ADP
cuesj-706	11	7	scales	scale	NOUN
cuesj-706	11	8	,	,	PUNCT
cuesj-706	11	9	particularly	particularly	ADV
cuesj-706	11	10	in	in	ADP
cuesj-706	11	11	the	the	DET
cuesj-706	11	12	scalp	scalp	NOUN
cuesj-706	11	13	and	and	CCONJ
cuesj-706	11	14	on	on	ADP
cuesj-706	11	15	extensor	extensor	NOUN
cuesj-706	11	16	prominences	prominence	NOUN
cuesj-706	11	17	,	,	PUNCT
cuesj-706	11	18	are	be	AUX
cuesj-706	11	19	used	use	VERB
cuesj-706	11	20	to	to	PART
cuesj-706	11	21	categorize	categorize	VERB
cuesj-706	11	22	psoriasis.[3	psoriasis.[3	NOUN
cuesj-706	11	23	]	]	X
cuesj-706	11	24	dendritic	dendritic	ADJ
cuesj-706	11	25	cells	cell	NOUN
cuesj-706	11	26	and	and	CCONJ
cuesj-706	11	27	t	t	NOUN
cuesj-706	11	28	-	-	PUNCT
cuesj-706	11	29	cells	cell	NOUN
cuesj-706	11	30	multiply	multiply	VERB
cuesj-706	11	31	in	in	ADP
cuesj-706	11	32	the	the	DET
cuesj-706	11	33	immune	immune	ADJ
cuesj-706	11	34	system	system	NOUN
cuesj-706	11	35	,	,	PUNCT
cuesj-706	11	36	releasing	release	VERB
cuesj-706	11	37	a	a	DET
cuesj-706	11	38	range	range	NOUN
cuesj-706	11	39	of	of	ADP
cuesj-706	11	40	inflammatory	inflammatory	ADJ
cuesj-706	11	41	precursors	precursor	NOUN
cuesj-706	11	42	cytokines	cytokine	NOUN
cuesj-706	11	43	and	and	CCONJ
cuesj-706	11	44	chemokines	chemokine	NOUN
cuesj-706	11	45	,	,	PUNCT
cuesj-706	11	46	as	as	ADV
cuesj-706	11	47	well	well	ADV
cuesj-706	11	48	as	as	ADP
cuesj-706	11	49	growth	growth	NOUN
cuesj-706	11	50	factors	factor	NOUN
cuesj-706	11	51	,	,	PUNCT
cuesj-706	11	52	which	which	PRON
cuesj-706	11	53	all	all	PRON
cuesj-706	11	54	have	have	VERB
cuesj-706	11	55	a	a	DET
cuesj-706	11	56	role	role	NOUN
cuesj-706	11	57	in	in	ADP
cuesj-706	11	58	the	the	DET
cuesj-706	11	59	pathogenesis	pathogenesis	NOUN
cuesj-706	11	60	of	of	ADP
cuesj-706	11	61	psoriasis.[4	psoriasis.[4	NOUN
cuesj-706	11	62	]	]	PUNCT
cuesj-706	11	63	in	in	ADP
cuesj-706	11	64	contrast	contrast	NOUN
cuesj-706	11	65	to	to	ADP
cuesj-706	11	66	most	most	ADJ
cuesj-706	11	67	other	other	ADJ
cuesj-706	11	68	fibroblast	fibroblast	ADJ
cuesj-706	11	69	growth	growth	NOUN
cuesj-706	11	70	factors	factor	NOUN
cuesj-706	11	71	(	(	PUNCT
cuesj-706	11	72	fgfs	fgfs	PROPN
cuesj-706	11	73	)	)	PUNCT
cuesj-706	11	74	,	,	PUNCT
cuesj-706	11	75	which	which	PRON
cuesj-706	11	76	do	do	AUX
cuesj-706	11	77	not	not	PART
cuesj-706	11	78	behave	behave	VERB
cuesj-706	11	79	as	as	ADP
cuesj-706	11	80	traditional	traditional	ADJ
cuesj-706	11	81	hormones	hormone	NOUN
cuesj-706	11	82	,	,	PUNCT
cuesj-706	11	83	the	the	DET
cuesj-706	11	84	fgf23	fgf23	NOUN
cuesj-706	11	85	gene	gene	NOUN
cuesj-706	11	86	is	be	AUX
cuesj-706	11	87	located	locate	VERB
cuesj-706	11	88	on	on	ADP
cuesj-706	11	89	chromosome	chromosome	NOUN
cuesj-706	11	90	12p13	12p13	NUM
cuesj-706	11	91	and	and	CCONJ
cuesj-706	11	92	characterized	characterize	VERB
cuesj-706	11	93	by	by	ADP
cuesj-706	11	94	endocrine	endocrine	NOUN
cuesj-706	11	95	and	and	CCONJ
cuesj-706	11	96	paracrine	paracrine	NOUN
cuesj-706	11	97	effects.[5	effects.[5	ADV
cuesj-706	11	98	]	]	PUNCT
cuesj-706	11	99	it	it	PRON
cuesj-706	11	100	is	be	AUX
cuesj-706	11	101	a	a	DET
cuesj-706	11	102	phosphaturic	phosphaturic	ADJ
cuesj-706	11	103	proteohormone	proteohormone	NOUN
cuesj-706	11	104	produced	produce	VERB
cuesj-706	11	105	mostly	mostly	ADV
cuesj-706	11	106	by	by	ADP
cuesj-706	11	107	osteoblasts	osteoblast	NOUN
cuesj-706	11	108	/	/	SYM
cuesj-706	11	109	osteocytes	osteocyte	NOUN
cuesj-706	11	110	in	in	ADP
cuesj-706	11	111	the	the	DET
cuesj-706	11	112	bone	bone	NOUN
cuesj-706	11	113	that	that	PRON
cuesj-706	11	114	is	be	AUX
cuesj-706	11	115	plays	play	VERB
cuesj-706	11	116	a	a	DET
cuesj-706	11	117	function	function	NOUN
cuesj-706	11	118	in	in	ADP
cuesj-706	11	119	phosphate	phosphate	ADJ
cuesj-706	11	120	reabsorption	reabsorption	NOUN
cuesj-706	11	121	and	and	CCONJ
cuesj-706	11	122	1,25	1,25	NUM
cuesj-706	11	123	(	(	PUNCT
cuesj-706	11	124	oh	oh	INTJ
cuesj-706	11	125	)	)	PUNCT
cuesj-706	11	126	2d3	2d3	NUM
cuesj-706	11	127	synthesis	synthesis	NOUN
cuesj-706	11	128	in	in	ADP
cuesj-706	11	129	the	the	DET
cuesj-706	11	130	kidney	kidney	NOUN
cuesj-706	11	131	.	.	PUNCT
cuesj-706	12	1	metabolism	metabolism	NOUN
cuesj-706	12	2	of	of	ADP
cuesj-706	12	3	fgf23	fgf23	NOUN
cuesj-706	12	4	included	include	VERB
cuesj-706	12	5	the	the	DET
cuesj-706	12	6	cleavage	cleavage	NOUN
cuesj-706	12	7	of	of	ADP
cuesj-706	12	8	bioactive	bioactive	ADJ
cuesj-706	12	9	intact	intact	ADJ
cuesj-706	12	10	fgf23	fgf23	NOUN
cuesj-706	12	11	(	(	PUNCT
cuesj-706	12	12	ifgf23	ifgf23	NOUN
cuesj-706	12	13	,	,	PUNCT
cuesj-706	12	14	30	30	NUM
cuesj-706	12	15	kd	kd	NOUN
cuesj-706	12	16	)	)	PUNCT
cuesj-706	12	17	into	into	ADP
cuesj-706	12	18	c	c	NOUN
cuesj-706	12	19	-	-	PUNCT
cuesj-706	12	20	terminal	terminal	ADJ
cuesj-706	12	21	(	(	PUNCT
cuesj-706	12	22	cfgf23	cfgf23	PROPN
cuesj-706	12	23	,	,	PUNCT
cuesj-706	12	24	12	12	NUM
cuesj-706	12	25	kd	kd	NOUN
cuesj-706	12	26	)	)	PUNCT
cuesj-706	12	27	and	and	CCONJ
cuesj-706	12	28	n	n	CCONJ
cuesj-706	12	29	-	-	PUNCT
cuesj-706	12	30	terminal	terminal	NOUN
cuesj-706	12	31	(	(	PUNCT
cuesj-706	12	32	18	18	NUM
cuesj-706	12	33	kd	kd	NOUN
cuesj-706	12	34	)	)	PUNCT
cuesj-706	12	35	fragments	fragment	NOUN
cuesj-706	12	36	.	.	PUNCT
cuesj-706	13	1	fgf23	fgf23	NOUN
cuesj-706	13	2	could	could	AUX
cuesj-706	13	3	be	be	AUX
cuesj-706	13	4	cleared	clear	VERB
cuesj-706	13	5	by	by	ADP
cuesj-706	13	6	kidneys	kidney	NOUN
cuesj-706	13	7	through	through	ADP
cuesj-706	13	8	filtration	filtration	NOUN
cuesj-706	13	9	and	and	CCONJ
cuesj-706	13	10	catabolism,[6,7	catabolism,[6,7	NOUN
cuesj-706	13	11	]	]	PUNCT
cuesj-706	13	12	ffgf23	ffgf23	NOUN
cuesj-706	13	13	a	a	DET
cuesj-706	13	14	protein	protein	NOUN
cuesj-706	13	15	with	with	ADP
cuesj-706	13	16	classical	classical	ADJ
cuesj-706	13	17	endocrine	endocrine	NOUN
cuesj-706	13	18	,	,	PUNCT
cuesj-706	13	19	but	but	CCONJ
cuesj-706	13	20	also	also	ADV
cuesj-706	13	21	paracrine	paracrine	VERB
cuesj-706	13	22	effects	effect	NOUN
cuesj-706	13	23	.	.	PUNCT
cuesj-706	14	1	klotho	klotho	PROPN
cuesj-706	14	2	,	,	PUNCT
cuesj-706	14	3	a	a	DET
cuesj-706	14	4	transmembrane	transmembrane	ADJ
cuesj-706	14	5	protein	protein	NOUN
cuesj-706	14	6	,	,	PUNCT
cuesj-706	14	7	is	be	AUX
cuesj-706	14	8	required	require	VERB
cuesj-706	14	9	for	for	ADP
cuesj-706	14	10	fgf23	fgf23	NOUN
cuesj-706	14	11	-	-	PUNCT
cuesj-706	14	12	mediated	mediate	VERB
cuesj-706	14	13	regulation	regulation	NOUN
cuesj-706	14	14	of	of	ADP
cuesj-706	14	15	the	the	DET
cuesj-706	14	16	renal	renal	ADJ
cuesj-706	14	17	phosphate	phosphate	NOUN
cuesj-706	14	18	transporter	transporter	NOUN
cuesj-706	14	19	napiiia	napiiia	NOUN
cuesj-706	14	20	and	and	CCONJ
cuesj-706	14	21	cyp27b1	cyp27b1	NOUN
cuesj-706	14	22	,	,	PUNCT
cuesj-706	14	23	the	the	DET
cuesj-706	14	24	major	major	ADJ
cuesj-706	14	25	enzyme	enzyme	NOUN
cuesj-706	14	26	in	in	ADP
cuesj-706	14	27	the	the	DET
cuesj-706	14	28	production	production	NOUN
cuesj-706	14	29	of	of	ADP
cuesj-706	14	30	1,25(oh)2d3.[8	1,25(oh)2d3.[8	NOUN
cuesj-706	14	31	]	]	PUNCT
cuesj-706	14	32	adipose	adipose	ADP
cuesj-706	14	33	tissue	tissue	NOUN
cuesj-706	14	34	is	be	AUX
cuesj-706	14	35	a	a	DET
cuesj-706	14	36	metabolic	metabolic	NOUN
cuesj-706	14	37	and	and	CCONJ
cuesj-706	14	38	endocrine	endocrine	ADJ
cuesj-706	14	39	organ	organ	NOUN
cuesj-706	14	40	that	that	PRON
cuesj-706	14	41	is	be	AUX
cuesj-706	14	42	complicated	complicated	ADJ
cuesj-706	14	43	,	,	PUNCT
cuesj-706	14	44	critical	critical	ADJ
cuesj-706	14	45	,	,	PUNCT
cuesj-706	14	46	and	and	CCONJ
cuesj-706	14	47	highly	highly	ADV
cuesj-706	14	48	active	active	ADJ
cuesj-706	14	49	.	.	PUNCT
cuesj-706	15	1	chemerin	chemerin	PROPN
cuesj-706	15	2	is	be	AUX
cuesj-706	15	3	one	one	NUM
cuesj-706	15	4	of	of	ADP
cuesj-706	15	5	the	the	DET
cuesj-706	15	6	metabolically	metabolically	ADV
cuesj-706	15	7	active	active	ADJ
cuesj-706	15	8	peptide	peptide	ADJ
cuesj-706	15	9	hormones	hormone	NOUN
cuesj-706	15	10	,	,	PUNCT
cuesj-706	15	11	cytokines	cytokine	NOUN
cuesj-706	15	12	,	,	PUNCT
cuesj-706	15	13	chemokines	chemokine	NOUN
cuesj-706	15	14	,	,	PUNCT
cuesj-706	15	15	and	and	CCONJ
cuesj-706	15	16	adipokines	adipokine	NOUN
cuesj-706	15	17	released	release	VERB
cuesj-706	15	18	by	by	ADP
cuesj-706	15	19	this	this	DET
cuesj-706	15	20	gland.[9	gland.[9	NOUN
cuesj-706	15	21	-	-	SYM
cuesj-706	15	22	11	11	NUM
cuesj-706	15	23	]	]	PUNCT
cuesj-706	15	24	chemerin	chemerin	NOUN
cuesj-706	15	25	(	(	PUNCT
cuesj-706	15	26	16	16	NUM
cuesj-706	15	27	kda	kda	NOUN
cuesj-706	15	28	)	)	PUNCT
cuesj-706	15	29	,	,	PUNCT
cuesj-706	15	30	also	also	ADV
cuesj-706	15	31	known	know	VERB
cuesj-706	15	32	as	as	ADP
cuesj-706	15	33	tig2	tig2	NOUN
cuesj-706	15	34	or	or	CCONJ
cuesj-706	15	35	rarres2	rarres2	NOUN
cuesj-706	15	36	,	,	PUNCT
cuesj-706	15	37	is	be	AUX
cuesj-706	15	38	a	a	DET
cuesj-706	15	39	newly	newly	ADV
cuesj-706	15	40	discovered	discover	VERB
cuesj-706	15	41	adipocyte	adipocyte	NOUN
cuesj-706	15	42	-	-	PUNCT
cuesj-706	15	43	secreted	secrete	VERB
cuesj-706	15	44	factor	factor	NOUN
cuesj-706	15	45	that	that	PRON
cuesj-706	15	46	has	have	VERB
cuesj-706	15	47	both	both	CCONJ
cuesj-706	15	48	pro	pro	ADJ
cuesj-706	15	49	and	and	CCONJ
cuesj-706	15	50	anti	anti	ADJ
cuesj-706	15	51	-	-	ADJ
cuesj-706	15	52	inflammatory	inflammatory	ADJ
cuesj-706	15	53	properties	property	NOUN
cuesj-706	15	54	.	.	PUNCT
cuesj-706	16	1	it	it	PRON
cuesj-706	16	2	is	be	AUX
cuesj-706	16	3	made	make	VERB
cuesj-706	16	4	as	as	ADP
cuesj-706	16	5	an	an	DET
cuesj-706	16	6	inactive	inactive	ADJ
cuesj-706	16	7	prochemerin	prochemerin	NOUN
cuesj-706	16	8	that	that	PRON
cuesj-706	16	9	is	be	AUX
cuesj-706	16	10	transformed	transform	VERB
cuesj-706	16	11	to	to	ADP
cuesj-706	16	12	its	its	PRON
cuesj-706	16	13	active	active	ADJ
cuesj-706	16	14	state	state	NOUN
cuesj-706	16	15	by	by	ADP
cuesj-706	16	16	serine	serine	NOUN
cuesj-706	16	17	proteases	protease	NOUN
cuesj-706	16	18	.	.	PUNCT
cuesj-706	17	1	not	not	PART
cuesj-706	17	2	just	just	ADV
cuesj-706	17	3	in	in	ADP
cuesj-706	17	4	wat	wat	NOUN
cuesj-706	17	5	,	,	PUNCT
cuesj-706	17	6	it	it	PRON
cuesj-706	17	7	can	can	AUX
cuesj-706	17	8	even	even	ADV
cuesj-706	17	9	be	be	AUX
cuesj-706	17	10	found	find	VERB
cuesj-706	17	11	in	in	ADP
cuesj-706	17	12	the	the	DET
cuesj-706	17	13	skin	skin	NOUN
cuesj-706	17	14	,	,	PUNCT
cuesj-706	17	15	intestines	intestine	NOUN
cuesj-706	17	16	,	,	PUNCT
cuesj-706	17	17	and	and	CCONJ
cuesj-706	17	18	airways	airways	PROPN
cuesj-706	17	19	,	,	PUNCT
cuesj-706	17	20	chemerin	chemerin	PROPN
cuesj-706	17	21	is	be	AUX
cuesj-706	17	22	secreted	secrete	VERB
cuesj-706	17	23	in	in	ADP
cuesj-706	17	24	enormous	enormous	ADJ
cuesj-706	17	25	levels	level	NOUN
cuesj-706	17	26	.	.	PUNCT
cuesj-706	18	1	chemr23	chemr23	NOUN
cuesj-706	18	2	,	,	PUNCT
cuesj-706	18	3	gpr-1	gpr-1	NOUN
cuesj-706	18	4	,	,	PUNCT
cuesj-706	18	5	and	and	CCONJ
cuesj-706	18	6	ccrl2	ccrl2	NOUN
cuesj-706	18	7	are	be	AUX
cuesj-706	18	8	the	the	DET
cuesj-706	18	9	three	three	NUM
cuesj-706	18	10	kinds	kind	NOUN
cuesj-706	18	11	of	of	ADP
cuesj-706	18	12	receptors	receptor	NOUN
cuesj-706	18	13	that	that	PRON
cuesj-706	18	14	chemerin	chemerin	NOUN
cuesj-706	18	15	interacts	interact	VERB
cuesj-706	18	16	to	to	ADP
cuesj-706	18	17	.	.	PUNCT
cuesj-706	19	1	chemerin	chemerin	PROPN
cuesj-706	19	2	inhibits	inhibit	VERB
cuesj-706	19	3	neutrophil	neutrophil	ADJ
cuesj-706	19	4	transepithelial	transepithelial	ADJ
cuesj-706	19	5	migratory	migratory	NOUN
cuesj-706	19	6	process	process	NOUN
cuesj-706	19	7	and	and	CCONJ
cuesj-706	19	8	increases	increase	VERB
cuesj-706	19	9	apical	apical	ADJ
cuesj-706	19	10	neutrophil	neutrophil	ADJ
cuesj-706	19	11	evacuation	evacuation	NOUN
cuesj-706	19	12	when	when	SCONJ
cuesj-706	19	13	chemr23	chemr23	NOUN
cuesj-706	19	14	is	be	AUX
cuesj-706	19	15	activated.[12,13	activated.[12,13	NOUN
cuesj-706	19	16	]	]	PUNCT
cuesj-706	19	17	cihan	cihan	VERB
cuesj-706	19	18	university	university	NOUN
cuesj-706	19	19	-	-	PUNCT
cuesj-706	19	20	erbil	erbil	PROPN
cuesj-706	19	21	scientific	scientific	ADJ
cuesj-706	19	22	journal	journal	NOUN
cuesj-706	19	23	(	(	PUNCT
cuesj-706	19	24	cuesj	cuesj	PROPN
cuesj-706	19	25	)	)	PUNCT
cuesj-706	19	26	corresponding	correspond	VERB
cuesj-706	19	27	author	author	NOUN
cuesj-706	19	28	:	:	PUNCT
cuesj-706	19	29	shatha	shatha	PROPN
cuesj-706	19	30	n.	n.	PROPN
cuesj-706	19	31	tawfeeq	tawfeeq	PROPN
cuesj-706	19	32	,	,	PUNCT
cuesj-706	19	33	department	department	NOUN
cuesj-706	19	34	of	of	ADP
cuesj-706	19	35	medical	medical	ADJ
cuesj-706	19	36	microbiology	microbiology	NOUN
cuesj-706	19	37	,	,	PUNCT
cuesj-706	19	38	cihan	cihan	VERB
cuesj-706	19	39	university	university	NOUN
cuesj-706	19	40	-	-	PUNCT
cuesj-706	19	41	erbil	erbil	PROPN
cuesj-706	19	42	,	,	PUNCT
cuesj-706	19	43	kurdistan	kurdistan	PROPN
cuesj-706	19	44	region	region	NOUN
cuesj-706	19	45	,	,	PUNCT
cuesj-706	19	46	iraq	iraq	PROPN
cuesj-706	19	47	.	.	PUNCT
cuesj-706	20	1	e	e	X
cuesj-706	20	2	-	-	NOUN
cuesj-706	20	3	mail	mail	NOUN
cuesj-706	20	4	:	:	PUNCT
cuesj-706	20	5	shatha.nasih@cihanuniversity.edu.iq	shatha.nasih@cihanuniversity.edu.iq	NOUN
cuesj-706	20	6	received	receive	VERB
cuesj-706	20	7	:	:	PUNCT
cuesj-706	20	8	june	june	PROPN
cuesj-706	20	9	23	23	NUM
cuesj-706	20	10	,	,	PUNCT
cuesj-706	20	11	2022	2022	NUM
cuesj-706	20	12	accepted	accept	VERB
cuesj-706	20	13	:	:	PUNCT
cuesj-706	20	14	july	july	PROPN
cuesj-706	20	15	15	15	NUM
cuesj-706	20	16	,	,	PUNCT
cuesj-706	20	17	2022	2022	NUM
cuesj-706	20	18	published	publish	VERB
cuesj-706	20	19	:	:	PUNCT
cuesj-706	20	20	august	august	PROPN
cuesj-706	20	21	20	20	NUM
cuesj-706	20	22	,	,	PUNCT
cuesj-706	20	23	2022	2022	NUM
cuesj-706	20	24	doi	doi	NOUN
cuesj-706	20	25	:	:	PUNCT
cuesj-706	20	26	10.24086	10.24086	NUM
cuesj-706	20	27	/	/	SYM
cuesj-706	20	28	cuesj.v6n2y2022.pp57	cuesj.v6n2y2022.pp57	NUM
cuesj-706	20	29	-	-	SYM
cuesj-706	20	30	61	61	NUM
cuesj-706	20	31	copyright	copyright	NOUN
cuesj-706	20	32	©	©	ADP
cuesj-706	20	33	2022	2022	NUM
cuesj-706	20	34	shatha	shatha	PROPN
cuesj-706	20	35	n.	n.	PROPN
cuesj-706	20	36	tawfeeq	tawfeeq	PROPN
cuesj-706	20	37	,	,	PUNCT
cuesj-706	21	1	moayad	moayad	PROPN
cuesj-706	21	2	m.	m.	PROPN
cuesj-706	21	3	al	al	PROPN
cuesj-706	21	4	anzy	anzy	PROPN
cuesj-706	21	5	,	,	PUNCT
cuesj-706	21	6	entedhar	entedhar	PROPN
cuesj-706	21	7	r.	r.	PROPN
cuesj-706	21	8	sarhat	sarhat	PROPN
cuesj-706	21	9	.	.	PUNCT
cuesj-706	22	1	this	this	PRON
cuesj-706	22	2	is	be	AUX
cuesj-706	22	3	an	an	DET
cuesj-706	22	4	open	open	ADJ
cuesj-706	22	5	-	-	PUNCT
cuesj-706	22	6	access	access	NOUN
cuesj-706	22	7	article	article	NOUN
cuesj-706	22	8	distributed	distribute	VERB
cuesj-706	22	9	under	under	ADP
cuesj-706	22	10	the	the	DET
cuesj-706	22	11	creative	creative	ADJ
cuesj-706	22	12	commons	common	NOUN
cuesj-706	22	13	attribution	attribution	NOUN
cuesj-706	22	14	license	license	NOUN
cuesj-706	22	15	(	(	PUNCT
cuesj-706	22	16	cc	cc	NOUN
cuesj-706	22	17	by	by	ADP
cuesj-706	22	18	-	-	PUNCT
cuesj-706	22	19	nc	nc	VERB
cuesj-706	22	20	-	-	PROPN
cuesj-706	22	21	nd	nd	PRON
cuesj-706	22	22	4.0	4.0	NUM
cuesj-706	22	23	)	)	PUNCT
cuesj-706	22	24	.	.	PUNCT
cuesj-706	23	1	tawfeeq	tawfeeq	ADJ
cuesj-706	23	2	,	,	PUNCT
cuesj-706	23	3	et	et	PROPN
cuesj-706	23	4	al	al	PROPN
cuesj-706	23	5	.	.	PUNCT
cuesj-706	23	6	:	:	PUNCT
cuesj-706	24	1	role	role	NOUN
cuesj-706	24	2	of	of	ADP
cuesj-706	24	3	fibroblast	fibroblast	ADJ
cuesj-706	24	4	growth	growth	NOUN
cuesj-706	24	5	factors	factor	NOUN
cuesj-706	24	6	23	23	NUM
cuesj-706	24	7	,	,	PUNCT
cuesj-706	24	8	chemerin	chemerin	NOUN
cuesj-706	24	9	,	,	PUNCT
cuesj-706	24	10	and	and	CCONJ
cuesj-706	24	11	vitamin	vitamin	NOUN
cuesj-706	24	12	d	d	NOUN
cuesj-706	24	13	in	in	ADP
cuesj-706	24	14	psoriasis	psoriasis	NOUN
cuesj-706	24	15	58	58	NUM
cuesj-706	24	16	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-706	24	17	cuesj	cuesj	ADJ
cuesj-706	24	18	2022	2022	NUM
cuesj-706	24	19	,	,	PUNCT
cuesj-706	24	20	6	6	NUM
cuesj-706	24	21	(	(	PUNCT
cuesj-706	24	22	2	2	NUM
cuesj-706	24	23	):	):	PUNCT
cuesj-706	24	24	57	57	NUM
cuesj-706	24	25	-	-	SYM
cuesj-706	24	26	61	61	NUM
cuesj-706	24	27	vitamin	vitamin	NOUN
cuesj-706	24	28	d	d	NOUN
cuesj-706	24	29	is	be	AUX
cuesj-706	24	30	also	also	ADV
cuesj-706	24	31	known	know	VERB
cuesj-706	24	32	as	as	ADP
cuesj-706	24	33	vitamin	vitamin	NOUN
cuesj-706	24	34	that	that	PRON
cuesj-706	24	35	excreted	excrete	VERB
cuesj-706	24	36	in	in	ADP
cuesj-706	24	37	the	the	DET
cuesj-706	24	38	body	body	NOUN
cuesj-706	24	39	after	after	ADP
cuesj-706	24	40	sun	sun	NOUN
cuesj-706	24	41	exposure	exposure	NOUN
cuesj-706	24	42	.	.	PUNCT
cuesj-706	25	1	it	it	PRON
cuesj-706	25	2	refers	refer	VERB
cuesj-706	25	3	to	to	ADP
cuesj-706	25	4	a	a	DET
cuesj-706	25	5	group	group	NOUN
cuesj-706	25	6	of	of	ADP
cuesj-706	25	7	fat	fat	ADJ
cuesj-706	25	8	-	-	PUNCT
cuesj-706	25	9	soluble	soluble	ADJ
cuesj-706	25	10	a	a	DET
cuesj-706	25	11	fat	fat	ADJ
cuesj-706	25	12	-	-	PUNCT
cuesj-706	25	13	soluble	soluble	ADJ
cuesj-706	25	14	biomolecule	biomolecule	NOUN
cuesj-706	25	15	,	,	PUNCT
cuesj-706	25	16	connected	connect	VERB
cuesj-706	25	17	to	to	ADP
cuesj-706	25	18	bone	bone	NOUN
cuesj-706	25	19	metabolism	metabolism	NOUN
cuesj-706	25	20	and	and	CCONJ
cuesj-706	25	21	skeletal	skeletal	ADJ
cuesj-706	25	22	integrity	integrity	NOUN
cuesj-706	25	23	as	as	ADV
cuesj-706	25	24	well	well	ADV
cuesj-706	25	25	as	as	ADP
cuesj-706	25	26	generated	generate	VERB
cuesj-706	25	27	in	in	ADP
cuesj-706	25	28	the	the	DET
cuesj-706	25	29	skin	skin	NOUN
cuesj-706	25	30	by	by	ADP
cuesj-706	25	31	the	the	DET
cuesj-706	25	32	impact	impact	NOUN
cuesj-706	25	33	of	of	ADP
cuesj-706	25	34	uv	uv	NOUN
cuesj-706	25	35	irradiation	irradiation	NOUN
cuesj-706	25	36	from	from	ADP
cuesj-706	25	37	the	the	DET
cuesj-706	25	38	sun	sun	NOUN
cuesj-706	25	39	.	.	PUNCT
cuesj-706	26	1	it	it	PRON
cuesj-706	26	2	has	have	AUX
cuesj-706	26	3	historically	historically	ADV
cuesj-706	26	4	been	be	AUX
cuesj-706	26	5	known	know	VERB
cuesj-706	26	6	as	as	ADP
cuesj-706	26	7	a	a	DET
cuesj-706	26	8	hormone	hormone	NOUN
cuesj-706	26	9	that	that	PRON
cuesj-706	26	10	maintains	maintain	VERB
cuesj-706	26	11	calcium	calcium	NOUN
cuesj-706	26	12	-	-	PUNCT
cuesj-706	26	13	phosphorous	phosphorous	ADJ
cuesj-706	26	14	balance	balance	NOUN
cuesj-706	26	15	and	and	CCONJ
cuesj-706	26	16	protects	protect	VERB
cuesj-706	26	17	the	the	DET
cuesj-706	26	18	musculoskeletal	musculoskeletal	ADJ
cuesj-706	26	19	system	system	NOUN
cuesj-706	26	20	’s	’s	PART
cuesj-706	26	21	structure	structure	NOUN
cuesj-706	26	22	.	.	PUNCT
cuesj-706	27	1	vitamin	vitamin	NOUN
cuesj-706	27	2	d	d	NOUN
cuesj-706	27	3	modulates	modulate	VERB
cuesj-706	27	4	immunity	immunity	NOUN
cuesj-706	27	5	by	by	ADP
cuesj-706	27	6	transforming	transform	VERB
cuesj-706	27	7	25(oh)d	25(oh)d	NOUN
cuesj-706	27	8	(	(	PUNCT
cuesj-706	27	9	vitamin	vitamin	NOUN
cuesj-706	27	10	d	d	NOUN
cuesj-706	27	11	’s	’s	ADJ
cuesj-706	27	12	hormonallyactive	hormonallyactive	ADJ
cuesj-706	27	13	form	form	NOUN
cuesj-706	27	14	)	)	PUNCT
cuesj-706	27	15	into	into	ADP
cuesj-706	27	16	tissue	tissue	NOUN
cuesj-706	27	17	-	-	PUNCT
cuesj-706	27	18	specific	specific	ADJ
cuesj-706	27	19	,	,	PUNCT
cuesj-706	27	20	locally	locally	ADV
cuesj-706	27	21	produced	produce	VERB
cuesj-706	27	22	1,25(oh)2d	1,25(oh)2d	NUM
cuesj-706	27	23	(	(	PUNCT
cuesj-706	27	24	vitamin	vitamin	NOUN
cuesj-706	27	25	d	d	X
cuesj-706	27	26	’s	’s	PART
cuesj-706	27	27	hormonally	hormonally	ADV
cuesj-706	27	28	-	-	PUNCT
cuesj-706	27	29	active	active	ADJ
cuesj-706	27	30	component	component	NOUN
cuesj-706	27	31	)	)	PUNCT
cuesj-706	27	32	.	.	PUNCT
cuesj-706	28	1	macrophages	macrophage	NOUN
cuesj-706	28	2	,	,	PUNCT
cuesj-706	28	3	t	t	NOUN
cuesj-706	28	4	-	-	PUNCT
cuesj-706	28	5	cells	cell	NOUN
cuesj-706	28	6	,	,	PUNCT
cuesj-706	28	7	keratinocytes	keratinocyte	NOUN
cuesj-706	28	8	,	,	PUNCT
cuesj-706	28	9	and	and	CCONJ
cuesj-706	28	10	dendritic	dendritic	ADJ
cuesj-706	28	11	cells	cell	NOUN
cuesj-706	28	12	involved	involve	VERB
cuesj-706	28	13	in	in	ADP
cuesj-706	28	14	psoriasis	psoriasis	NOUN
cuesj-706	28	15	pathogenesis	pathogenesis	NOUN
cuesj-706	28	16	can	can	AUX
cuesj-706	28	17	produce	produce	VERB
cuesj-706	28	18	and	and	CCONJ
cuesj-706	28	19	respond	respond	VERB
cuesj-706	28	20	to	to	ADP
cuesj-706	28	21	1,25	1,25	NUM
cuesj-706	28	22	(	(	PUNCT
cuesj-706	28	23	oh)2d	oh)2d	NOUN
cuesj-706	28	24	in	in	ADP
cuesj-706	28	25	a	a	DET
cuesj-706	28	26	paracrine	paracrine	NOUN
cuesj-706	28	27	and	and	CCONJ
cuesj-706	28	28	autocrine	autocrine	NOUN
cuesj-706	28	29	way	way	NOUN
cuesj-706	28	30	when	when	SCONJ
cuesj-706	28	31	25	25	NUM
cuesj-706	28	32	(	(	PUNCT
cuesj-706	28	33	oh)2d	oh)2d	NOUN
cuesj-706	28	34	is	be	AUX
cuesj-706	28	35	directly	directly	ADV
cuesj-706	28	36	accessible	accessible	ADJ
cuesj-706	28	37	for	for	ADP
cuesj-706	28	38	cellular	cellular	ADJ
cuesj-706	28	39	absorption.[14	absorption.[14	PROPN
cuesj-706	28	40	]	]	PUNCT
cuesj-706	28	41	a	a	DET
cuesj-706	28	42	25(oh)d	25(oh)d	NUM
cuesj-706	28	43	level	level	NOUN
cuesj-706	28	44	of	of	ADP
cuesj-706	28	45	<	<	X
cuesj-706	28	46	20	20	NUM
cuesj-706	28	47	ng	ng	PROPN
cuesj-706	28	48	/	/	SYM
cuesj-706	28	49	mll	mll	PROPN
cuesj-706	28	50	indicates	indicate	VERB
cuesj-706	28	51	vitamin	vitamin	NOUN
cuesj-706	28	52	d	d	PROPN
cuesj-706	28	53	insufficiency.[15	insufficiency.[15	PROPN
cuesj-706	28	54	]	]	PUNCT
cuesj-706	28	55	our	our	PRON
cuesj-706	28	56	study	study	NOUN
cuesj-706	28	57	’s	’s	PART
cuesj-706	28	58	purpose	purpose	NOUN
cuesj-706	28	59	is	be	AUX
cuesj-706	28	60	to	to	PART
cuesj-706	28	61	compare	compare	VERB
cuesj-706	28	62	the	the	DET
cuesj-706	28	63	concentrations	concentration	NOUN
cuesj-706	28	64	of	of	ADP
cuesj-706	28	65	serum	serum	PROPN
cuesj-706	28	66	fgf23	fgf23	PROPN
cuesj-706	28	67	,	,	PUNCT
cuesj-706	28	68	chemerin	chemerin	NOUN
cuesj-706	28	69	,	,	PUNCT
cuesj-706	28	70	and	and	CCONJ
cuesj-706	28	71	vitamin	vitamin	NOUN
cuesj-706	28	72	d	d	NOUN
cuesj-706	28	73	in	in	ADP
cuesj-706	28	74	psoriasis	psoriasis	NOUN
cuesj-706	28	75	patients	patient	NOUN
cuesj-706	28	76	to	to	ADP
cuesj-706	28	77	those	those	PRON
cuesj-706	28	78	of	of	ADP
cuesj-706	28	79	a	a	DET
cuesj-706	28	80	healthy	healthy	ADJ
cuesj-706	28	81	population	population	NOUN
cuesj-706	28	82	of	of	ADP
cuesj-706	28	83	similar	similar	ADJ
cuesj-706	28	84	age	age	NOUN
cuesj-706	28	85	and	and	CCONJ
cuesj-706	28	86	gender	gender	NOUN
cuesj-706	28	87	.	.	PUNCT
cuesj-706	29	1	materials	material	NOUN
cuesj-706	29	2	and	and	CCONJ
cuesj-706	29	3	methods	method	NOUN
cuesj-706	29	4	patients	patient	NOUN
cuesj-706	29	5	and	and	CCONJ
cuesj-706	29	6	controls	control	VERB
cuesj-706	29	7	forty	forty	NUM
cuesj-706	29	8	-	-	PUNCT
cuesj-706	29	9	five	five	NUM
cuesj-706	29	10	patients	patient	NOUN
cuesj-706	29	11	of	of	ADP
cuesj-706	29	12	psoriasis	psoriasis	NOUN
cuesj-706	29	13	(	(	PUNCT
cuesj-706	29	14	18	18	NUM
cuesj-706	29	15	males	male	NOUN
cuesj-706	29	16	[	[	X
cuesj-706	29	17	40	40	NUM
cuesj-706	29	18	%	%	NOUN
cuesj-706	29	19	]	]	PUNCT
cuesj-706	29	20	and	and	CCONJ
cuesj-706	29	21	27	27	NUM
cuesj-706	29	22	females	female	NOUN
cuesj-706	29	23	[	[	X
cuesj-706	29	24	60	60	NUM
cuesj-706	29	25	%	%	NOUN
cuesj-706	29	26	]	]	PUNCT
cuesj-706	29	27	)	)	PUNCT
cuesj-706	29	28	with	with	ADP
cuesj-706	29	29	a	a	DET
cuesj-706	29	30	mean	mean	ADJ
cuesj-706	29	31	age	age	NOUN
cuesj-706	29	32	of	of	ADP
cuesj-706	29	33	38.6	38.6	NUM
cuesj-706	29	34	±	±	NUM
cuesj-706	29	35	11.2	11.2	NUM
cuesj-706	29	36	were	be	AUX
cuesj-706	29	37	included	include	VERB
cuesj-706	29	38	in	in	ADP
cuesj-706	29	39	the	the	DET
cuesj-706	29	40	study	study	NOUN
cuesj-706	29	41	.	.	PUNCT
cuesj-706	30	1	forty	forty	NUM
cuesj-706	30	2	-	-	PUNCT
cuesj-706	30	3	five	five	NUM
cuesj-706	30	4	ageand	ageand	NOUN
cuesj-706	30	5	sex	sex	NOUN
cuesj-706	30	6	-	-	PUNCT
cuesj-706	30	7	matched	match	VERB
cuesj-706	30	8	normal	normal	ADJ
cuesj-706	30	9	healthy	healthy	ADJ
cuesj-706	30	10	controls	control	NOUN
cuesj-706	30	11	(	(	PUNCT
cuesj-706	30	12	16	16	NUM
cuesj-706	30	13	males	male	NOUN
cuesj-706	30	14	[	[	PUNCT
cuesj-706	30	15	35.5	35.5	NUM
cuesj-706	30	16	%	%	NOUN
cuesj-706	30	17	]	]	PUNCT
cuesj-706	30	18	and	and	CCONJ
cuesj-706	30	19	29	29	NUM
cuesj-706	30	20	females	female	NOUN
cuesj-706	30	21	[	[	X
cuesj-706	30	22	64.5	64.5	NUM
cuesj-706	30	23	%	%	NOUN
cuesj-706	30	24	]	]	PUNCT
cuesj-706	30	25	)	)	PUNCT
cuesj-706	30	26	with	with	ADP
cuesj-706	30	27	a	a	DET
cuesj-706	30	28	mean	mean	ADJ
cuesj-706	30	29	age	age	NOUN
cuesj-706	30	30	of	of	ADP
cuesj-706	30	31	37.3	37.3	NUM
cuesj-706	30	32	±	±	NUM
cuesj-706	30	33	11.21	11.21	NUM
cuesj-706	30	34	year	year	NOUN
cuesj-706	30	35	as	as	SCONJ
cuesj-706	30	36	shown	show	VERB
cuesj-706	30	37	in	in	ADP
cuesj-706	30	38	table	table	NOUN
cuesj-706	30	39	1	1	NUM
cuesj-706	30	40	.	.	PUNCT
cuesj-706	31	1	patients	patient	NOUN
cuesj-706	31	2	were	be	AUX
cuesj-706	31	3	collected	collect	VERB
cuesj-706	31	4	from	from	ADP
cuesj-706	31	5	the	the	DET
cuesj-706	31	6	biochemistry	biochemistry	NOUN
cuesj-706	31	7	department	department	PROPN
cuesj-706	31	8	of	of	ADP
cuesj-706	31	9	tikrit	tikrit	PROPN
cuesj-706	31	10	teaching	teach	VERB
cuesj-706	31	11	hospital	hospital	NOUN
cuesj-706	31	12	in	in	ADP
cuesj-706	31	13	tikrit	tikrit	NOUN
cuesj-706	31	14	city	city	NOUN
cuesj-706	31	15	during	during	ADP
cuesj-706	31	16	the	the	DET
cuesj-706	31	17	period	period	NOUN
cuesj-706	31	18	from	from	ADP
cuesj-706	31	19	april	april	PROPN
cuesj-706	31	20	18	18	NUM
cuesj-706	31	21	,	,	PUNCT
cuesj-706	31	22	2021	2021	NUM
cuesj-706	31	23	,	,	PUNCT
cuesj-706	31	24	to	to	ADP
cuesj-706	31	25	january	january	PROPN
cuesj-706	31	26	17	17	NUM
cuesj-706	31	27	,	,	PUNCT
cuesj-706	31	28	2022	2022	NUM
cuesj-706	31	29	.	.	PUNCT
cuesj-706	32	1	pregnancy	pregnancy	NOUN
cuesj-706	32	2	,	,	PUNCT
cuesj-706	32	3	diabetes	diabetes	NOUN
cuesj-706	32	4	,	,	PUNCT
cuesj-706	32	5	hypertension	hypertension	NOUN
cuesj-706	32	6	,	,	PUNCT
cuesj-706	32	7	and	and	CCONJ
cuesj-706	32	8	inflammatory	inflammatory	ADJ
cuesj-706	32	9	diseases	disease	NOUN
cuesj-706	32	10	other	other	ADJ
cuesj-706	32	11	than	than	ADP
cuesj-706	32	12	psoriasis	psoriasis	NOUN
cuesj-706	32	13	comprised	comprise	VERB
cuesj-706	32	14	the	the	DET
cuesj-706	32	15	criterion	criterion	NOUN
cuesj-706	32	16	of	of	ADP
cuesj-706	32	17	exclusion	exclusion	NOUN
cuesj-706	32	18	.	.	PUNCT
cuesj-706	33	1	the	the	DET
cuesj-706	33	2	study	study	NOUN
cuesj-706	33	3	was	be	AUX
cuesj-706	33	4	authorized	authorize	VERB
cuesj-706	33	5	by	by	ADP
cuesj-706	33	6	the	the	DET
cuesj-706	33	7	local	local	ADJ
cuesj-706	33	8	ethics	ethic	NOUN
cuesj-706	33	9	committee	committee	NOUN
cuesj-706	33	10	,	,	PUNCT
cuesj-706	33	11	and	and	CCONJ
cuesj-706	33	12	all	all	DET
cuesj-706	33	13	patients	patient	NOUN
cuesj-706	33	14	and	and	CCONJ
cuesj-706	33	15	volunteers	volunteer	NOUN
cuesj-706	33	16	in	in	ADP
cuesj-706	33	17	the	the	DET
cuesj-706	33	18	control	control	NOUN
cuesj-706	33	19	group	group	NOUN
cuesj-706	33	20	gave	give	VERB
cuesj-706	33	21	their	their	PRON
cuesj-706	33	22	informed	informed	ADJ
cuesj-706	33	23	permission	permission	NOUN
cuesj-706	33	24	.	.	PUNCT
cuesj-706	34	1	measurement	measurement	NOUN
cuesj-706	34	2	of	of	ADP
cuesj-706	34	3	fgf23	fgf23	NOUN
cuesj-706	34	4	,	,	PUNCT
cuesj-706	34	5	and	and	CCONJ
cuesj-706	34	6	chemerin	chemerin	VERB
cuesj-706	34	7	in	in	ADP
cuesj-706	34	8	serum	serum	NOUN
cuesj-706	34	9	after	after	ADP
cuesj-706	34	10	an	an	DET
cuesj-706	34	11	overnight	overnight	ADJ
cuesj-706	34	12	fast	fast	ADV
cuesj-706	34	13	,	,	PUNCT
cuesj-706	34	14	blood	blood	NOUN
cuesj-706	34	15	was	be	AUX
cuesj-706	34	16	drawn	draw	VERB
cuesj-706	34	17	from	from	ADP
cuesj-706	34	18	patients	patient	NOUN
cuesj-706	34	19	and	and	CCONJ
cuesj-706	34	20	controls	control	NOUN
cuesj-706	34	21	.	.	PUNCT
cuesj-706	35	1	after	after	ADP
cuesj-706	35	2	clotting	clotting	NOUN
cuesj-706	35	3	,	,	PUNCT
cuesj-706	35	4	serum	serum	NOUN
cuesj-706	35	5	was	be	AUX
cuesj-706	35	6	extracted	extract	VERB
cuesj-706	35	7	and	and	CCONJ
cuesj-706	35	8	kept	keep	VERB
cuesj-706	35	9	in	in	ADP
cuesj-706	35	10	aliquots	aliquot	NOUN
cuesj-706	35	11	at	at	ADP
cuesj-706	35	12	−70	−70	NOUN
cuesj-706	35	13	°	°	NOUN
cuesj-706	35	14	c	c	NOUN
cuesj-706	35	15	until	until	SCONJ
cuesj-706	35	16	needed	need	VERB
cuesj-706	35	17	.	.	PUNCT
cuesj-706	36	1	the	the	DET
cuesj-706	36	2	enzyme	enzyme	NOUN
cuesj-706	36	3	-	-	PUNCT
cuesj-706	36	4	linked	link	VERB
cuesj-706	36	5	immunosorbent	immunosorbent	NOUN
cuesj-706	36	6	assay	assay	NOUN
cuesj-706	36	7	was	be	AUX
cuesj-706	36	8	used	use	VERB
cuesj-706	36	9	to	to	PART
cuesj-706	36	10	assess	assess	VERB
cuesj-706	36	11	fgf23	fgf23	NOUN
cuesj-706	36	12	and	and	CCONJ
cuesj-706	36	13	chemerin	chemerin	NOUN
cuesj-706	36	14	(	(	PUNCT
cuesj-706	36	15	mybiosource	mybiosource	PROPN
cuesj-706	36	16	,	,	PUNCT
cuesj-706	36	17	usa	usa	PROPN
cuesj-706	36	18	)	)	PUNCT
cuesj-706	36	19	.	.	PUNCT
cuesj-706	37	1	statistical	statistical	ADJ
cuesj-706	37	2	analysis	analysis	NOUN
cuesj-706	37	3	statistical	statistical	ADJ
cuesj-706	37	4	analysis	analysis	NOUN
cuesj-706	37	5	was	be	AUX
cuesj-706	37	6	done	do	VERB
cuesj-706	37	7	using	use	VERB
cuesj-706	37	8	t	t	NOUN
cuesj-706	37	9	-	-	PUNCT
cuesj-706	37	10	test	test	NOUN
cuesj-706	37	11	.	.	PUNCT
cuesj-706	38	1	correlation	correlation	NOUN
cuesj-706	38	2	between	between	ADP
cuesj-706	38	3	continuous	continuous	ADJ
cuesj-706	38	4	variables	variable	NOUN
cuesj-706	38	5	was	be	AUX
cuesj-706	38	6	estimated	estimate	VERB
cuesj-706	38	7	by	by	ADP
cuesj-706	38	8	pearson	pearson	PROPN
cuesj-706	38	9	’s	’s	PART
cuesj-706	38	10	correlation	correlation	NOUN
cuesj-706	38	11	coefficients	coefficient	NOUN
cuesj-706	38	12	.	.	PUNCT
cuesj-706	39	1	a	a	DET
cuesj-706	39	2	value	value	NOUN
cuesj-706	39	3	of	of	ADP
cuesj-706	39	4	p	p	NOUN
cuesj-706	39	5	<	<	X
cuesj-706	39	6	0.05	0.05	NUM
cuesj-706	39	7	was	be	AUX
cuesj-706	39	8	considered	consider	VERB
cuesj-706	39	9	statistically	statistically	ADV
cuesj-706	39	10	significant	significant	ADJ
cuesj-706	39	11	for	for	ADP
cuesj-706	39	12	each	each	DET
cuesj-706	39	13	test	test	NOUN
cuesj-706	39	14	.	.	PUNCT
cuesj-706	40	1	results	result	VERB
cuesj-706	40	2	the	the	DET
cuesj-706	40	3	study	study	NOUN
cuesj-706	40	4	revealed	reveal	VERB
cuesj-706	40	5	that	that	SCONJ
cuesj-706	40	6	,	,	PUNCT
cuesj-706	40	7	in	in	ADP
cuesj-706	40	8	comparison	comparison	NOUN
cuesj-706	40	9	to	to	ADP
cuesj-706	40	10	the	the	DET
cuesj-706	40	11	healthy	healthy	ADJ
cuesj-706	40	12	control	control	NOUN
cuesj-706	40	13	group	group	NOUN
cuesj-706	40	14	,	,	PUNCT
cuesj-706	40	15	psoriatic	psoriatic	ADJ
cuesj-706	40	16	cases	case	NOUN
cuesj-706	40	17	had	have	VERB
cuesj-706	40	18	the	the	DET
cuesj-706	40	19	highest	high	ADJ
cuesj-706	40	20	mean	mean	NOUN
cuesj-706	40	21	of	of	ADP
cuesj-706	40	22	fgf23	fgf23	NOUN
cuesj-706	40	23	enzyme	enzyme	NOUN
cuesj-706	40	24	level	level	NOUN
cuesj-706	40	25	(	(	PUNCT
cuesj-706	40	26	109	109	NUM
cuesj-706	40	27	93	93	NUM
cuesj-706	40	28	pg	pg	NOUN
cuesj-706	40	29	/	/	SYM
cuesj-706	40	30	ml	ml	VERB
cuesj-706	40	31	)	)	PUNCT
cuesj-706	40	32	.	.	PUNCT
cuesj-706	41	1	as	as	SCONJ
cuesj-706	41	2	demonstrated	demonstrate	VERB
cuesj-706	41	3	in	in	ADP
cuesj-706	41	4	figure	figure	NOUN
cuesj-706	41	5	1	1	NUM
cuesj-706	41	6	and	and	CCONJ
cuesj-706	41	7	table	table	NOUN
cuesj-706	41	8	2	2	NUM
cuesj-706	41	9	,	,	PUNCT
cuesj-706	41	10	the	the	DET
cuesj-706	41	11	difference	difference	NOUN
cuesj-706	41	12	was	be	AUX
cuesj-706	41	13	extremely	extremely	ADV
cuesj-706	41	14	significant	significant	ADJ
cuesj-706	41	15	(	(	PUNCT
cuesj-706	41	16	p	p	X
cuesj-706	41	17	=	=	NOUN
cuesj-706	41	18	0.0001	0.0001	NUM
cuesj-706	41	19	)	)	PUNCT
cuesj-706	41	20	.	.	PUNCT
cuesj-706	42	1	the	the	DET
cuesj-706	42	2	study	study	NOUN
cuesj-706	42	3	showed	show	VERB
cuesj-706	42	4	that	that	SCONJ
cuesj-706	42	5	psoriatic	psoriatic	ADJ
cuesj-706	42	6	patients	patient	NOUN
cuesj-706	42	7	had	have	VERB
cuesj-706	42	8	a	a	DET
cuesj-706	42	9	greater	great	ADJ
cuesj-706	42	10	mean	mean	NOUN
cuesj-706	42	11	of	of	ADP
cuesj-706	42	12	serum	serum	NOUN
cuesj-706	42	13	chemerin	chemerin	NOUN
cuesj-706	42	14	(	(	PUNCT
cuesj-706	42	15	328.6	328.6	NUM
cuesj-706	42	16	25.2	25.2	NUM
cuesj-706	42	17	ng	ng	NOUN
cuesj-706	42	18	/	/	SYM
cuesj-706	42	19	ml	ml	NOUN
cuesj-706	42	20	)	)	PUNCT
cuesj-706	42	21	than	than	ADP
cuesj-706	42	22	the	the	DET
cuesj-706	42	23	healthy	healthy	ADJ
cuesj-706	42	24	control	control	NOUN
cuesj-706	42	25	group	group	NOUN
cuesj-706	42	26	,	,	PUNCT
cuesj-706	42	27	(	(	PUNCT
cuesj-706	42	28	229.1	229.1	NUM
cuesj-706	42	29	±	±	NUM
cuesj-706	42	30	15.4	15.4	NUM
cuesj-706	42	31	ng	ng	NOUN
cuesj-706	42	32	/	/	SYM
cuesj-706	42	33	ml	ml	NOUN
cuesj-706	43	1	according	accord	VERB
cuesj-706	43	2	to	to	ADP
cuesj-706	43	3	the	the	DET
cuesj-706	43	4	research	research	NOUN
cuesj-706	43	5	)	)	PUNCT
cuesj-706	43	6	.	.	PUNCT
cuesj-706	44	1	while	while	SCONJ
cuesj-706	44	2	s.	s.	PROPN
cuesj-706	44	3	vitamin	vitamin	PROPN
cuesj-706	44	4	d	d	PROPN
cuesj-706	44	5	(	(	PUNCT
cuesj-706	44	6	21.68	21.68	NUM
cuesj-706	44	7	±	±	NUM
cuesj-706	44	8	1.79	1.79	NUM
cuesj-706	44	9	ng	ng	PROPN
cuesj-706	44	10	/	/	SYM
cuesj-706	44	11	ml	ml	PROPN
cuesj-706	44	12	)	)	PUNCT
cuesj-706	44	13	was	be	AUX
cuesj-706	44	14	significantly	significantly	ADV
cuesj-706	44	15	reduced	reduce	VERB
cuesj-706	44	16	in	in	ADP
cuesj-706	44	17	psoriatic	psoriatic	ADJ
cuesj-706	44	18	patients	patient	NOUN
cuesj-706	44	19	(	(	PUNCT
cuesj-706	44	20	45.19	45.19	NUM
cuesj-706	44	21	±	±	NUM
cuesj-706	44	22	4.31	4.31	NUM
cuesj-706	44	23	pg	pg	NOUN
cuesj-706	44	24	/	/	SYM
cuesj-706	44	25	ml	ml	VERB
cuesj-706	44	26	)	)	PUNCT
cuesj-706	44	27	comparing	compare	VERB
cuesj-706	44	28	with	with	ADP
cuesj-706	44	29	the	the	DET
cuesj-706	44	30	control	control	NOUN
cuesj-706	44	31	group	group	NOUN
cuesj-706	44	32	(	(	PUNCT
cuesj-706	44	33	29.92	29.92	NUM
cuesj-706	44	34	±	±	NUM
cuesj-706	44	35	1.55	1.55	NUM
cuesj-706	44	36	ng	ng	PROPN
cuesj-706	44	37	/	/	SYM
cuesj-706	44	38	ml	ml	NOUN
cuesj-706	44	39	)	)	PUNCT
cuesj-706	44	40	.	.	PUNCT
cuesj-706	45	1	furthermore	furthermore	ADV
cuesj-706	45	2	,	,	PUNCT
cuesj-706	45	3	parathyroid	parathyroid	ADJ
cuesj-706	45	4	hormone	hormone	NOUN
cuesj-706	45	5	(	(	PUNCT
cuesj-706	45	6	pth	pth	NOUN
cuesj-706	45	7	)	)	PUNCT
cuesj-706	45	8	was	be	AUX
cuesj-706	45	9	significantly	significantly	ADV
cuesj-706	45	10	higher	high	ADJ
cuesj-706	45	11	among	among	ADP
cuesj-706	45	12	patients	patient	NOUN
cuesj-706	45	13	’	'	PUNCT
cuesj-706	45	14	group	group	NOUN
cuesj-706	45	15	(	(	PUNCT
cuesj-706	45	16	45.19	45.19	NUM
cuesj-706	45	17	±	±	NUM
cuesj-706	45	18	4.31	4.31	NUM
cuesj-706	45	19	pg	pg	NOUN
cuesj-706	45	20	/	/	SYM
cuesj-706	45	21	ml	ml	VERB
cuesj-706	45	22	)	)	PUNCT
cuesj-706	45	23	compared	compare	VERB
cuesj-706	45	24	to	to	ADP
cuesj-706	45	25	the	the	DET
cuesj-706	45	26	control	control	NOUN
cuesj-706	45	27	group	group	NOUN
cuesj-706	45	28	(	(	PUNCT
cuesj-706	45	29	20.78	20.78	NUM
cuesj-706	45	30	±	±	NUM
cuesj-706	45	31	1.50	1.50	NUM
cuesj-706	45	32	pg	pg	NOUN
cuesj-706	45	33	/	/	SYM
cuesj-706	45	34	ml).as	ml).as	NOUN
cuesj-706	45	35	shown	show	VERB
cuesj-706	45	36	in	in	ADP
cuesj-706	45	37	figures	figure	NOUN
cuesj-706	45	38	1	1	NUM
cuesj-706	45	39	-	-	SYM
cuesj-706	45	40	4	4	NUM
cuesj-706	45	41	and	and	CCONJ
cuesj-706	45	42	table	table	NOUN
cuesj-706	45	43	2	2	NUM
cuesj-706	45	44	.	.	PUNCT
cuesj-706	45	45	discussion	discussion	NOUN
cuesj-706	45	46	the	the	DET
cuesj-706	45	47	kidneys	kidney	NOUN
cuesj-706	45	48	maintain	maintain	VERB
cuesj-706	45	49	phosphorus	phosphorus	NOUN
cuesj-706	45	50	homeostasis	homeostasis	NOUN
cuesj-706	45	51	in	in	ADP
cuesj-706	45	52	healthy	healthy	ADJ
cuesj-706	45	53	humans	human	NOUN
cuesj-706	45	54	by	by	ADP
cuesj-706	45	55	proximal	proximal	ADJ
cuesj-706	45	56	tubular	tubular	ADJ
cuesj-706	45	57	active	active	ADJ
cuesj-706	45	58	absorption	absorption	NOUN
cuesj-706	45	59	or	or	CCONJ
cuesj-706	45	60	filtered	filter	VERB
cuesj-706	45	61	phosphorus	phosphorus	NOUN
cuesj-706	45	62	pass	pass	NOUN
cuesj-706	45	63	-	-	PUNCT
cuesj-706	45	64	through	through	NOUN
cuesj-706	45	65	.	.	PUNCT
cuesj-706	46	1	25	25	NUM
cuesj-706	46	2	-	-	PUNCT
cuesj-706	46	3	dihydroxyvitamin	dihydroxyvitamin	NOUN
cuesj-706	46	4	d	d	NOUN
cuesj-706	46	5	(	(	PUNCT
cuesj-706	46	6	1,25	1,25	X
cuesj-706	46	7	(	(	PUNCT
cuesj-706	46	8	oh)2d	oh)2d	NOUN
cuesj-706	46	9	,	,	PUNCT
cuesj-706	46	10	parathyroid	parathyroid	ADJ
cuesj-706	46	11	hormone	hormone	NOUN
cuesj-706	46	12	and	and	CCONJ
cuesj-706	46	13	fibroblast	fibroblast	ADJ
cuesj-706	46	14	growth	growth	NOUN
cuesj-706	46	15	factor-231	factor-231	NOUN
cuesj-706	46	16	are	be	AUX
cuesj-706	46	17	hormones	hormone	NOUN
cuesj-706	46	18	and	and	CCONJ
cuesj-706	46	19	factors	factor	NOUN
cuesj-706	46	20	that	that	PRON
cuesj-706	46	21	help	help	VERB
cuesj-706	46	22	kidneys	kidney	NOUN
cuesj-706	46	23	regulate	regulate	VERB
cuesj-706	46	24	phosphorus	phosphorus	NOUN
cuesj-706	46	25	(	(	PUNCT
cuesj-706	46	26	fgf-23).[16	fgf-23).[16	PROPN
cuesj-706	46	27	]	]	X
cuesj-706	46	28	the	the	DET
cuesj-706	46	29	parathyroid	parathyroid	PROPN
cuesj-706	46	30	gland	gland	NOUN
cuesj-706	46	31	’s	’s	PART
cuesj-706	46	32	main	main	ADJ
cuesj-706	46	33	cells	cell	NOUN
cuesj-706	46	34	table	table	NOUN
cuesj-706	46	35	1	1	NUM
cuesj-706	46	36	:	:	PUNCT
cuesj-706	46	37	demographic	demographic	ADJ
cuesj-706	46	38	characteristics	characteristic	NOUN
cuesj-706	46	39	of	of	ADP
cuesj-706	46	40	patients	patient	NOUN
cuesj-706	46	41	(	(	PUNCT
cuesj-706	46	42	n=45	n=45	NOUN
cuesj-706	46	43	)	)	PUNCT
cuesj-706	46	44	and	and	CCONJ
cuesj-706	46	45	controls	control	NOUN
cuesj-706	46	46	(	(	PUNCT
cuesj-706	46	47	n=45	n=45	NOUN
cuesj-706	46	48	)	)	PUNCT
cuesj-706	46	49	patients	patient	NOUN
cuesj-706	46	50	control	control	VERB
cuesj-706	46	51	age	age	NOUN
cuesj-706	46	52	38.6±11.2	38.6±11.2	NUM
cuesj-706	46	53	37.3±11.21	37.3±11.21	NUM
cuesj-706	46	54	gender	gender	NOUN
cuesj-706	46	55	male	male	NOUN
cuesj-706	46	56	18	18	NUM
cuesj-706	46	57	16	16	NUM
cuesj-706	46	58	female	female	ADJ
cuesj-706	46	59	27	27	NUM
cuesj-706	46	60	29	29	NUM
cuesj-706	46	61	figure	figure	NOUN
cuesj-706	46	62	1	1	NUM
cuesj-706	46	63	:	:	PUNCT
cuesj-706	46	64	serum	serum	VERB
cuesj-706	46	65	pgf23	pgf23	PROPN
cuesj-706	46	66	in	in	ADP
cuesj-706	46	67	patients	patient	NOUN
cuesj-706	46	68	with	with	ADP
cuesj-706	46	69	psoriasis	psoriasis	NOUN
cuesj-706	46	70	and	and	CCONJ
cuesj-706	46	71	the	the	DET
cuesj-706	46	72	controls	control	NOUN
cuesj-706	46	73	figure	figure	NOUN
cuesj-706	46	74	2	2	NUM
cuesj-706	46	75	:	:	PUNCT
cuesj-706	46	76	serum	serum	NOUN
cuesj-706	46	77	chemerin	chemerin	NOUN
cuesj-706	46	78	in	in	ADP
cuesj-706	46	79	patients	patient	NOUN
cuesj-706	46	80	with	with	ADP
cuesj-706	46	81	psoriasis	psoriasis	NOUN
cuesj-706	46	82	and	and	CCONJ
cuesj-706	46	83	the	the	DET
cuesj-706	46	84	controls	control	NOUN
cuesj-706	46	85	tawfeeq	tawfeeq	ADJ
cuesj-706	46	86	,	,	PUNCT
cuesj-706	46	87	et	et	PROPN
cuesj-706	46	88	al	al	PROPN
cuesj-706	46	89	.	.	PUNCT
cuesj-706	46	90	:	:	PUNCT
cuesj-706	47	1	role	role	NOUN
cuesj-706	47	2	of	of	ADP
cuesj-706	47	3	fibroblast	fibroblast	ADJ
cuesj-706	47	4	growth	growth	NOUN
cuesj-706	47	5	factors	factor	NOUN
cuesj-706	47	6	23	23	NUM
cuesj-706	47	7	,	,	PUNCT
cuesj-706	47	8	chemerin	chemerin	NOUN
cuesj-706	47	9	,	,	PUNCT
cuesj-706	47	10	and	and	CCONJ
cuesj-706	47	11	vitamin	vitamin	NOUN
cuesj-706	47	12	d	d	NOUN
cuesj-706	47	13	in	in	ADP
cuesj-706	47	14	psoriasis	psoriasis	NOUN
cuesj-706	47	15	59	59	NUM
cuesj-706	47	16	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-706	47	17	cuesj	cuesj	ADJ
cuesj-706	47	18	2022	2022	NUM
cuesj-706	47	19	,	,	PUNCT
cuesj-706	47	20	6	6	NUM
cuesj-706	47	21	(	(	PUNCT
cuesj-706	47	22	2	2	NUM
cuesj-706	47	23	):	):	PUNCT
cuesj-706	47	24	57	57	NUM
cuesj-706	47	25	-	-	SYM
cuesj-706	47	26	61	61	NUM
cuesj-706	47	27	manufacture	manufacture	NOUN
cuesj-706	47	28	and	and	CCONJ
cuesj-706	47	29	emit	emit	NOUN
cuesj-706	47	30	pth	pth	NOUN
cuesj-706	47	31	.	.	PUNCT
cuesj-706	47	32	pth	pth	NOUN
cuesj-706	47	33	is	be	AUX
cuesj-706	47	34	a	a	DET
cuesj-706	47	35	hormone	hormone	NOUN
cuesj-706	47	36	made	make	VERB
cuesj-706	47	37	up	up	ADP
cuesj-706	47	38	of	of	ADP
cuesj-706	47	39	peptides	peptide	NOUN
cuesj-706	47	40	,	,	PUNCT
cuesj-706	47	41	released	release	VERB
cuesj-706	47	42	as	as	ADP
cuesj-706	47	43	a	a	DET
cuesj-706	47	44	115	115	NUM
cuesj-706	47	45	-	-	PUNCT
cuesj-706	47	46	amino	amino	NOUN
cuesj-706	47	47	-	-	PUNCT
cuesj-706	47	48	acid	acid	NOUN
cuesj-706	48	1	long	long	ADJ
cuesj-706	48	2	pre	pre	ADJ
cuesj-706	48	3	-	-	ADJ
cuesj-706	48	4	pro	pro	ADJ
cuesj-706	48	5	-	-	ADJ
cuesj-706	48	6	pth	pth	NOUN
cuesj-706	48	7	at	at	ADP
cuesj-706	48	8	first	first	ADV
cuesj-706	48	9	.	.	PUNCT
cuesj-706	49	1	then	then	ADV
cuesj-706	49	2	,	,	PUNCT
cuesj-706	49	3	it	it	PRON
cuesj-706	49	4	turns	turn	VERB
cuesj-706	49	5	into	into	ADP
cuesj-706	49	6	about	about	ADV
cuesj-706	49	7	84	84	NUM
cuesj-706	49	8	amino	amino	ADJ
cuesj-706	49	9	acids	acid	NOUN
cuesj-706	49	10	when	when	SCONJ
cuesj-706	49	11	pre	pre	ADJ
cuesj-706	49	12	-	-	ADJ
cuesj-706	49	13	propth	propth	ADJ
cuesj-706	49	14	is	be	AUX
cuesj-706	49	15	degraded	degrade	VERB
cuesj-706	49	16	twice.[17	twice.[17	PROPN
cuesj-706	49	17	]	]	PUNCT
cuesj-706	49	18	pth	pth	NOUN
cuesj-706	49	19	is	be	AUX
cuesj-706	49	20	a	a	DET
cuesj-706	49	21	critical	critical	ADJ
cuesj-706	49	22	regulator	regulator	NOUN
cuesj-706	49	23	of	of	ADP
cuesj-706	49	24	bone	bone	NOUN
cuesj-706	49	25	and	and	CCONJ
cuesj-706	49	26	mineral	mineral	NOUN
cuesj-706	49	27	metabolic	metabolic	NOUN
cuesj-706	49	28	process	process	NOUN
cuesj-706	49	29	,	,	PUNCT
cuesj-706	49	30	and	and	CCONJ
cuesj-706	49	31	its	its	PRON
cuesj-706	49	32	biosynthesis	biosynthesis	NOUN
cuesj-706	49	33	is	be	AUX
cuesj-706	49	34	influenced	influence	VERB
cuesj-706	49	35	by	by	ADP
cuesj-706	49	36	changes	change	NOUN
cuesj-706	49	37	in	in	ADP
cuesj-706	49	38	blood	blood	NOUN
cuesj-706	49	39	calcium	calcium	NOUN
cuesj-706	49	40	levels	level	NOUN
cuesj-706	49	41	,	,	PUNCT
cuesj-706	49	42	which	which	PRON
cuesj-706	49	43	trigger	trigger	NOUN
cuesj-706	49	44	responses	response	NOUN
cuesj-706	49	45	in	in	ADP
cuesj-706	49	46	several	several	ADJ
cuesj-706	49	47	pathways.[18	pathways.[18	PROPN
cuesj-706	49	48	]	]	PUNCT
cuesj-706	49	49	pth	pth	NOUN
cuesj-706	49	50	levels	level	NOUN
cuesj-706	49	51	in	in	ADP
cuesj-706	49	52	relation	relation	NOUN
cuesj-706	49	53	to	to	ADP
cuesj-706	49	54	25(oh)d	25(oh)d	NUM
cuesj-706	49	55	levels	level	NOUN
cuesj-706	49	56	are	be	AUX
cuesj-706	49	57	often	often	ADV
cuesj-706	49	58	used	use	VERB
cuesj-706	49	59	to	to	PART
cuesj-706	49	60	determine	determine	VERB
cuesj-706	49	61	vitamin	vitamin	NOUN
cuesj-706	49	62	d	d	NOUN
cuesj-706	49	63	insufficiency	insufficiency	NOUN
cuesj-706	49	64	levels	level	NOUN
cuesj-706	49	65	.	.	PUNCT
cuesj-706	50	1	vitamin	vitamin	NOUN
cuesj-706	50	2	d	d	PROPN
cuesj-706	50	3	insufficiency	insufficiency	NOUN
cuesj-706	50	4	appears	appear	VERB
cuesj-706	50	5	to	to	PART
cuesj-706	50	6	lower	lower	VERB
cuesj-706	50	7	serum	serum	NOUN
cuesj-706	50	8	calcium	calcium	NOUN
cuesj-706	50	9	levels	level	NOUN
cuesj-706	50	10	,	,	PUNCT
cuesj-706	50	11	resulting	result	VERB
cuesj-706	50	12	in	in	ADP
cuesj-706	50	13	elevated	elevated	ADJ
cuesj-706	50	14	pth	pth	NOUN
cuesj-706	50	15	levels	level	NOUN
cuesj-706	50	16	.	.	PUNCT
cuesj-706	51	1	vitamin	vitamin	NOUN
cuesj-706	51	2	d	d	NOUN
cuesj-706	51	3	is	be	AUX
cuesj-706	51	4	required	require	VERB
cuesj-706	51	5	for	for	ADP
cuesj-706	51	6	calcium	calcium	NOUN
cuesj-706	51	7	absorption	absorption	NOUN
cuesj-706	51	8	in	in	ADP
cuesj-706	51	9	the	the	DET
cuesj-706	51	10	intestines	intestine	NOUN
cuesj-706	51	11	in	in	ADP
cuesj-706	51	12	humans	human	NOUN
cuesj-706	51	13	.	.	PUNCT
cuesj-706	52	1	furthermore	furthermore	ADV
cuesj-706	52	2	,	,	PUNCT
cuesj-706	52	3	the	the	DET
cuesj-706	52	4	25(oh)d	25(oh)d	NUM
cuesj-706	52	5	concentration	concentration	NOUN
cuesj-706	52	6	,	,	PUNCT
cuesj-706	52	7	which	which	PRON
cuesj-706	52	8	begins	begin	VERB
cuesj-706	52	9	to	to	PART
cuesj-706	52	10	climb	climb	VERB
cuesj-706	52	11	or	or	CCONJ
cuesj-706	52	12	no	no	ADV
cuesj-706	52	13	longer	long	ADV
cuesj-706	52	14	falls	fall	VERB
cuesj-706	52	15	as	as	ADP
cuesj-706	52	16	the	the	DET
cuesj-706	52	17	pth	pth	NOUN
cuesj-706	52	18	concentration	concentration	NOUN
cuesj-706	52	19	lowers	lower	NOUN
cuesj-706	52	20	,	,	PUNCT
cuesj-706	52	21	may	may	AUX
cuesj-706	52	22	indicate	indicate	VERB
cuesj-706	52	23	vitamin	vitamin	NOUN
cuesj-706	52	24	d	d	NOUN
cuesj-706	52	25	inadequacy.[19	inadequacy.[19	NOUN
cuesj-706	52	26	]	]	PUNCT
cuesj-706	52	27	pth	pth	NOUN
cuesj-706	52	28	is	be	AUX
cuesj-706	52	29	elevated	elevate	VERB
cuesj-706	52	30	when	when	SCONJ
cuesj-706	52	31	calcium	calcium	NOUN
cuesj-706	52	32	levels	level	NOUN
cuesj-706	52	33	are	be	AUX
cuesj-706	52	34	low	low	ADJ
cuesj-706	52	35	,	,	PUNCT
cuesj-706	52	36	or	or	CCONJ
cuesj-706	52	37	phosphate	phosphate	NOUN
cuesj-706	52	38	levels	level	NOUN
cuesj-706	52	39	are	be	AUX
cuesj-706	52	40	high	high	ADJ
cuesj-706	52	41	.	.	PUNCT
cuesj-706	53	1	high	high	ADJ
cuesj-706	53	2	levels	level	NOUN
cuesj-706	53	3	of	of	ADP
cuesj-706	53	4	parathyroid	parathyroid	ADJ
cuesj-706	53	5	hormone	hormone	NOUN
cuesj-706	53	6	damage	damage	NOUN
cuesj-706	53	7	bones	bone	NOUN
cuesj-706	53	8	and	and	CCONJ
cuesj-706	53	9	cause	cause	VERB
cuesj-706	53	10	phosphate	phosphate	ADJ
cuesj-706	53	11	and	and	CCONJ
cuesj-706	53	12	calcium	calcium	NOUN
cuesj-706	53	13	levels	level	NOUN
cuesj-706	53	14	in	in	ADP
cuesj-706	53	15	the	the	DET
cuesj-706	53	16	bones	bone	NOUN
cuesj-706	53	17	to	to	ADP
cuesj-706	53	18	fluctuate.[9	fluctuate.[9	NOUN
cuesj-706	53	19	]	]	X
cuesj-706	53	20	pth	pth	NOUN
cuesj-706	53	21	-	-	NOUN
cuesj-706	53	22	rp	rp	NOUN
cuesj-706	53	23	is	be	AUX
cuesj-706	53	24	only	only	ADV
cuesj-706	53	25	found	find	VERB
cuesj-706	53	26	typical	typical	ADJ
cuesj-706	53	27	skin	skin	NOUN
cuesj-706	53	28	’s	’s	PART
cuesj-706	53	29	basal	basal	ADJ
cuesj-706	53	30	lamina	lamina	NOUN
cuesj-706	53	31	and	and	CCONJ
cuesj-706	53	32	acts	act	VERB
cuesj-706	53	33	as	as	ADP
cuesj-706	53	34	a	a	DET
cuesj-706	53	35	powerful	powerful	ADJ
cuesj-706	53	36	epidermal	epidermal	ADJ
cuesj-706	53	37	cell	cell	NOUN
cuesj-706	53	38	proliferation	proliferation	NOUN
cuesj-706	53	39	inhibitor	inhibitor	NOUN
cuesj-706	53	40	.	.	PUNCT
cuesj-706	54	1	pth	pth	NOUN
cuesj-706	54	2	-	-	NOUN
cuesj-706	54	3	rp	rp	NOUN
cuesj-706	54	4	is	be	AUX
cuesj-706	54	5	prevalent	prevalent	ADJ
cuesj-706	54	6	in	in	ADP
cuesj-706	54	7	keratinocytes	keratinocyte	NOUN
cuesj-706	54	8	,	,	PUNCT
cuesj-706	54	9	and	and	CCONJ
cuesj-706	54	10	1,25	1,25	NUM
cuesj-706	54	11	(	(	PUNCT
cuesj-706	54	12	oh)2	oh)2	PROPN
cuesj-706	54	13	d3	d3	PROPN
cuesj-706	54	14	regulates	regulate	VERB
cuesj-706	54	15	it.[20	it.[20	NOUN
cuesj-706	54	16	]	]	PUNCT
cuesj-706	54	17	in	in	ADP
cuesj-706	54	18	psoriatic	psoriatic	ADJ
cuesj-706	54	19	lesions	lesion	NOUN
cuesj-706	54	20	,	,	PUNCT
cuesj-706	54	21	pth	pth	NOUN
cuesj-706	54	22	is	be	AUX
cuesj-706	54	23	not	not	PART
cuesj-706	54	24	present	present	ADJ
cuesj-706	54	25	.	.	PUNCT
cuesj-706	55	1	pth	pth	NOUN
cuesj-706	55	2	-	-	PUNCT
cuesj-706	55	3	rp	rp	NOUN
cuesj-706	55	4	expression	expression	NOUN
cuesj-706	55	5	was	be	AUX
cuesj-706	55	6	recovered	recover	VERB
cuesj-706	55	7	in	in	ADP
cuesj-706	55	8	psoriatic	psoriatic	ADJ
cuesj-706	55	9	skin	skin	NOUN
cuesj-706	55	10	when	when	SCONJ
cuesj-706	55	11	lesions	lesion	NOUN
cuesj-706	55	12	were	be	AUX
cuesj-706	55	13	medicated	medicate	VERB
cuesj-706	55	14	with	with	ADP
cuesj-706	55	15	1,25	1,25	NUM
cuesj-706	55	16	(	(	PUNCT
cuesj-706	55	17	oh)2d3	oh)2d3	PROPN
cuesj-706	55	18	.	.	PROPN
cuesj-706	56	1	inflammation	inflammation	NOUN
cuesj-706	56	2	is	be	AUX
cuesj-706	56	3	one	one	NUM
cuesj-706	56	4	of	of	ADP
cuesj-706	56	5	the	the	DET
cuesj-706	56	6	main	main	ADJ
cuesj-706	56	7	causes	cause	NOUN
cuesj-706	56	8	that	that	PRON
cuesj-706	56	9	leads	lead	VERB
cuesj-706	56	10	to	to	ADP
cuesj-706	56	11	an	an	DET
cuesj-706	56	12	increase	increase	NOUN
cuesj-706	56	13	in	in	ADP
cuesj-706	56	14	fgf23	fgf23	NOUN
cuesj-706	56	15	transcription	transcription	NOUN
cuesj-706	56	16	.	.	PUNCT
cuesj-706	57	1	nuclear	nuclear	ADJ
cuesj-706	57	2	factor	factor	NOUN
cuesj-706	57	3	-	-	PUNCT
cuesj-706	57	4	kb	kb	PROPN
cuesj-706	57	5	,	,	PUNCT
cuesj-706	57	6	a	a	DET
cuesj-706	57	7	critical	critical	ADJ
cuesj-706	57	8	component	component	NOUN
cuesj-706	57	9	of	of	ADP
cuesj-706	57	10	the	the	DET
cuesj-706	57	11	inflammatory	inflammatory	ADJ
cuesj-706	57	12	signaling	signal	VERB
cuesj-706	57	13	pathway	pathway	NOUN
cuesj-706	57	14	,	,	PUNCT
cuesj-706	57	15	affects	affect	VERB
cuesj-706	57	16	the	the	DET
cuesj-706	57	17	expression	expression	NOUN
cuesj-706	57	18	of	of	ADP
cuesj-706	57	19	target	target	NOUN
cuesj-706	57	20	genes	gene	NOUN
cuesj-706	57	21	,	,	PUNCT
cuesj-706	57	22	including	include	VERB
cuesj-706	57	23	fgf23	fgf23	NOUN
cuesj-706	57	24	,	,	PUNCT
cuesj-706	57	25	through	through	ADP
cuesj-706	57	26	transcriptional	transcriptional	ADJ
cuesj-706	57	27	regulation	regulation	NOUN
cuesj-706	57	28	.	.	PUNCT
cuesj-706	58	1	nfat	nfat	NOUN
cuesj-706	58	2	was	be	AUX
cuesj-706	58	3	first	first	ADV
cuesj-706	58	4	discovered	discover	VERB
cuesj-706	58	5	as	as	ADP
cuesj-706	58	6	a	a	DET
cuesj-706	58	7	nuclear	nuclear	ADJ
cuesj-706	58	8	factor	factor	NOUN
cuesj-706	58	9	that	that	PRON
cuesj-706	58	10	can	can	AUX
cuesj-706	58	11	bind	bind	VERB
cuesj-706	58	12	to	to	ADP
cuesj-706	58	13	the	the	DET
cuesj-706	58	14	interleukin-2	interleukin-2	NUM
cuesj-706	58	15	promoter	promoter	NOUN
cuesj-706	58	16	in	in	ADP
cuesj-706	58	17	activated	activate	VERB
cuesj-706	58	18	t	t	NOUN
cuesj-706	58	19	cells	cell	NOUN
cuesj-706	58	20	.	.	PUNCT
cuesj-706	59	1	nfat	nfat	PROPN
cuesj-706	59	2	also	also	ADV
cuesj-706	59	3	has	have	VERB
cuesj-706	59	4	a	a	DET
cuesj-706	59	5	role	role	NOUN
cuesj-706	59	6	in	in	ADP
cuesj-706	59	7	innate	innate	ADJ
cuesj-706	59	8	immunological	immunological	ADJ
cuesj-706	59	9	and	and	CCONJ
cuesj-706	59	10	inflammatory	inflammatory	ADJ
cuesj-706	59	11	responses	response	NOUN
cuesj-706	59	12	,	,	PUNCT
cuesj-706	59	13	according	accord	VERB
cuesj-706	59	14	to	to	ADP
cuesj-706	59	15	research.[21	research.[21	PROPN
cuesj-706	59	16	-	-	PUNCT
cuesj-706	59	17	23	23	NUM
cuesj-706	59	18	]	]	PUNCT
cuesj-706	59	19	fgf23	fgf23	NOUN
cuesj-706	59	20	promotes	promote	VERB
cuesj-706	59	21	hepatocytes	hepatocyte	NOUN
cuesj-706	59	22	to	to	PART
cuesj-706	59	23	secrete	secrete	VERB
cuesj-706	59	24	inflammatory	inflammatory	ADJ
cuesj-706	59	25	markers	marker	NOUN
cuesj-706	59	26	including	include	VERB
cuesj-706	59	27	il6	il6	NOUN
cuesj-706	59	28	and	and	CCONJ
cuesj-706	59	29	tnf	tnf	PROPN
cuesj-706	59	30	,	,	PUNCT
cuesj-706	59	31	as	as	ADV
cuesj-706	59	32	well	well	ADV
cuesj-706	59	33	as	as	ADP
cuesj-706	59	34	fibrinogen	fibrinogen	NOUN
cuesj-706	59	35	,	,	PUNCT
cuesj-706	59	36	c	c	NOUN
cuesj-706	59	37	-	-	PUNCT
cuesj-706	59	38	reactive	reactive	ADJ
cuesj-706	59	39	protein	protein	NOUN
cuesj-706	59	40	,	,	PUNCT
cuesj-706	59	41	and	and	CCONJ
cuesj-706	59	42	vascular	vascular	ADJ
cuesj-706	59	43	cell	cell	NOUN
cuesj-706	59	44	adhesion	adhesion	NOUN
cuesj-706	59	45	molecule-1.[24	molecule-1.[24	NOUN
cuesj-706	59	46	]	]	PUNCT
cuesj-706	59	47	increased	increase	VERB
cuesj-706	59	48	fgf23	fgf23	NOUN
cuesj-706	59	49	has	have	VERB
cuesj-706	59	50	the	the	DET
cuesj-706	59	51	ability	ability	NOUN
cuesj-706	59	52	to	to	PART
cuesj-706	59	53	trigger	trigger	VERB
cuesj-706	59	54	the	the	DET
cuesj-706	59	55	inflammatory	inflammatory	ADJ
cuesj-706	59	56	response	response	NOUN
cuesj-706	59	57	by	by	ADP
cuesj-706	59	58	suppressing	suppress	VERB
cuesj-706	59	59	of	of	ADP
cuesj-706	59	60	1,25	1,25	NUM
cuesj-706	59	61	-	-	PUNCT
cuesj-706	59	62	dihydroxyvitamin	dihydroxyvitamin	ADJ
cuesj-706	59	63	d	d	NOUN
cuesj-706	59	64	,	,	PUNCT
cuesj-706	59	65	a	a	DET
cuesj-706	59	66	strong	strong	ADJ
cuesj-706	59	67	inhibitor	inhibitor	NOUN
cuesj-706	59	68	of	of	ADP
cuesj-706	59	69	inflammatory	inflammatory	ADJ
cuesj-706	59	70	cytokine	cytokine	NOUN
cuesj-706	59	71	release.[25	release.[25	NOUN
cuesj-706	59	72	]	]	PUNCT
cuesj-706	59	73	chemerin	chemerin	NOUN
cuesj-706	59	74	was	be	AUX
cuesj-706	59	75	validated	validate	VERB
cuesj-706	59	76	to	to	PART
cuesj-706	59	77	play	play	VERB
cuesj-706	59	78	as	as	ADP
cuesj-706	59	79	an	an	DET
cuesj-706	59	80	inflammatory	inflammatory	ADJ
cuesj-706	59	81	intermediary	intermediary	NOUN
cuesj-706	59	82	to	to	ADP
cuesj-706	59	83	production	production	NOUN
cuesj-706	59	84	of	of	ADP
cuesj-706	59	85	proinflammatory	proinflammatory	ADJ
cuesj-706	59	86	cytokines	cytokine	NOUN
cuesj-706	59	87	and	and	CCONJ
cuesj-706	59	88	encourage	encourage	VERB
cuesj-706	59	89	the	the	DET
cuesj-706	59	90	relocation	relocation	NOUN
cuesj-706	59	91	of	of	ADP
cuesj-706	59	92	immature	immature	ADJ
cuesj-706	59	93	dendritic	dendritic	ADJ
cuesj-706	59	94	cells	cell	NOUN
cuesj-706	59	95	and	and	CCONJ
cuesj-706	59	96	macrophages.[26	macrophages.[26	NOUN
cuesj-706	59	97	]	]	PUNCT
cuesj-706	59	98	chemerin	chemerin	NOUN
cuesj-706	59	99	concentrations	concentration	NOUN
cuesj-706	59	100	in	in	ADP
cuesj-706	59	101	serum	serum	NOUN
cuesj-706	59	102	samples	sample	NOUN
cuesj-706	59	103	were	be	AUX
cuesj-706	59	104	observed	observe	VERB
cuesj-706	59	105	to	to	PART
cuesj-706	59	106	be	be	AUX
cuesj-706	59	107	greater	great	ADJ
cuesj-706	59	108	in	in	ADP
cuesj-706	59	109	psoriatic	psoriatic	ADJ
cuesj-706	59	110	patients	patient	NOUN
cuesj-706	59	111	than	than	ADP
cuesj-706	59	112	in	in	ADP
cuesj-706	59	113	the	the	DET
cuesj-706	59	114	control	control	NOUN
cuesj-706	59	115	group	group	NOUN
cuesj-706	59	116	in	in	ADP
cuesj-706	59	117	this	this	DET
cuesj-706	59	118	investigation	investigation	NOUN
cuesj-706	59	119	.	.	PUNCT
cuesj-706	60	1	in	in	ADP
cuesj-706	60	2	a	a	DET
cuesj-706	60	3	similar	similar	ADJ
cuesj-706	60	4	manner	manner	NOUN
cuesj-706	60	5	,	,	PUNCT
cuesj-706	60	6	gisondi	gisondi	NOUN
cuesj-706	60	7	et	et	NOUN
cuesj-706	60	8	al	al	PROPN
cuesj-706	60	9	.	.	PROPN
cuesj-706	60	10	and	and	CCONJ
cuesj-706	60	11	lora	lora	PROPN
cuesj-706	60	12	et	et	PROPN
cuesj-706	60	13	al.[27,28	al.[27,28	PROPN
cuesj-706	60	14	]	]	PUNCT
cuesj-706	60	15	discovered	discover	VERB
cuesj-706	60	16	elevated	elevated	ADJ
cuesj-706	60	17	levels	level	NOUN
cuesj-706	60	18	of	of	ADP
cuesj-706	60	19	chemerin	chemerin	NOUN
cuesj-706	60	20	in	in	ADP
cuesj-706	60	21	psoriasis	psoriasis	NOUN
cuesj-706	60	22	patients	patient	NOUN
cuesj-706	60	23	having	have	VERB
cuesj-706	60	24	high	high	ADJ
cuesj-706	60	25	disease	disease	NOUN
cuesj-706	60	26	activity	activity	NOUN
cuesj-706	60	27	.	.	PUNCT
cuesj-706	61	1	xue	xue	PROPN
cuesj-706	61	2	et	et	PROPN
cuesj-706	61	3	al.[29	al.[29	PROPN
cuesj-706	61	4	]	]	PUNCT
cuesj-706	61	5	found	find	VERB
cuesj-706	61	6	that	that	SCONJ
cuesj-706	61	7	patients	patient	NOUN
cuesj-706	61	8	with	with	ADP
cuesj-706	61	9	psoriasis	psoriasis	NOUN
cuesj-706	61	10	had	have	VERB
cuesj-706	61	11	considerably	considerably	ADV
cuesj-706	61	12	lower	low	ADJ
cuesj-706	61	13	amounts	amount	NOUN
cuesj-706	61	14	of	of	ADP
cuesj-706	61	15	circulating	circulate	VERB
cuesj-706	61	16	chemerin	chemerin	NOUN
cuesj-706	61	17	than	than	ADP
cuesj-706	61	18	healthy	healthy	ADJ
cuesj-706	61	19	controls	control	NOUN
cuesj-706	61	20	.	.	PUNCT
cuesj-706	62	1	it	it	PRON
cuesj-706	62	2	is	be	AUX
cuesj-706	62	3	unclear	unclear	ADJ
cuesj-706	62	4	what	what	DET
cuesj-706	62	5	mechanism	mechanism	NOUN
cuesj-706	62	6	could	could	AUX
cuesj-706	62	7	explain	explain	VERB
cuesj-706	62	8	these	these	DET
cuesj-706	62	9	findings	finding	NOUN
cuesj-706	62	10	.	.	PUNCT
cuesj-706	63	1	we	we	PRON
cuesj-706	63	2	hypothesized	hypothesize	VERB
cuesj-706	63	3	that	that	SCONJ
cuesj-706	63	4	the	the	DET
cuesj-706	63	5	mechanism	mechanism	NOUN
cuesj-706	63	6	was	be	AUX
cuesj-706	63	7	linked	link	VERB
cuesj-706	63	8	to	to	ADP
cuesj-706	63	9	chemerin	chemerin	PROPN
cuesj-706	63	10	’s	’s	PART
cuesj-706	63	11	angiogenic	angiogenic	PROPN
cuesj-706	63	12	properties.[30	properties.[30	PROPN
cuesj-706	63	13	]	]	X
cuesj-706	63	14	chemerin	chemerin	NOUN
cuesj-706	63	15	is	be	AUX
cuesj-706	63	16	a	a	DET
cuesj-706	63	17	protein	protein	NOUN
cuesj-706	63	18	produced	produce	VERB
cuesj-706	63	19	mostly	mostly	ADV
cuesj-706	63	20	by	by	ADP
cuesj-706	63	21	keratinocytes	keratinocyte	NOUN
cuesj-706	63	22	and	and	CCONJ
cuesj-706	63	23	endothelial	endothelial	ADJ
cuesj-706	63	24	cells	cell	NOUN
cuesj-706	63	25	,	,	PUNCT
cuesj-706	63	26	as	as	ADV
cuesj-706	63	27	well	well	ADV
cuesj-706	63	28	as	as	ADP
cuesj-706	63	29	white	white	ADJ
cuesj-706	63	30	adipose	adipose	ADP
cuesj-706	63	31	tissue	tissue	NOUN
cuesj-706	63	32	.	.	PUNCT
cuesj-706	64	1	il1	il1	NOUN
cuesj-706	64	2	and	and	CCONJ
cuesj-706	64	3	tn	tn	PROPN
cuesj-706	64	4	f	f	X
cuesj-706	64	5	-	-	PUNCT
cuesj-706	64	6	both	both	PRON
cuesj-706	64	7	boost	boost	VERB
cuesj-706	64	8	its	its	PRON
cuesj-706	64	9	production	production	NOUN
cuesj-706	64	10	.	.	PUNCT
cuesj-706	65	1	chemerin	chemerin	PROPN
cuesj-706	65	2	increases	increase	VERB
cuesj-706	65	3	angiogenesis	angiogenesis	NOUN
cuesj-706	65	4	in	in	ADP
cuesj-706	65	5	psoriatic	psoriatic	ADJ
cuesj-706	65	6	skin	skin	NOUN
cuesj-706	65	7	through	through	ADP
cuesj-706	65	8	stimulating	stimulate	VERB
cuesj-706	65	9	adipocytes	adipocyte	NOUN
cuesj-706	65	10	and	and	CCONJ
cuesj-706	65	11	endothelial	endothelial	ADJ
cuesj-706	65	12	cells	cell	NOUN
cuesj-706	65	13	.	.	PUNCT
cuesj-706	66	1	in	in	ADP
cuesj-706	66	2	psoriasis	psoriasis	NOUN
cuesj-706	66	3	patients	patient	NOUN
cuesj-706	66	4	’	'	PUNCT
cuesj-706	66	5	growing	grow	VERB
cuesj-706	66	6	skin	skin	NOUN
cuesj-706	66	7	lesions	lesion	NOUN
cuesj-706	66	8	,	,	PUNCT
cuesj-706	66	9	chemerin	chemerin	NOUN
cuesj-706	66	10	can	can	AUX
cuesj-706	66	11	stimulate	stimulate	VERB
cuesj-706	66	12	chemotaxis	chemotaxis	NOUN
cuesj-706	66	13	of	of	ADP
cuesj-706	66	14	immature	immature	ADJ
cuesj-706	66	15	myeloid	myeloid	PROPN
cuesj-706	66	16	dcs	dcs	PROPN
cuesj-706	66	17	and	and	CCONJ
cuesj-706	66	18	plasmatoid	plasmatoid	ADJ
cuesj-706	66	19	dendritic	dendritic	ADJ
cuesj-706	66	20	cells.[31	cells.[31	NOUN
cuesj-706	66	21	]	]	X
cuesj-706	66	22	chemerin	chemerin	NOUN
cuesj-706	66	23	may	may	AUX
cuesj-706	66	24	be	be	AUX
cuesj-706	66	25	implicated	implicate	VERB
cuesj-706	66	26	in	in	ADP
cuesj-706	66	27	psoriasis	psoriasis	NOUN
cuesj-706	66	28	pathophysiological	pathophysiological	ADJ
cuesj-706	66	29	processes	process	NOUN
cuesj-706	66	30	.	.	PUNCT
cuesj-706	67	1	chemerin	chemerin	NOUN
cuesj-706	67	2	expression	expression	NOUN
cuesj-706	67	3	was	be	AUX
cuesj-706	67	4	shown	show	VERB
cuesj-706	67	5	to	to	PART
cuesj-706	67	6	be	be	AUX
cuesj-706	67	7	higher	high	ADJ
cuesj-706	67	8	in	in	ADP
cuesj-706	67	9	psoriatic	psoriatic	ADJ
cuesj-706	67	10	skin	skin	NOUN
cuesj-706	67	11	biopsies	biopsy	NOUN
cuesj-706	67	12	.	.	PUNCT
cuesj-706	68	1	the	the	DET
cuesj-706	68	2	enhanced	enhance	VERB
cuesj-706	68	3	migration	migration	NOUN
cuesj-706	68	4	of	of	ADP
cuesj-706	68	5	dendritic	dendritic	ADJ
cuesj-706	68	6	cells	cell	NOUN
cuesj-706	68	7	and	and	CCONJ
cuesj-706	68	8	nk	nk	PROPN
cuesj-706	68	9	cells	cell	NOUN
cuesj-706	68	10	to	to	ADP
cuesj-706	68	11	the	the	DET
cuesj-706	68	12	inflammation	inflammation	NOUN
cuesj-706	68	13	may	may	AUX
cuesj-706	68	14	be	be	AUX
cuesj-706	68	15	due	due	ADJ
cuesj-706	68	16	to	to	ADP
cuesj-706	68	17	an	an	DET
cuesj-706	68	18	increase	increase	NOUN
cuesj-706	68	19	in	in	ADP
cuesj-706	68	20	the	the	DET
cuesj-706	68	21	concentration	concentration	NOUN
cuesj-706	68	22	of	of	ADP
cuesj-706	68	23	this	this	DET
cuesj-706	68	24	protein	protein	NOUN
cuesj-706	68	25	in	in	ADP
cuesj-706	68	26	mast	mast	NOUN
cuesj-706	68	27	cells	cell	NOUN
cuesj-706	68	28	,	,	PUNCT
cuesj-706	68	29	dermal	dermal	NOUN
cuesj-706	68	30	fibroblasts	fibroblast	NOUN
cuesj-706	68	31	,	,	PUNCT
cuesj-706	68	32	and	and	CCONJ
cuesj-706	68	33	endothelial	endothelial	ADJ
cuesj-706	68	34	cells	cell	NOUN
cuesj-706	68	35	throughout	throughout	ADP
cuesj-706	68	36	early	early	ADJ
cuesj-706	68	37	phases	phase	NOUN
cuesj-706	68	38	of	of	ADP
cuesj-706	68	39	psoriasis	psoriasis	NOUN
cuesj-706	68	40	.	.	PUNCT
cuesj-706	69	1	the	the	DET
cuesj-706	69	2	stimulation	stimulation	NOUN
cuesj-706	69	3	of	of	ADP
cuesj-706	69	4	angiogenesis	angiogenesis	NOUN
cuesj-706	69	5	may	may	AUX
cuesj-706	69	6	also	also	ADV
cuesj-706	69	7	play	play	VERB
cuesj-706	69	8	a	a	DET
cuesj-706	69	9	role	role	NOUN
cuesj-706	69	10	in	in	ADP
cuesj-706	69	11	the	the	DET
cuesj-706	69	12	evolution	evolution	NOUN
cuesj-706	69	13	of	of	ADP
cuesj-706	69	14	psoriatic	psoriatic	ADJ
cuesj-706	69	15	inflammation	inflammation	NOUN
cuesj-706	69	16	.	.	PUNCT
cuesj-706	70	1	chemerin	chemerin	PROPN
cuesj-706	70	2	’s	’s	PART
cuesj-706	70	3	ability	ability	NOUN
cuesj-706	70	4	to	to	PART
cuesj-706	70	5	induce	induce	VERB
cuesj-706	70	6	the	the	DET
cuesj-706	70	7	development	development	NOUN
cuesj-706	70	8	of	of	ADP
cuesj-706	70	9	new	new	ADJ
cuesj-706	70	10	vasculature	vasculature	NOUN
cuesj-706	70	11	could	could	AUX
cuesj-706	70	12	indicate	indicate	VERB
cuesj-706	70	13	a	a	DET
cuesj-706	70	14	role	role	NOUN
cuesj-706	70	15	for	for	ADP
cuesj-706	70	16	this	this	DET
cuesj-706	70	17	adipokine	adipokine	NOUN
cuesj-706	70	18	in	in	ADP
cuesj-706	70	19	psoriasis.[32	psoriasis.[32	PROPN
cuesj-706	70	20	]	]	PUNCT
cuesj-706	70	21	physiologically	physiologically	ADV
cuesj-706	70	22	,	,	PUNCT
cuesj-706	70	23	1,25	1,25	NUM
cuesj-706	70	24	-	-	PUNCT
cuesj-706	70	25	dihydroxyvitamin	dihydroxyvitamin	ADJ
cuesj-706	70	26	d	d	NOUN
cuesj-706	70	27	and	and	CCONJ
cuesj-706	70	28	vitamin	vitamin	NOUN
cuesj-706	70	29	d	d	NOUN
cuesj-706	70	30	receptor	receptor	NOUN
cuesj-706	70	31	directly	directly	ADV
cuesj-706	70	32	regulates	regulate	VERB
cuesj-706	70	33	the	the	DET
cuesj-706	70	34	proliferation	proliferation	NOUN
cuesj-706	70	35	and	and	CCONJ
cuesj-706	70	36	growth	growth	NOUN
cuesj-706	70	37	of	of	ADP
cuesj-706	70	38	keratinocytes	keratinocyte	NOUN
cuesj-706	70	39	through	through	ADP
cuesj-706	70	40	vitamin	vitamin	NOUN
cuesj-706	70	41	d	d	NOUN
cuesj-706	70	42	receptors	receptor	NOUN
cuesj-706	70	43	.	.	PUNCT
cuesj-706	71	1	there	there	PRON
cuesj-706	71	2	are	be	VERB
cuesj-706	71	3	several	several	ADJ
cuesj-706	71	4	pathways	pathway	NOUN
cuesj-706	71	5	for	for	ADP
cuesj-706	71	6	the	the	DET
cuesj-706	71	7	effect	effect	NOUN
cuesj-706	71	8	of	of	ADP
cuesj-706	71	9	vitamin	vitamin	NOUN
cuesj-706	71	10	d	d	NOUN
cuesj-706	71	11	deficiency	deficiency	NOUN
cuesj-706	71	12	in	in	ADP
cuesj-706	71	13	psoriasis	psoriasis	NOUN
cuesj-706	71	14	pathogenesis	pathogenesis	NOUN
cuesj-706	71	15	:	:	PUNCT
cuesj-706	71	16	loss	loss	NOUN
cuesj-706	71	17	of	of	ADP
cuesj-706	71	18	antiproliferative	antiproliferative	NOUN
cuesj-706	71	19	,	,	PUNCT
cuesj-706	71	20	anti	anti	ADJ
cuesj-706	71	21	-	-	ADJ
cuesj-706	71	22	inflammatory	inflammatory	ADJ
cuesj-706	71	23	,	,	PUNCT
cuesj-706	71	24	and	and	CCONJ
cuesj-706	71	25	antiangiogenic	antiangiogenic	ADJ
cuesj-706	71	26	activities.[33	activities.[33	NUM
cuesj-706	71	27	-	-	PUNCT
cuesj-706	71	28	35	35	NUM
cuesj-706	71	29	]	]	PUNCT
cuesj-706	71	30	table	table	NOUN
cuesj-706	71	31	2	2	NUM
cuesj-706	71	32	:	:	PUNCT
cuesj-706	71	33	descriptive	descriptive	ADJ
cuesj-706	71	34	characteristics	characteristic	NOUN
cuesj-706	71	35	of	of	ADP
cuesj-706	71	36	serum	serum	PROPN
cuesj-706	71	37	fgf23	fgf23	PROPN
cuesj-706	71	38	,	,	PUNCT
cuesj-706	71	39	chemerin	chemerin	NOUN
cuesj-706	71	40	,	,	PUNCT
cuesj-706	71	41	vitamin	vitamin	NOUN
cuesj-706	71	42	d	d	NOUN
cuesj-706	71	43	,	,	PUNCT
cuesj-706	71	44	and	and	CCONJ
cuesj-706	71	45	pth	pth	AUX
cuesj-706	71	46	between	between	ADP
cuesj-706	71	47	between	between	ADP
cuesj-706	71	48	studied	study	VERB
cuesj-706	71	49	groups	group	NOUN
cuesj-706	71	50	fgf23	fgf23	PROPN
cuesj-706	71	51	(	(	PUNCT
cuesj-706	71	52	pg	pg	NOUN
cuesj-706	71	53	/	/	SYM
cuesj-706	71	54	ml	ml	NOUN
cuesj-706	71	55	)	)	PUNCT
cuesj-706	71	56	vitamin	vitamin	NOUN
cuesj-706	71	57	d	d	NOUN
cuesj-706	71	58	(	(	PUNCT
cuesj-706	71	59	ng	ng	PROPN
cuesj-706	71	60	/	/	SYM
cuesj-706	71	61	ml	ml	PROPN
cuesj-706	71	62	)	)	PUNCT
cuesj-706	71	63	chemerin	chemerin	NOUN
cuesj-706	71	64	(	(	PUNCT
cuesj-706	71	65	ng	ng	NOUN
cuesj-706	71	66	/	/	SYM
cuesj-706	71	67	ml	ml	NOUN
cuesj-706	71	68	)	)	PUNCT
cuesj-706	71	69	pth	pth	NOUN
cuesj-706	71	70	(	(	PUNCT
cuesj-706	71	71	pg	pg	NOUN
cuesj-706	71	72	/	/	SYM
cuesj-706	71	73	ml	ml	NOUN
cuesj-706	71	74	)	)	PUNCT
cuesj-706	71	75	patients	patient	NOUN
cuesj-706	71	76	106.1±15.2	106.1±15.2	NUM
cuesj-706	71	77	21.68±1.79	21.68±1.79	NUM
cuesj-706	71	78	328.6±25.2	328.6±25.2	NOUN
cuesj-706	71	79	45.19±4.31	45.19±4.31	PROPN
cuesj-706	71	80	control	control	VERB
cuesj-706	71	81	265.7±22.1	265.7±22.1	NOUN
cuesj-706	71	82	*	*	X
cuesj-706	71	83	*	*	PUNCT
cuesj-706	71	84	29.92±1.55	29.92±1.55	NUM
cuesj-706	71	85	*	*	SYM
cuesj-706	71	86	*	*	PROPN
cuesj-706	71	87	229.1±15.4	229.1±15.4	NUM
cuesj-706	71	88	*	*	X
cuesj-706	71	89	*	*	PUNCT
cuesj-706	71	90	20.78±1.50	20.78±1.50	NUM
cuesj-706	71	91	*	*	PUNCT
cuesj-706	71	92	*	*	PUNCT
cuesj-706	71	93	*	*	PUNCT
cuesj-706	71	94	p<0.05	p<0.05	NOUN
cuesj-706	71	95	significant	significant	ADJ
cuesj-706	71	96	,	,	PUNCT
cuesj-706	71	97	*	*	PUNCT
cuesj-706	71	98	*	*	NOUN
cuesj-706	71	99	p<0.0001	p<0.0001	NOUN
cuesj-706	71	100	.	.	PUNCT
cuesj-706	72	1	pth	pth	NOUN
cuesj-706	72	2	:	:	PUNCT
cuesj-706	72	3	parathyroid	parathyroid	ADJ
cuesj-706	72	4	hormone	hormone	NOUN
cuesj-706	72	5	figure	figure	NOUN
cuesj-706	72	6	3	3	NUM
cuesj-706	72	7	:	:	PUNCT
cuesj-706	72	8	serum	serum	NOUN
cuesj-706	72	9	pth	pth	NOUN
cuesj-706	72	10	in	in	ADP
cuesj-706	72	11	patients	patient	NOUN
cuesj-706	72	12	with	with	ADP
cuesj-706	72	13	psoriasis	psoriasis	NOUN
cuesj-706	72	14	and	and	CCONJ
cuesj-706	72	15	the	the	DET
cuesj-706	72	16	controls	control	NOUN
cuesj-706	72	17	figure	figure	VERB
cuesj-706	72	18	4	4	NUM
cuesj-706	72	19	:	:	PUNCT
cuesj-706	72	20	serum	serum	NOUN
cuesj-706	72	21	vitamin	vitamin	NOUN
cuesj-706	72	22	d	d	NOUN
cuesj-706	72	23	in	in	ADP
cuesj-706	72	24	patients	patient	NOUN
cuesj-706	72	25	with	with	ADP
cuesj-706	72	26	psoriasis	psoriasis	NOUN
cuesj-706	72	27	and	and	CCONJ
cuesj-706	72	28	the	the	DET
cuesj-706	72	29	controls	control	NOUN
cuesj-706	72	30	tawfeeq	tawfeeq	ADJ
cuesj-706	72	31	,	,	PUNCT
cuesj-706	72	32	et	et	PROPN
cuesj-706	72	33	al	al	PROPN
cuesj-706	72	34	.	.	PUNCT
cuesj-706	72	35	:	:	PUNCT
cuesj-706	73	1	role	role	NOUN
cuesj-706	73	2	of	of	ADP
cuesj-706	73	3	fibroblast	fibroblast	ADJ
cuesj-706	73	4	growth	growth	NOUN
cuesj-706	73	5	factors	factor	NOUN
cuesj-706	73	6	23	23	NUM
cuesj-706	73	7	,	,	PUNCT
cuesj-706	73	8	chemerin	chemerin	NOUN
cuesj-706	73	9	,	,	PUNCT
cuesj-706	73	10	and	and	CCONJ
cuesj-706	73	11	vitamin	vitamin	NOUN
cuesj-706	73	12	d	d	NOUN
cuesj-706	73	13	in	in	ADP
cuesj-706	73	14	psoriasis	psoriasis	NOUN
cuesj-706	73	15	60	60	NUM
cuesj-706	73	16	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-706	73	17	cuesj	cuesj	ADJ
cuesj-706	73	18	2022	2022	NUM
cuesj-706	73	19	,	,	PUNCT
cuesj-706	73	20	6	6	NUM
cuesj-706	73	21	(	(	PUNCT
cuesj-706	73	22	2	2	NUM
cuesj-706	73	23	):	):	PUNCT
cuesj-706	73	24	57	57	NUM
cuesj-706	73	25	-	-	SYM
cuesj-706	73	26	61	61	NUM
cuesj-706	73	27	psoriasis	psoriasis	NOUN
cuesj-706	73	28	is	be	AUX
cuesj-706	73	29	an	an	DET
cuesj-706	73	30	autoimmune	autoimmune	ADJ
cuesj-706	73	31	inflammatory	inflammatory	ADJ
cuesj-706	73	32	disease	disease	NOUN
cuesj-706	73	33	involving	involve	VERB
cuesj-706	73	34	both	both	CCONJ
cuesj-706	73	35	innate	innate	ADJ
cuesj-706	73	36	and	and	CCONJ
cuesj-706	73	37	acquired	acquire	VERB
cuesj-706	73	38	immunity	immunity	NOUN
cuesj-706	73	39	.	.	PUNCT
cuesj-706	74	1	it	it	PRON
cuesj-706	74	2	is	be	AUX
cuesj-706	74	3	defined	define	VERB
cuesj-706	74	4	as	as	ADP
cuesj-706	74	5	an	an	DET
cuesj-706	74	6	autoimmune	autoimmune	ADJ
cuesj-706	74	7	inflammatory	inflammatory	ADJ
cuesj-706	74	8	sickness	sickness	NOUN
cuesj-706	74	9	with	with	ADP
cuesj-706	74	10	th1	th1	PROPN
cuesj-706	74	11	-	-	PUNCT
cuesj-706	74	12	th17	th17	PROPN
cuesj-706	74	13	-	-	PUNCT
cuesj-706	74	14	th22	th22	ADJ
cuesj-706	74	15	components	component	NOUN
cuesj-706	74	16	.	.	PUNCT
cuesj-706	75	1	decreased	decrease	VERB
cuesj-706	75	2	amounts	amount	NOUN
cuesj-706	75	3	of	of	ADP
cuesj-706	75	4	25(oh)d	25(oh)d	NOUN
cuesj-706	75	5	have	have	AUX
cuesj-706	75	6	also	also	ADV
cuesj-706	75	7	been	be	AUX
cuesj-706	75	8	linked	link	VERB
cuesj-706	75	9	to	to	ADP
cuesj-706	75	10	a	a	DET
cuesj-706	75	11	higher	high	ADJ
cuesj-706	75	12	risk	risk	NOUN
cuesj-706	75	13	of	of	ADP
cuesj-706	75	14	developing	develop	VERB
cuesj-706	75	15	autoimmune	autoimmune	ADJ
cuesj-706	75	16	pathologies	pathology	NOUN
cuesj-706	75	17	mediated	mediate	VERB
cuesj-706	75	18	by	by	ADP
cuesj-706	75	19	th1.[36	th1.[36	NOUN
cuesj-706	75	20	]	]	PUNCT
cuesj-706	75	21	the	the	DET
cuesj-706	75	22	reason	reason	NOUN
cuesj-706	75	23	for	for	ADP
cuesj-706	75	24	the	the	DET
cuesj-706	75	25	lower	low	ADJ
cuesj-706	75	26	level	level	NOUN
cuesj-706	75	27	of	of	ADP
cuesj-706	75	28	serum	serum	NOUN
cuesj-706	75	29	25(oh)d	25(oh)d	NOUN
cuesj-706	75	30	in	in	ADP
cuesj-706	75	31	these	these	DET
cuesj-706	75	32	patients	patient	NOUN
cuesj-706	75	33	may	may	AUX
cuesj-706	75	34	be	be	AUX
cuesj-706	75	35	due	due	ADJ
cuesj-706	75	36	to	to	ADP
cuesj-706	75	37	inadequate	inadequate	ADJ
cuesj-706	75	38	25(oh	25(oh	NOUN
cuesj-706	75	39	)	)	PUNCT
cuesj-706	75	40	d	d	NOUN
cuesj-706	75	41	intake	intake	NOUN
cuesj-706	75	42	,	,	PUNCT
cuesj-706	75	43	paucity	paucity	NOUN
cuesj-706	75	44	of	of	ADP
cuesj-706	75	45	sunlight	sunlight	NOUN
cuesj-706	75	46	exposure	exposure	NOUN
cuesj-706	75	47	,	,	PUNCT
cuesj-706	75	48	or	or	CCONJ
cuesj-706	75	49	usage	usage	NOUN
cuesj-706	75	50	of	of	ADP
cuesj-706	75	51	medicines	medicine	NOUN
cuesj-706	75	52	(	(	PUNCT
cuesj-706	75	53	e.g.	e.g.	ADV
cuesj-706	75	54	,	,	PUNCT
cuesj-706	75	55	glucocorticoids	glucocorticoid	NOUN
cuesj-706	75	56	and	and	CCONJ
cuesj-706	75	57	immunosuppressive	immunosuppressive	ADJ
cuesj-706	75	58	agents	agent	NOUN
cuesj-706	75	59	)	)	PUNCT
cuesj-706	75	60	that	that	PRON
cuesj-706	75	61	interact	interact	VERB
cuesj-706	75	62	with	with	ADP
cuesj-706	75	63	25(oh)d	25(oh)d	NOUN
cuesj-706	75	64	breakdown	breakdown	NOUN
cuesj-706	75	65	on	on	ADP
cuesj-706	75	66	a	a	DET
cuesj-706	75	67	regular	regular	ADJ
cuesj-706	75	68	basis.[37	basis.[37	PROPN
cuesj-706	75	69	]	]	PUNCT
cuesj-706	75	70	conclusion	conclusion	NOUN
cuesj-706	75	71	based	base	VERB
cuesj-706	75	72	on	on	ADP
cuesj-706	75	73	our	our	PRON
cuesj-706	75	74	observations	observation	NOUN
cuesj-706	75	75	,	,	PUNCT
cuesj-706	75	76	we	we	PRON
cuesj-706	75	77	have	have	AUX
cuesj-706	75	78	come	come	VERB
cuesj-706	75	79	to	to	ADP
cuesj-706	75	80	the	the	DET
cuesj-706	75	81	conclusion	conclusion	NOUN
cuesj-706	75	82	that	that	SCONJ
cuesj-706	75	83	psoriasis	psoriasis	NOUN
cuesj-706	75	84	sufferers	sufferer	NOUN
cuesj-706	75	85	’	'	PUNCT
cuesj-706	75	86	serum	serum	NOUN
cuesj-706	75	87	fgf23	fgf23	PROPN
cuesj-706	75	88	and	and	CCONJ
cuesj-706	75	89	chemerin	chemerin	NOUN
cuesj-706	75	90	levels	level	NOUN
cuesj-706	75	91	are	be	AUX
cuesj-706	75	92	higher	high	ADJ
cuesj-706	75	93	than	than	ADP
cuesj-706	75	94	healthy	healthy	ADJ
cuesj-706	75	95	controls	control	NOUN
cuesj-706	75	96	.	.	PUNCT
cuesj-706	76	1	patients	patient	NOUN
cuesj-706	76	2	with	with	ADP
cuesj-706	76	3	psoriasis	psoriasis	NOUN
cuesj-706	76	4	,	,	PUNCT
cuesj-706	76	5	on	on	ADP
cuesj-706	76	6	the	the	DET
cuesj-706	76	7	other	other	ADJ
cuesj-706	76	8	hand	hand	NOUN
cuesj-706	76	9	,	,	PUNCT
cuesj-706	76	10	had	have	VERB
cuesj-706	76	11	considerably	considerably	ADV
cuesj-706	76	12	lower	low	ADJ
cuesj-706	76	13	serum	serum	NOUN
cuesj-706	76	14	vitamin	vitamin	NOUN
cuesj-706	76	15	d	d	NOUN
cuesj-706	76	16	levels	level	NOUN
cuesj-706	76	17	than	than	ADP
cuesj-706	76	18	healthy	healthy	ADJ
cuesj-706	76	19	controls	control	NOUN
cuesj-706	76	20	.	.	PUNCT
cuesj-706	77	1	therefore	therefore	ADV
cuesj-706	77	2	,	,	PUNCT
cuesj-706	77	3	fgf23	fgf23	PROPN
cuesj-706	77	4	,	,	PUNCT
cuesj-706	77	5	chemerin	chemerin	NOUN
cuesj-706	77	6	,	,	PUNCT
cuesj-706	77	7	and	and	CCONJ
cuesj-706	77	8	vitamin	vitamin	NOUN
cuesj-706	77	9	d	d	NOUN
cuesj-706	77	10	levels	level	NOUN
cuesj-706	77	11	may	may	AUX
cuesj-706	77	12	be	be	AUX
cuesj-706	77	13	a	a	DET
cuesj-706	77	14	novel	novel	ADJ
cuesj-706	77	15	diagnostic	diagnostic	ADJ
cuesj-706	77	16	marker	marker	NOUN
cuesj-706	77	17	in	in	ADP
cuesj-706	77	18	psoriasis	psoriasis	NOUN
cuesj-706	77	19	and	and	CCONJ
cuesj-706	77	20	may	may	AUX
cuesj-706	77	21	predict	predict	VERB
cuesj-706	77	22	the	the	DET
cuesj-706	77	23	occurrence	occurrence	NOUN
cuesj-706	77	24	of	of	ADP
cuesj-706	77	25	comorbidities	comorbiditie	NOUN
cuesj-706	77	26	in	in	ADP
cuesj-706	77	27	psoriasis	psoriasis	NOUN
cuesj-706	77	28	patients	patient	NOUN
cuesj-706	77	29	.	.	PUNCT
cuesj-706	78	1	references	reference	NOUN
cuesj-706	78	2	1	1	NUM
cuesj-706	78	3	.	.	PUNCT
cuesj-706	78	4	s.	s.	PROPN
cuesj-706	78	5	pal	pal	PROPN
cuesj-706	78	6	,	,	PUNCT
cuesj-706	78	7	s.	s.	PROPN
cuesj-706	78	8	sen	sen	PROPN
cuesj-706	78	9	,	,	PUNCT
cuesj-706	78	10	i.	i.	PROPN
cuesj-706	78	11	nath	nath	PROPN
cuesj-706	78	12	,	,	PUNCT
cuesj-706	78	13	a.	a.	PROPN
cuesj-706	78	14	kumar	kumar	PROPN
cuesj-706	78	15	and	and	CCONJ
cuesj-706	78	16	u.	u.	PROPN
cuesj-706	78	17	k.	k.	PROPN
cuesj-706	78	18	biswas	biswas	PROPN
cuesj-706	78	19	.	.	PUNCT
cuesj-706	79	1	psoriasis	psoriasis	NOUN
cuesj-706	79	2	,	,	PUNCT
cuesj-706	79	3	an	an	DET
cuesj-706	79	4	inflammatory	inflammatory	ADJ
cuesj-706	79	5	condition	condition	NOUN
cuesj-706	79	6	associated	associate	VERB
cuesj-706	79	7	with	with	ADP
cuesj-706	79	8	oxidative	oxidative	ADJ
cuesj-706	79	9	stress	stress	NOUN
cuesj-706	79	10	.	.	PUNCT
cuesj-706	80	1	asian	asian	ADJ
cuesj-706	80	2	journal	journal	PROPN
cuesj-706	80	3	of	of	ADP
cuesj-706	80	4	medical	medical	ADJ
cuesj-706	80	5	sciences	science	NOUN
cuesj-706	80	6	,	,	PUNCT
cuesj-706	80	7	vol	vol	NOUN
cuesj-706	80	8	.	.	PROPN
cuesj-706	80	9	12	12	NUM
cuesj-706	80	10	,	,	PUNCT
cuesj-706	80	11	no	no	INTJ
cuesj-706	80	12	.	.	NOUN
cuesj-706	80	13	4	4	NUM
cuesj-706	80	14	,	,	PUNCT
cuesj-706	80	15	pp	pp	ADJ
cuesj-706	80	16	.	.	PUNCT
cuesj-706	81	1	24	24	NUM
cuesj-706	81	2	-	-	SYM
cuesj-706	81	3	30	30	NUM
cuesj-706	81	4	,	,	PUNCT
cuesj-706	81	5	2021	2021	NUM
cuesj-706	81	6	.	.	PUNCT
cuesj-706	82	1	2	2	X
cuesj-706	82	2	.	.	PUNCT
cuesj-706	82	3	i.	i.	PROPN
cuesj-706	82	4	olejniczak	olejniczak	PROPN
cuesj-706	82	5	-	-	PUNCT
cuesj-706	82	6	staruch	staruch	ADJ
cuesj-706	82	7	,	,	PUNCT
cuesj-706	82	8	m.	m.	NOUN
cuesj-706	82	9	ciążyńska	ciążyńska	PROPN
cuesj-706	82	10	,	,	PUNCT
cuesj-706	82	11	d.	d.	PROPN
cuesj-706	82	12	sobolewska	sobolewska	PROPN
cuesj-706	82	13	-	-	PUNCT
cuesj-706	82	14	sztychny	sztychny	PROPN
cuesj-706	82	15	,	,	PUNCT
cuesj-706	82	16	j.	j.	PROPN
cuesj-706	82	17	narbutt	narbutt	PROPN
cuesj-706	82	18	,	,	PUNCT
cuesj-706	82	19	m.	m.	NOUN
cuesj-706	82	20	skibińska	skibińska	NOUN
cuesj-706	82	21	and	and	CCONJ
cuesj-706	82	22	a.	a.	PROPN
cuesj-706	82	23	lesiak	lesiak	PROPN
cuesj-706	82	24	.	.	PUNCT
cuesj-706	83	1	alterations	alteration	NOUN
cuesj-706	83	2	of	of	ADP
cuesj-706	83	3	the	the	DET
cuesj-706	83	4	skin	skin	NOUN
cuesj-706	83	5	and	and	CCONJ
cuesj-706	83	6	gut	gut	NOUN
cuesj-706	83	7	microbiome	microbiome	NOUN
cuesj-706	83	8	in	in	ADP
cuesj-706	83	9	psoriasis	psoriasis	NOUN
cuesj-706	83	10	and	and	CCONJ
cuesj-706	83	11	psoriatic	psoriatic	ADJ
cuesj-706	83	12	arthritis	arthritis	NOUN
cuesj-706	83	13	.	.	PUNCT
cuesj-706	84	1	international	international	ADJ
cuesj-706	84	2	journal	journal	NOUN
cuesj-706	84	3	of	of	ADP
cuesj-706	84	4	molecular	molecular	ADJ
cuesj-706	84	5	sciences	science	NOUN
cuesj-706	84	6	.	.	PUNCT
cuesj-706	85	1	vol	vol	NOUN
cuesj-706	85	2	.	.	PROPN
cuesj-706	86	1	22	22	NUM
cuesj-706	86	2	,	,	PUNCT
cuesj-706	86	3	no	no	INTJ
cuesj-706	86	4	.	.	NOUN
cuesj-706	86	5	8	8	NUM
cuesj-706	86	6	,	,	PUNCT
cuesj-706	86	7	pp	pp	ADJ
cuesj-706	86	8	.	.	PUNCT
cuesj-706	87	1	3998	3998	NUM
cuesj-706	87	2	,	,	PUNCT
cuesj-706	87	3	2021	2021	NUM
cuesj-706	87	4	.	.	PUNCT
cuesj-706	88	1	3	3	X
cuesj-706	88	2	.	.	X
cuesj-706	88	3	r.	r.	PROPN
cuesj-706	88	4	k.	k.	PROPN
cuesj-706	88	5	jha	jha	PROPN
cuesj-706	88	6	,	,	PUNCT
cuesj-706	88	7	a.	a.	PROPN
cuesj-706	88	8	singh	singh	PROPN
cuesj-706	88	9	,	,	PUNCT
cuesj-706	88	10	p.	p.	NOUN
cuesj-706	88	11	koundal	koundal	PROPN
cuesj-706	88	12	and	and	CCONJ
cuesj-706	88	13	r.	r.	PROPN
cuesj-706	88	14	s.	s.	PROPN
cuesj-706	88	15	ambad	ambad	PROPN
cuesj-706	88	16	.	.	PUNCT
cuesj-706	89	1	role	role	NOUN
cuesj-706	89	2	of	of	ADP
cuesj-706	89	3	lipid	lipid	NOUN
cuesj-706	89	4	and	and	CCONJ
cuesj-706	89	5	oxidative	oxidative	ADJ
cuesj-706	89	6	stress	stress	NOUN
cuesj-706	89	7	in	in	ADP
cuesj-706	89	8	psoriatic	psoriatic	ADJ
cuesj-706	89	9	patients	patient	NOUN
cuesj-706	89	10	--	--	PUNCT
cuesj-706	89	11	a	a	DET
cuesj-706	89	12	case	case	NOUN
cuesj-706	89	13	control	control	NOUN
cuesj-706	89	14	study	study	NOUN
cuesj-706	89	15	.	.	PUNCT
cuesj-706	90	1	journal	journal	NOUN
cuesj-706	90	2	of	of	ADP
cuesj-706	90	3	evolution	evolution	NOUN
cuesj-706	90	4	of	of	ADP
cuesj-706	90	5	medical	medical	ADJ
cuesj-706	90	6	and	and	CCONJ
cuesj-706	90	7	dental	dental	ADJ
cuesj-706	90	8	sciences	science	NOUN
cuesj-706	90	9	,	,	PUNCT
cuesj-706	90	10	vol	vol	NOUN
cuesj-706	90	11	.	.	PROPN
cuesj-706	91	1	10	10	NUM
cuesj-706	91	2	,	,	PUNCT
cuesj-706	91	3	no	no	INTJ
cuesj-706	91	4	.	.	NOUN
cuesj-706	91	5	3	3	NUM
cuesj-706	91	6	,	,	PUNCT
cuesj-706	91	7	pp	pp	ADJ
cuesj-706	91	8	.	.	PUNCT
cuesj-706	92	1	132	132	NUM
cuesj-706	92	2	-	-	SYM
cuesj-706	92	3	137	137	NUM
cuesj-706	92	4	,	,	PUNCT
cuesj-706	92	5	2021	2021	NUM
cuesj-706	92	6	.	.	PUNCT
cuesj-706	93	1	4	4	X
cuesj-706	93	2	.	.	X
cuesj-706	93	3	v.	v.	ADP
cuesj-706	93	4	gangadevi	gangadevi	NOUN
cuesj-706	93	5	,	,	PUNCT
cuesj-706	93	6	s.	s.	PROPN
cuesj-706	93	7	thatikonda	thatikonda	PROPN
cuesj-706	93	8	,	,	PUNCT
cuesj-706	93	9	v.	v.	ADP
cuesj-706	93	10	pooladanda	pooladanda	NOUN
cuesj-706	93	11	,	,	PUNCT
cuesj-706	93	12	g.	g.	PROPN
cuesj-706	93	13	devabattula	devabattula	NOUN
cuesj-706	93	14	and	and	CCONJ
cuesj-706	93	15	c.	c.	PROPN
cuesj-706	93	16	godugu	godugu	NOUN
cuesj-706	93	17	.	.	PUNCT
cuesj-706	94	1	selenium	selenium	NOUN
cuesj-706	94	2	nanoparticles	nanoparticle	NOUN
cuesj-706	94	3	produce	produce	VERB
cuesj-706	94	4	a	a	DET
cuesj-706	94	5	beneficial	beneficial	ADJ
cuesj-706	94	6	effect	effect	NOUN
cuesj-706	94	7	in	in	ADP
cuesj-706	94	8	psoriasis	psoriasis	NOUN
cuesj-706	94	9	by	by	ADP
cuesj-706	94	10	reducing	reduce	VERB
cuesj-706	94	11	epidermal	epidermal	ADJ
cuesj-706	94	12	hyperproliferation	hyperproliferation	NOUN
cuesj-706	94	13	and	and	CCONJ
cuesj-706	94	14	inflammation	inflammation	NOUN
cuesj-706	94	15	.	.	PUNCT
cuesj-706	95	1	journal	journal	PROPN
cuesj-706	95	2	nanobiotechnology	nanobiotechnology	PROPN
cuesj-706	95	3	.	.	PUNCT
cuesj-706	96	1	vol	vol	NOUN
cuesj-706	96	2	.	.	PROPN
cuesj-706	97	1	19	19	NUM
cuesj-706	97	2	,	,	PUNCT
cuesj-706	97	3	no	no	INTJ
cuesj-706	97	4	.	.	NOUN
cuesj-706	97	5	1	1	NUM
cuesj-706	97	6	,	,	PUNCT
cuesj-706	97	7	pp	pp	ADJ
cuesj-706	97	8	.	.	PUNCT
cuesj-706	98	1	1	1	NUM
cuesj-706	98	2	-	-	SYM
cuesj-706	98	3	19	19	NUM
cuesj-706	98	4	,	,	PUNCT
cuesj-706	98	5	2021	2021	NUM
cuesj-706	98	6	.	.	PUNCT
cuesj-706	99	1	5	5	NUM
cuesj-706	99	2	.	.	X
cuesj-706	99	3	f.	f.	PROPN
cuesj-706	99	4	ewendt	ewendt	PROPN
cuesj-706	99	5	,	,	PUNCT
cuesj-706	99	6	m.	m.	NOUN
cuesj-706	99	7	feger	feger	PROPN
cuesj-706	99	8	and	and	CCONJ
cuesj-706	99	9	m.	m.	NOUN
cuesj-706	99	10	föller	föller	PROPN
cuesj-706	99	11	.	.	PUNCT
cuesj-706	100	1	role	role	NOUN
cuesj-706	100	2	of	of	ADP
cuesj-706	100	3	fibroblast	fibroblast	ADJ
cuesj-706	100	4	growth	growth	NOUN
cuesj-706	100	5	factor	factor	NOUN
cuesj-706	100	6	23	23	NUM
cuesj-706	100	7	(	(	PUNCT
cuesj-706	100	8	fgf23	fgf23	NOUN
cuesj-706	100	9	)	)	PUNCT
cuesj-706	100	10	and	and	CCONJ
cuesj-706	100	11	αklotho	αklotho	NOUN
cuesj-706	100	12	in	in	ADP
cuesj-706	100	13	cancer	cancer	NOUN
cuesj-706	100	14	.	.	PUNCT
cuesj-706	101	1	frontiers	frontier	NOUN
cuesj-706	101	2	in	in	ADP
cuesj-706	101	3	cell	cell	NOUN
cuesj-706	101	4	and	and	CCONJ
cuesj-706	101	5	developmental	developmental	ADJ
cuesj-706	101	6	biology	biology	NOUN
cuesj-706	101	7	,	,	PUNCT
cuesj-706	101	8	vol	vol	NOUN
cuesj-706	101	9	.	.	PROPN
cuesj-706	101	10	8	8	NUM
cuesj-706	101	11	,	,	PUNCT
cuesj-706	101	12	pp	pp	ADJ
cuesj-706	101	13	.	.	PUNCT
cuesj-706	101	14	1272	1272	NUM
cuesj-706	101	15	,	,	PUNCT
cuesj-706	101	16	2021	2021	NUM
cuesj-706	101	17	.	.	PUNCT
cuesj-706	102	1	6	6	NUM
cuesj-706	102	2	.	.	PUNCT
cuesj-706	102	3	o.	o.	PROPN
cuesj-706	102	4	tsuprykov	tsuprykov	PROPN
cuesj-706	102	5	,	,	PUNCT
cuesj-706	102	6	x.	x.	PROPN
cuesj-706	102	7	chen	chen	PROPN
cuesj-706	102	8	,	,	PUNCT
cuesj-706	102	9	c.	c.	PROPN
cuesj-706	102	10	f.	f.	PROPN
cuesj-706	102	11	hocher	hocher	PROPN
cuesj-706	102	12	,	,	PUNCT
cuesj-706	102	13	r.	r.	PROPN
cuesj-706	102	14	skoblo	skoblo	PROPN
cuesj-706	102	15	,	,	PUNCT
cuesj-706	102	16	l.	l.	PROPN
cuesj-706	102	17	yin	yin	PROPN
cuesj-706	102	18	and	and	CCONJ
cuesj-706	102	19	b.	b.	PROPN
cuesj-706	103	1	hocher.why	hocher.why	PRON
cuesj-706	103	2	should	should	AUX
cuesj-706	103	3	we	we	PRON
cuesj-706	103	4	measure	measure	VERB
cuesj-706	103	5	free	free	ADJ
cuesj-706	103	6	25	25	NUM
cuesj-706	103	7	(	(	PUNCT
cuesj-706	103	8	oh	oh	INTJ
cuesj-706	103	9	)	)	PUNCT
cuesj-706	103	10	vitamin	vitamin	NOUN
cuesj-706	104	1	d	d	NOUN
cuesj-706	104	2	?	?	PUNCT
cuesj-706	105	1	the	the	DET
cuesj-706	105	2	journal	journal	NOUN
cuesj-706	105	3	of	of	ADP
cuesj-706	105	4	steroid	steroid	PROPN
cuesj-706	105	5	biochemistry	biochemistry	NOUN
cuesj-706	105	6	and	and	CCONJ
cuesj-706	105	7	molecular	molecular	ADJ
cuesj-706	105	8	biology	biology	NOUN
cuesj-706	105	9	,	,	PUNCT
cuesj-706	105	10	vol	vol	NOUN
cuesj-706	105	11	.	.	PROPN
cuesj-706	105	12	180	180	NUM
cuesj-706	105	13	,	,	PUNCT
cuesj-706	105	14	pp	pp	ADJ
cuesj-706	105	15	.	.	PUNCT
cuesj-706	106	1	87	87	NUM
cuesj-706	106	2	-	-	SYM
cuesj-706	106	3	104	104	NUM
cuesj-706	106	4	,	,	PUNCT
cuesj-706	106	5	2018	2018	NUM
cuesj-706	106	6	.	.	PUNCT
cuesj-706	107	1	7	7	X
cuesj-706	107	2	.	.	PUNCT
cuesj-706	107	3	s.	s.	PROPN
cuesj-706	107	4	sun	sun	PROPN
cuesj-706	107	5	,	,	PUNCT
cuesj-706	107	6	z.	z.	PROPN
cuesj-706	107	7	liu	liu	PROPN
cuesj-706	107	8	,	,	PUNCT
cuesj-706	107	9	j.	j.	PROPN
cuesj-706	107	10	fang	fang	PROPN
cuesj-706	107	11	,	,	PUNCT
cuesj-706	107	12	y.	y.	PROPN
cuesj-706	107	13	xie	xie	PROPN
cuesj-706	107	14	and	and	CCONJ
cuesj-706	107	15	m.	m.	PROPN
cuesj-706	107	16	zhang	zhang	PROPN
cuesj-706	107	17	,	,	PUNCT
cuesj-706	107	18	j.	j.	PROPN
cuesj-706	107	19	yang	yang	PROPN
cuesj-706	107	20	.	.	PUNCT
cuesj-706	108	1	serum	serum	PROPN
cuesj-706	108	2	fibroblast	fibroblast	ADJ
cuesj-706	108	3	growth	growth	NOUN
cuesj-706	108	4	factor	factor	NOUN
cuesj-706	108	5	23	23	NUM
cuesj-706	108	6	for	for	ADP
cuesj-706	108	7	early	early	ADJ
cuesj-706	108	8	detection	detection	NOUN
cuesj-706	108	9	of	of	ADP
cuesj-706	108	10	acute	acute	ADJ
cuesj-706	108	11	kidney	kidney	NOUN
cuesj-706	108	12	injury	injury	NOUN
cuesj-706	108	13	in	in	ADP
cuesj-706	108	14	critical	critical	ADJ
cuesj-706	108	15	illness	illness	NOUN
cuesj-706	108	16	.	.	PUNCT
cuesj-706	109	1	american	american	ADJ
cuesj-706	109	2	journal	journal	PROPN
cuesj-706	109	3	of	of	ADP
cuesj-706	109	4	translational	translational	ADJ
cuesj-706	109	5	research	research	NOUN
cuesj-706	109	6	,	,	PUNCT
cuesj-706	109	7	vol	vol	NOUN
cuesj-706	109	8	.	.	PROPN
cuesj-706	109	9	13	13	NUM
cuesj-706	109	10	,	,	PUNCT
cuesj-706	109	11	no	no	INTJ
cuesj-706	109	12	.	.	NOUN
cuesj-706	109	13	11	11	NUM
cuesj-706	109	14	,	,	PUNCT
cuesj-706	109	15	p.	p.	NOUN
cuesj-706	109	16	12141	12141	NUM
cuesj-706	109	17	,	,	PUNCT
cuesj-706	109	18	2021	2021	NUM
cuesj-706	109	19	.	.	PUNCT
cuesj-706	110	1	8	8	NUM
cuesj-706	110	2	.	.	X
cuesj-706	110	3	l.	l.	PROPN
cuesj-706	110	4	bär	bär	PROPN
cuesj-706	110	5	,	,	PUNCT
cuesj-706	110	6	p.	p.	NOUN
cuesj-706	110	7	hase	hase	PROPN
cuesj-706	110	8	and	and	CCONJ
cuesj-706	110	9	m.	m.	NOUN
cuesj-706	110	10	föller	föller	PROPN
cuesj-706	110	11	.	.	PUNCT
cuesj-706	111	1	pkc	pkc	PROPN
cuesj-706	111	2	regulates	regulate	VERB
cuesj-706	111	3	the	the	DET
cuesj-706	111	4	production	production	NOUN
cuesj-706	111	5	of	of	ADP
cuesj-706	111	6	fibroblast	fibroblast	ADJ
cuesj-706	111	7	growth	growth	NOUN
cuesj-706	111	8	factor	factor	NOUN
cuesj-706	111	9	23	23	NUM
cuesj-706	111	10	(	(	PUNCT
cuesj-706	111	11	fgf23	fgf23	NOUN
cuesj-706	111	12	)	)	PUNCT
cuesj-706	111	13	.	.	PUNCT
cuesj-706	112	1	plos	plos	PROPN
cuesj-706	112	2	one	one	NUM
cuesj-706	112	3	,	,	PUNCT
cuesj-706	112	4	vol	vol	NOUN
cuesj-706	112	5	.	.	PROPN
cuesj-706	112	6	14	14	NUM
cuesj-706	112	7	,	,	PUNCT
cuesj-706	112	8	no	no	INTJ
cuesj-706	112	9	.	.	NOUN
cuesj-706	112	10	3	3	NUM
cuesj-706	112	11	,	,	PUNCT
cuesj-706	112	12	p.	p.	NOUN
cuesj-706	112	13	e0211309	e0211309	PROPN
cuesj-706	112	14	,	,	PUNCT
cuesj-706	112	15	2019	2019	NUM
cuesj-706	112	16	.	.	PUNCT
cuesj-706	113	1	9	9	NUM
cuesj-706	113	2	.	.	X
cuesj-706	113	3	e.	e.	PROPN
cuesj-706	113	4	r.	r.	PROPN
cuesj-706	113	5	sarhat	sarhat	PROPN
cuesj-706	113	6	and	and	CCONJ
cuesj-706	113	7	n.	n.	PROPN
cuesj-706	113	8	murtadha	murtadha	PROPN
cuesj-706	113	9	.	.	PUNCT
cuesj-706	114	1	biochemical	biochemical	ADJ
cuesj-706	114	2	changes	change	NOUN
cuesj-706	114	3	in	in	ADP
cuesj-706	114	4	chronic	chronic	ADJ
cuesj-706	114	5	renal	renal	ADJ
cuesj-706	114	6	failure	failure	NOUN
cuesj-706	114	7	pre	pre	VERB
cuesj-706	114	8	and	and	CCONJ
cuesj-706	114	9	post	post	VERB
cuesj-706	114	10	hemodialysis	hemodialysis	NOUN
cuesj-706	114	11	.	.	PUNCT
cuesj-706	115	1	primary	primary	ADJ
cuesj-706	115	2	health	health	NOUN
cuesj-706	115	3	care	care	NOUN
cuesj-706	115	4	,	,	PUNCT
cuesj-706	115	5	vol	vol	NOUN
cuesj-706	115	6	.	.	PROPN
cuesj-706	116	1	190	190	NUM
cuesj-706	116	2	,	,	PUNCT
cuesj-706	116	3	pp	pp	ADJ
cuesj-706	116	4	.	.	PUNCT
cuesj-706	117	1	1	1	NUM
cuesj-706	117	2	-	-	SYM
cuesj-706	117	3	3	3	NUM
cuesj-706	117	4	,	,	PUNCT
cuesj-706	117	5	2016	2016	NUM
cuesj-706	117	6	.	.	PUNCT
cuesj-706	118	1	10	10	NUM
cuesj-706	118	2	.	.	PUNCT
cuesj-706	118	3	e.	e.	PROPN
cuesj-706	118	4	r.	r.	PROPN
cuesj-706	118	5	r.	r.	PROPN
cuesj-706	118	6	sarhat	sarhat	PROPN
cuesj-706	118	7	,	,	PUNCT
cuesj-706	118	8	s.	s.	PROPN
cuesj-706	118	9	a.	a.	PROPN
cuesj-706	118	10	wadi	wadi	PROPN
cuesj-706	118	11	,	,	PUNCT
cuesj-706	118	12	n.	n.	PROPN
cuesj-706	118	13	awni	awni	PROPN
cuesj-706	118	14	,	,	PUNCT
cuesj-706	118	15	n.	n.	PROPN
cuesj-706	118	16	j.	j.	PROPN
cuesj-706	118	17	ali	ali	PROPN
cuesj-706	118	18	and	and	CCONJ
cuesj-706	118	19	t.	t.	PROPN
cuesj-706	118	20	r.	r.	PROPN
cuesj-706	118	21	sarhat	sarhat	PROPN
cuesj-706	118	22	.	.	PUNCT
cuesj-706	119	1	evaluation	evaluation	NOUN
cuesj-706	119	2	of	of	ADP
cuesj-706	119	3	vimentin	vimentin	NOUN
cuesj-706	119	4	and	and	CCONJ
cuesj-706	119	5	some	some	DET
cuesj-706	119	6	biochemical	biochemical	ADJ
cuesj-706	119	7	parameters	parameter	NOUN
cuesj-706	119	8	in	in	ADP
cuesj-706	119	9	the	the	DET
cuesj-706	119	10	blood	blood	NOUN
cuesj-706	119	11	of	of	ADP
cuesj-706	119	12	acute	acute	ADJ
cuesj-706	119	13	myocardial	myocardial	ADJ
cuesj-706	119	14	infarction	infarction	NOUN
cuesj-706	119	15	patients	patient	NOUN
cuesj-706	119	16	.	.	PUNCT
cuesj-706	120	1	egyptian	egyptian	ADJ
cuesj-706	120	2	journal	journal	PROPN
cuesj-706	120	3	of	of	ADP
cuesj-706	120	4	chemistry	chemistry	NOUN
cuesj-706	120	5	,	,	PUNCT
cuesj-706	120	6	vol	vol	NOUN
cuesj-706	120	7	.	.	PROPN
cuesj-706	120	8	65	65	NUM
cuesj-706	120	9	,	,	PUNCT
cuesj-706	120	10	no	no	INTJ
cuesj-706	120	11	.	.	NOUN
cuesj-706	120	12	1	1	NUM
cuesj-706	120	13	,	,	PUNCT
cuesj-706	120	14	pp	pp	ADJ
cuesj-706	120	15	.	.	PUNCT
cuesj-706	121	1	1	1	NUM
cuesj-706	121	2	-	-	SYM
cuesj-706	121	3	2	2	NUM
cuesj-706	121	4	,	,	PUNCT
cuesj-706	121	5	2022	2022	NUM
cuesj-706	121	6	.	.	PUNCT
cuesj-706	122	1	11	11	NUM
cuesj-706	122	2	.	.	PUNCT
cuesj-706	122	3	s.	s.	PROPN
cuesj-706	122	4	e.	e.	PROPN
cuesj-706	122	5	ahmed	ahmed	PROPN
cuesj-706	122	6	,	,	PUNCT
cuesj-706	122	7	e.	e.	PROPN
cuesj-706	122	8	r.	r.	PROPN
cuesj-706	122	9	sarhat	sarhat	PROPN
cuesj-706	122	10	,	,	PUNCT
cuesj-706	122	11	n.	n.	PROPN
cuesj-706	122	12	awni	awni	PROPN
cuesj-706	122	13	,	,	PUNCT
cuesj-706	122	14	t.	t.	PROPN
cuesj-706	122	15	sarhat	sarhat	PROPN
cuesj-706	122	16	,	,	PUNCT
cuesj-706	122	17	k.	k.	PROPN
cuesj-706	122	18	s.	s.	PROPN
cuesj-706	122	19	abass	abass	PROPN
cuesj-706	122	20	.	.	PROPN
cuesj-706	123	1	altered	alter	VERB
cuesj-706	123	2	serum	serum	NOUN
cuesj-706	123	3	marker	marker	NOUN
cuesj-706	123	4	of	of	ADP
cuesj-706	123	5	adipokines	adipokine	NOUN
cuesj-706	123	6	profile	profile	NOUN
cuesj-706	123	7	in	in	ADP
cuesj-706	123	8	breast	breast	NOUN
cuesj-706	123	9	cancer	cancer	NOUN
cuesj-706	123	10	women	woman	NOUN
cuesj-706	123	11	.	.	PUNCT
cuesj-706	124	1	indian	indian	PROPN
cuesj-706	124	2	journal	journal	PROPN
cuesj-706	124	3	of	of	ADP
cuesj-706	124	4	forensic	forensic	ADJ
cuesj-706	124	5	medicine	medicine	NOUN
cuesj-706	124	6	and	and	CCONJ
cuesj-706	124	7	toxicology	toxicology	NOUN
cuesj-706	124	8	,	,	PUNCT
cuesj-706	124	9	vol	vol	NOUN
cuesj-706	124	10	.	.	PROPN
cuesj-706	124	11	15	15	NUM
cuesj-706	124	12	,	,	PUNCT
cuesj-706	124	13	no	no	INTJ
cuesj-706	124	14	.	.	NOUN
cuesj-706	124	15	3	3	NUM
cuesj-706	124	16	,	,	PUNCT
cuesj-706	124	17	p.	p.	NOUN
cuesj-706	124	18	2599	2599	NUM
cuesj-706	124	19	,	,	PUNCT
cuesj-706	124	20	2021	2021	NUM
cuesj-706	124	21	.	.	PUNCT
cuesj-706	125	1	12	12	NUM
cuesj-706	125	2	.	.	PUNCT
cuesj-706	125	3	m.	m.	NOUN
cuesj-706	125	4	sochal	sochal	PROPN
cuesj-706	125	5	,	,	PUNCT
cuesj-706	125	6	j.	j.	PROPN
cuesj-706	125	7	fichna	fichna	PROPN
cuesj-706	125	8	,	,	PUNCT
cuesj-706	125	9	a.	a.	NOUN
cuesj-706	125	10	gabryelska	gabryelska	PROPN
cuesj-706	125	11	,	,	PUNCT
cuesj-706	125	12	r.	r.	PROPN
cuesj-706	125	13	talar	talar	ADJ
cuesj-706	125	14	-	-	PUNCT
cuesj-706	125	15	wojnarowska	wojnarowska	ADJ
cuesj-706	125	16	,	,	PUNCT
cuesj-706	125	17	p.	p.	NOUN
cuesj-706	125	18	białasiewicz	białasiewicz	PROPN
cuesj-706	125	19	and	and	CCONJ
cuesj-706	125	20	e.	e.	PROPN
cuesj-706	125	21	m.	m.	PROPN
cuesj-706	125	22	małecka	małecka	PROPN
cuesj-706	125	23	-	-	PUNCT
cuesj-706	125	24	wojciesko	wojciesko	PROPN
cuesj-706	125	25	.	.	PUNCT
cuesj-706	126	1	serum	serum	NOUN
cuesj-706	126	2	levels	level	NOUN
cuesj-706	126	3	of	of	ADP
cuesj-706	126	4	chemerin	chemerin	NOUN
cuesj-706	126	5	in	in	ADP
cuesj-706	126	6	patients	patient	NOUN
cuesj-706	126	7	with	with	ADP
cuesj-706	126	8	inflammatory	inflammatory	ADJ
cuesj-706	126	9	bowel	bowel	NOUN
cuesj-706	126	10	disease	disease	NOUN
cuesj-706	126	11	as	as	ADP
cuesj-706	126	12	an	an	DET
cuesj-706	126	13	indicator	indicator	NOUN
cuesj-706	126	14	of	of	ADP
cuesj-706	126	15	anti	anti	ADJ
cuesj-706	126	16	-	-	ADJ
cuesj-706	126	17	tnf	tnf	ADJ
cuesj-706	126	18	treatment	treatment	NOUN
cuesj-706	126	19	efficacy	efficacy	NOUN
cuesj-706	126	20	.	.	PUNCT
cuesj-706	127	1	journal	journal	NOUN
cuesj-706	127	2	of	of	ADP
cuesj-706	127	3	clinical	clinical	ADJ
cuesj-706	127	4	medicine	medicine	NOUN
cuesj-706	127	5	,	,	PUNCT
cuesj-706	127	6	vol	vol	NOUN
cuesj-706	127	7	.	.	PROPN
cuesj-706	127	8	10	10	NUM
cuesj-706	127	9	,	,	PUNCT
cuesj-706	127	10	no	no	INTJ
cuesj-706	127	11	.	.	NOUN
cuesj-706	127	12	19	19	NUM
cuesj-706	127	13	,	,	PUNCT
cuesj-706	127	14	p.	p.	NOUN
cuesj-706	127	15	4615	4615	NUM
cuesj-706	127	16	,	,	PUNCT
cuesj-706	127	17	2021	2021	NUM
cuesj-706	127	18	.	.	PUNCT
cuesj-706	128	1	13	13	NUM
cuesj-706	128	2	.	.	PUNCT
cuesj-706	128	3	e.	e.	PROPN
cuesj-706	128	4	r.	r.	PROPN
cuesj-706	128	5	sarhat	sarhat	PROPN
cuesj-706	128	6	,	,	PUNCT
cuesj-706	128	7	i.	i.	PROPN
cuesj-706	128	8	m.	m.	PROPN
cuesj-706	128	9	abid	abid	PROPN
cuesj-706	128	10	,	,	PUNCT
cuesj-706	128	11	n.	n.	PROPN
cuesj-706	128	12	a.	a.	PROPN
cuesj-706	128	13	kamel	kamel	PROPN
cuesj-706	128	14	,	,	PUNCT
cuesj-706	128	15	t.	t.	PROPN
cuesj-706	128	16	r.	r.	PROPN
cuesj-706	128	17	sarhat	sarhat	PROPN
cuesj-706	128	18	and	and	CCONJ
cuesj-706	128	19	k.	k.	PROPN
cuesj-706	128	20	s.	s.	PROPN
cuesj-706	128	21	abass	abass	PROPN
cuesj-706	128	22	.	.	PUNCT
cuesj-706	129	1	changes	change	NOUN
cuesj-706	129	2	of	of	ADP
cuesj-706	129	3	serum	serum	NOUN
cuesj-706	129	4	interleukin	interleukin	NOUN
cuesj-706	129	5	and	and	CCONJ
cuesj-706	129	6	chemerin	chemerin	NOUN
cuesj-706	129	7	levels	level	NOUN
cuesj-706	129	8	in	in	ADP
cuesj-706	129	9	patients	patient	NOUN
cuesj-706	129	10	with	with	ADP
cuesj-706	129	11	polycystic	polycystic	ADJ
cuesj-706	129	12	ovary	ovary	ADJ
cuesj-706	129	13	syndrome	syndrome	NOUN
cuesj-706	129	14	.	.	PUNCT
cuesj-706	130	1	journal	journal	NOUN
cuesj-706	130	2	of	of	ADP
cuesj-706	130	3	advanced	advanced	ADJ
cuesj-706	130	4	pharmacy	pharmacy	NOUN
cuesj-706	130	5	education	education	NOUN
cuesj-706	130	6	and	and	CCONJ
cuesj-706	130	7	research	research	NOUN
cuesj-706	130	8	,	,	PUNCT
cuesj-706	130	9	vol	vol	NOUN
cuesj-706	130	10	.	.	PROPN
cuesj-706	130	11	11	11	NUM
cuesj-706	130	12	,	,	PUNCT
cuesj-706	130	13	pp	pp	ADJ
cuesj-706	130	14	.	.	PUNCT
cuesj-706	131	1	11	11	NUM
cuesj-706	131	2	-	-	SYM
cuesj-706	131	3	13	13	NUM
cuesj-706	131	4	,	,	PUNCT
cuesj-706	131	5	no	no	INTJ
cuesj-706	131	6	.	.	NOUN
cuesj-706	131	7	4	4	NUM
cuesj-706	131	8	,	,	PUNCT
cuesj-706	131	9	2021	2021	NUM
cuesj-706	131	10	.	.	PUNCT
cuesj-706	132	1	14	14	NUM
cuesj-706	132	2	.	.	PUNCT
cuesj-706	132	3	m.	m.	PROPN
cuesj-706	132	4	s.	s.	PROPN
cuesj-706	132	5	vandikas	vandikas	PROPN
cuesj-706	132	6	,	,	PUNCT
cuesj-706	132	7	k.	k.	PROPN
cuesj-706	132	8	landin	landin	PROPN
cuesj-706	132	9	-	-	PUNCT
cuesj-706	132	10	wilhelmsen	wilhelmsen	NOUN
cuesj-706	132	11	,	,	PUNCT
cuesj-706	132	12	a.	a.	NOUN
cuesj-706	132	13	holmäng	holmäng	NOUN
cuesj-706	132	14	,	,	PUNCT
cuesj-706	132	15	m.	m.	NOUN
cuesj-706	132	16	gillstedt	gillstedt	NOUN
cuesj-706	132	17	and	and	CCONJ
cuesj-706	132	18	a.	a.	NOUN
cuesj-706	132	19	osmancevic	osmancevic	PROPN
cuesj-706	132	20	.	.	PUNCT
cuesj-706	133	1	high	high	ADJ
cuesj-706	133	2	levels	level	NOUN
cuesj-706	133	3	of	of	ADP
cuesj-706	133	4	serum	serum	NOUN
cuesj-706	133	5	vitamin	vitamin	NOUN
cuesj-706	133	6	d	d	NOUN
cuesj-706	133	7	-	-	ADJ
cuesj-706	133	8	binding	bind	VERB
cuesj-706	133	9	protein	protein	NOUN
cuesj-706	133	10	in	in	ADP
cuesj-706	133	11	patients	patient	NOUN
cuesj-706	133	12	with	with	ADP
cuesj-706	133	13	psoriasis	psoriasis	NOUN
cuesj-706	133	14	:	:	PUNCT
cuesj-706	133	15	a	a	DET
cuesj-706	133	16	case	case	NOUN
cuesj-706	133	17	-	-	PUNCT
cuesj-706	133	18	control	control	NOUN
cuesj-706	133	19	study	study	NOUN
cuesj-706	133	20	and	and	CCONJ
cuesj-706	133	21	effects	effect	NOUN
cuesj-706	133	22	of	of	ADP
cuesj-706	133	23	ultraviolet	ultraviolet	NOUN
cuesj-706	133	24	b	b	PROPN
cuesj-706	133	25	phototherapy	phototherapy	NOUN
cuesj-706	133	26	.	.	PUNCT
cuesj-706	134	1	the	the	DET
cuesj-706	134	2	journal	journal	NOUN
cuesj-706	134	3	of	of	ADP
cuesj-706	134	4	steroid	steroid	PROPN
cuesj-706	134	5	biochemistry	biochemistry	NOUN
cuesj-706	134	6	and	and	CCONJ
cuesj-706	134	7	molecular	molecular	ADJ
cuesj-706	134	8	biology	biology	NOUN
cuesj-706	134	9	,	,	PUNCT
cuesj-706	134	10	vol	vol	NOUN
cuesj-706	134	11	.	.	NOUN
cuesj-706	134	12	211	211	NUM
cuesj-706	134	13	,	,	PUNCT
cuesj-706	134	14	pp	pp	ADJ
cuesj-706	134	15	.	.	PUNCT
cuesj-706	134	16	105895	105895	NUM
cuesj-706	134	17	,	,	PUNCT
cuesj-706	134	18	2021	2021	NUM
cuesj-706	134	19	.	.	PUNCT
cuesj-706	135	1	15	15	NUM
cuesj-706	135	2	.	.	PUNCT
cuesj-706	135	3	y.	y.	PROPN
cuesj-706	135	4	kuang	kuang	PROPN
cuesj-706	135	5	,	,	PUNCT
cuesj-706	135	6	y.	y.	PROPN
cuesj-706	135	7	y.	y.	PROPN
cuesj-706	135	8	xiao	xiao	PROPN
cuesj-706	135	9	,	,	PUNCT
cuesj-706	135	10	z.	z.	PROPN
cuesj-706	135	11	fang	fang	PROPN
cuesj-706	135	12	,	,	PUNCT
cuesj-706	135	13	y.	y.	PROPN
cuesj-706	135	14	zhang	zhang	PROPN
cuesj-706	135	15	,	,	PUNCT
cuesj-706	135	16	m.	m.	PROPN
cuesj-706	135	17	shen	shen	PROPN
cuesj-706	135	18	,	,	PUNCT
cuesj-706	135	19	x.	x.	PROPN
cuesj-706	135	20	chen	chen	PROPN
cuesj-706	135	21	,	,	PUNCT
cuesj-706	135	22	m.	m.	PROPN
cuesj-706	135	23	chen	chen	PROPN
cuesj-706	135	24	,	,	PUNCT
cuesj-706	135	25	c.	c.	PROPN
cuesj-706	135	26	lv	lv	PROPN
cuesj-706	135	27	and	and	CCONJ
cuesj-706	135	28	w.	w.	PROPN
cuesj-706	135	29	zhu	zhu	PROPN
cuesj-706	135	30	.	.	PUNCT
cuesj-706	136	1	association	association	PROPN
cuesj-706	136	2	of	of	ADP
cuesj-706	136	3	serum	serum	NOUN
cuesj-706	136	4	vitamin	vitamin	NOUN
cuesj-706	136	5	d	d	NOUN
cuesj-706	136	6	with	with	ADP
cuesj-706	136	7	psoriasis	psoriasis	NOUN
cuesj-706	136	8	and	and	CCONJ
cuesj-706	136	9	effect	effect	VERB
cuesj-706	136	10	modification	modification	NOUN
cuesj-706	136	11	by	by	ADP
cuesj-706	136	12	central	central	ADJ
cuesj-706	136	13	obesity	obesity	NOUN
cuesj-706	136	14	.	.	PUNCT
cuesj-706	137	1	frontiers	frontier	NOUN
cuesj-706	137	2	in	in	ADP
cuesj-706	137	3	medicine	medicine	NOUN
cuesj-706	137	4	,	,	PUNCT
cuesj-706	137	5	vol	vol	NOUN
cuesj-706	137	6	.	.	PROPN
cuesj-706	137	7	7	7	NUM
cuesj-706	137	8	,	,	PUNCT
cuesj-706	137	9	p.	p.	NOUN
cuesj-706	137	10	236	236	NUM
cuesj-706	137	11	,	,	PUNCT
cuesj-706	137	12	2020	2020	NUM
cuesj-706	137	13	.	.	PUNCT
cuesj-706	138	1	16	16	NUM
cuesj-706	138	2	.	.	PUNCT
cuesj-706	139	1	c.	c.	PROPN
cuesj-706	139	2	b.	b.	PROPN
cuesj-706	139	3	langman	langman	PROPN
cuesj-706	139	4	and	and	CCONJ
cuesj-706	139	5	j.	j.	PROPN
cuesj-706	139	6	b.	b.	PROPN
cuesj-706	139	7	cannata	cannata	PROPN
cuesj-706	139	8	-	-	PUNCT
cuesj-706	139	9	andía	andía	NOUN
cuesj-706	139	10	.	.	PUNCT
cuesj-706	140	1	calcium	calcium	NOUN
cuesj-706	140	2	in	in	ADP
cuesj-706	140	3	chronic	chronic	ADJ
cuesj-706	140	4	kidney	kidney	NOUN
cuesj-706	140	5	disease	disease	NOUN
cuesj-706	140	6	:	:	PUNCT
cuesj-706	140	7	myths	myth	NOUN
cuesj-706	140	8	and	and	CCONJ
cuesj-706	140	9	realities	reality	NOUN
cuesj-706	140	10	.	.	PUNCT
cuesj-706	141	1	journal	journal	NOUN
cuesj-706	141	2	of	of	ADP
cuesj-706	141	3	the	the	DET
cuesj-706	141	4	american	american	ADJ
cuesj-706	141	5	society	society	NOUN
cuesj-706	141	6	of	of	ADP
cuesj-706	141	7	nephrology	nephrology	NOUN
cuesj-706	141	8	,	,	PUNCT
cuesj-706	141	9	vol	vol	NOUN
cuesj-706	141	10	.	.	PROPN
cuesj-706	141	11	5	5	NUM
cuesj-706	141	12	,	,	PUNCT
cuesj-706	141	13	pp	pp	ADJ
cuesj-706	141	14	.	.	PUNCT
cuesj-706	142	1	s1	s1	NOUN
cuesj-706	142	2	-	-	PUNCT
cuesj-706	142	3	s2	s2	NOUN
cuesj-706	142	4	,	,	PUNCT
cuesj-706	142	5	2010	2010	NUM
cuesj-706	142	6	.	.	PUNCT
cuesj-706	143	1	17	17	NUM
cuesj-706	143	2	.	.	PUNCT
cuesj-706	144	1	h.	h.	PROPN
cuesj-706	144	2	k.	k.	PROPN
cuesj-706	144	3	bhattarai	bhattarai	PROPN
cuesj-706	144	4	,	,	PUNCT
cuesj-706	144	5	s.	s.	PROPN
cuesj-706	144	6	shrestha	shrestha	PROPN
cuesj-706	144	7	,	,	PUNCT
cuesj-706	144	8	k.	k.	PROPN
cuesj-706	144	9	rokka	rokka	VERB
cuesj-706	144	10	and	and	CCONJ
cuesj-706	144	11	r.	r.	PROPN
cuesj-706	144	12	shakya	shakya	PROPN
cuesj-706	144	13	.	.	PUNCT
cuesj-706	145	1	vitamin	vitamin	PROPN
cuesj-706	145	2	d	d	NOUN
cuesj-706	145	3	,	,	PUNCT
cuesj-706	145	4	calcium	calcium	NOUN
cuesj-706	145	5	,	,	PUNCT
cuesj-706	145	6	parathyroid	parathyroid	ADJ
cuesj-706	145	7	hormone	hormone	NOUN
cuesj-706	145	8	,	,	PUNCT
cuesj-706	145	9	and	and	CCONJ
cuesj-706	145	10	sex	sex	NOUN
cuesj-706	145	11	steroids	steroid	NOUN
cuesj-706	145	12	in	in	ADP
cuesj-706	145	13	bone	bone	NOUN
cuesj-706	145	14	health	health	NOUN
cuesj-706	145	15	and	and	CCONJ
cuesj-706	145	16	effects	effect	NOUN
cuesj-706	145	17	of	of	ADP
cuesj-706	145	18	aging	aging	NOUN
cuesj-706	145	19	.	.	PUNCT
cuesj-706	146	1	journal	journal	NOUN
cuesj-706	146	2	of	of	ADP
cuesj-706	146	3	osteoporosis	osteoporosis	NOUN
cuesj-706	146	4	,	,	PUNCT
cuesj-706	146	5	vol	vol	NOUN
cuesj-706	146	6	.	.	PUNCT
cuesj-706	146	7	2020	2020	NUM
cuesj-706	146	8	,	,	PUNCT
cuesj-706	146	9	p.	p.	NOUN
cuesj-706	146	10	9324505	9324505	NUM
cuesj-706	146	11	,	,	PUNCT
cuesj-706	146	12	2020	2020	NUM
cuesj-706	146	13	.	.	PUNCT
cuesj-706	147	1	18	18	NUM
cuesj-706	147	2	.	.	PUNCT
cuesj-706	147	3	a.	a.	NOUN
cuesj-706	147	4	kolaszko	kolaszko	PROPN
cuesj-706	147	5	,	,	PUNCT
cuesj-706	147	6	e.	e.	PROPN
cuesj-706	147	7	nowalany	nowalany	PROPN
cuesj-706	147	8	-	-	PUNCT
cuesj-706	147	9	kozielska	kozielska	PROPN
cuesj-706	147	10	,	,	PUNCT
cuesj-706	147	11	p.	p.	PROPN
cuesj-706	147	12	ceranowicz	ceranowicz	PROPN
cuesj-706	147	13	,	,	PUNCT
cuesj-706	147	14	b.	b.	PROPN
cuesj-706	147	15	morawiec	morawiec	PROPN
cuesj-706	147	16	and	and	CCONJ
cuesj-706	147	17	g.	g.	PROPN
cuesj-706	147	18	j.	j.	PROPN
cuesj-706	147	19	d.	d.	PROPN
cuesj-706	147	20	m.	m.	PROPN
cuesj-706	147	21	kubiak	kubiak	PROPN
cuesj-706	147	22	.	.	PUNCT
cuesj-706	148	1	the	the	DET
cuesj-706	148	2	role	role	NOUN
cuesj-706	148	3	of	of	ADP
cuesj-706	148	4	parathyroid	parathyroid	ADJ
cuesj-706	148	5	hormone	hormone	NOUN
cuesj-706	148	6	and	and	CCONJ
cuesj-706	148	7	vitamin	vitamin	NOUN
cuesj-706	148	8	d	d	NOUN
cuesj-706	148	9	serum	serum	NOUN
cuesj-706	148	10	concentrations	concentration	NOUN
cuesj-706	148	11	in	in	ADP
cuesj-706	148	12	patients	patient	NOUN
cuesj-706	148	13	with	with	ADP
cuesj-706	148	14	cardiovascular	cardiovascular	ADJ
cuesj-706	148	15	diseases	disease	NOUN
cuesj-706	148	16	.	.	PUNCT
cuesj-706	149	1	disease	disease	NOUN
cuesj-706	149	2	markers	marker	NOUN
cuesj-706	149	3	,	,	PUNCT
cuesj-706	149	4	vol	vol	NOUN
cuesj-706	149	5	.	.	NOUN
cuesj-706	149	6	2018	2018	NUM
cuesj-706	149	7	,	,	PUNCT
cuesj-706	149	8	pp.1	pp.1	NOUN
cuesj-706	149	9	-	-	PUNCT
cuesj-706	149	10	9	9	NUM
cuesj-706	149	11	,	,	PUNCT
cuesj-706	149	12	2018	2018	NUM
cuesj-706	149	13	.	.	PUNCT
cuesj-706	150	1	19	19	NUM
cuesj-706	150	2	.	.	PUNCT
cuesj-706	150	3	j.	j.	PROPN
cuesj-706	150	4	mäkitaipale	mäkitaipale	PROPN
cuesj-706	150	5	,	,	PUNCT
cuesj-706	150	6	s.	s.	PROPN
cuesj-706	150	7	sankari	sankari	PROPN
cuesj-706	150	8	,	,	PUNCT
cuesj-706	150	9	h.	h.	PROPN
cuesj-706	150	10	sievänen	sievänen	PROPN
cuesj-706	150	11	and	and	CCONJ
cuesj-706	150	12	o.	o.	PROPN
cuesj-706	150	13	laitinenvapaavuori	laitinenvapaavuori	PROPN
cuesj-706	150	14	.	.	PUNCT
cuesj-706	151	1	the	the	DET
cuesj-706	151	2	relationship	relationship	NOUN
cuesj-706	151	3	between	between	ADP
cuesj-706	151	4	serum	serum	NOUN
cuesj-706	151	5	25	25	NUM
cuesj-706	151	6	-	-	PUNCT
cuesj-706	151	7	hydroxyvitamin	hydroxyvitamin	NOUN
cuesj-706	151	8	d	d	NOUN
cuesj-706	151	9	and	and	CCONJ
cuesj-706	151	10	parathyroid	parathyroid	ADJ
cuesj-706	151	11	hormone	hormone	NOUN
cuesj-706	151	12	concentration	concentration	NOUN
cuesj-706	151	13	in	in	ADP
cuesj-706	151	14	assessing	assess	VERB
cuesj-706	151	15	vitamin	vitamin	NOUN
cuesj-706	151	16	d	d	NOUN
cuesj-706	151	17	deficiency	deficiency	NOUN
cuesj-706	151	18	in	in	ADP
cuesj-706	151	19	pet	pet	ADJ
cuesj-706	151	20	rabbits	rabbit	NOUN
cuesj-706	151	21	.	.	PUNCT
cuesj-706	152	1	bmc	bmc	ADJ
cuesj-706	152	2	veterinary	veterinary	ADJ
cuesj-706	152	3	research	research	NOUN
cuesj-706	152	4	,	,	PUNCT
cuesj-706	152	5	vol	vol	NOUN
cuesj-706	152	6	.	.	PROPN
cuesj-706	153	1	16	16	NUM
cuesj-706	153	2	,	,	PUNCT
cuesj-706	153	3	no	no	INTJ
cuesj-706	153	4	.	.	NOUN
cuesj-706	153	5	1	1	NUM
cuesj-706	153	6	,	,	PUNCT
cuesj-706	153	7	pp	pp	ADJ
cuesj-706	153	8	.	.	PUNCT
cuesj-706	154	1	1	1	NUM
cuesj-706	154	2	-	-	SYM
cuesj-706	154	3	8	8	NUM
cuesj-706	154	4	,	,	PUNCT
cuesj-706	154	5	2020	2020	NUM
cuesj-706	154	6	.	.	PUNCT
cuesj-706	155	1	20	20	NUM
cuesj-706	155	2	.	.	PUNCT
cuesj-706	155	3	m.	m.	PROPN
cuesj-706	155	4	s.	s.	PROPN
cuesj-706	155	5	regaña	regaña	PROPN
cuesj-706	155	6	,	,	PUNCT
cuesj-706	155	7	g.	g.	PROPN
cuesj-706	155	8	m.	m.	PROPN
cuesj-706	155	9	ezquerra	ezquerra	PROPN
cuesj-706	155	10	and	and	CCONJ
cuesj-706	155	11	p.	p.	PROPN
cuesj-706	155	12	u.	u.	PROPN
cuesj-706	155	13	millet	millet	PROPN
cuesj-706	155	14	.	.	PUNCT
cuesj-706	156	1	serum	serum	PROPN
cuesj-706	156	2	levels	level	NOUN
cuesj-706	156	3	of	of	ADP
cuesj-706	156	4	parathyroid	parathyroid	ADJ
cuesj-706	156	5	hormone	hormone	NOUN
cuesj-706	156	6	and	and	CCONJ
cuesj-706	156	7	parathyroid‐related	parathyroid‐relate	VERB
cuesj-706	156	8	peptide	peptide	NOUN
cuesj-706	156	9	in	in	ADP
cuesj-706	156	10	psoriasis	psoriasis	NOUN
cuesj-706	156	11	.	.	PUNCT
cuesj-706	157	1	acta	acta	PROPN
cuesj-706	157	2	dermato	dermato	PROPN
cuesj-706	157	3	-	-	PUNCT
cuesj-706	157	4	venereologica	venereologica	PROPN
cuesj-706	157	5	,	,	PUNCT
cuesj-706	157	6	vol	vol	NOUN
cuesj-706	157	7	.	.	PROPN
cuesj-706	157	8	85	85	NUM
cuesj-706	157	9	,	,	PUNCT
cuesj-706	157	10	no	no	INTJ
cuesj-706	157	11	.	.	NOUN
cuesj-706	157	12	5	5	NUM
cuesj-706	157	13	,	,	PUNCT
cuesj-706	157	14	2005	2005	NUM
cuesj-706	157	15	.	.	PUNCT
cuesj-706	158	1	21	21	NUM
cuesj-706	158	2	.	.	PUNCT
cuesj-706	158	3	b.	b.	PROPN
cuesj-706	158	4	zhang	zhang	PROPN
cuesj-706	158	5	,	,	PUNCT
cuesj-706	158	6	a.	a.	NOUN
cuesj-706	158	7	t.	t.	PROPN
cuesj-706	158	8	umbach	umbach	PROPN
cuesj-706	158	9	,	,	PUNCT
cuesj-706	158	10	h.	h.	PROPN
cuesj-706	158	11	chen	chen	PROPN
cuesj-706	158	12	,	,	PUNCT
cuesj-706	158	13	j.	j.	PROPN
cuesj-706	158	14	yan	yan	PROPN
cuesj-706	158	15	,	,	PUNCT
cuesj-706	158	16	h.	h.	PROPN
cuesj-706	158	17	fakhri	fakhri	PROPN
cuesj-706	158	18	,	,	PUNCT
cuesj-706	158	19	a.	a.	NOUN
cuesj-706	158	20	fajol	fajol	NOUN
cuesj-706	158	21	,	,	PUNCT
cuesj-706	158	22	m.	m.	PROPN
cuesj-706	158	23	s.	s.	PROPN
cuesj-706	158	24	salker	salker	PROPN
cuesj-706	158	25	,	,	PUNCT
cuesj-706	158	26	d.	d.	PROPN
cuesj-706	158	27	spichtig	spichtig	PROPN
cuesj-706	158	28	,	,	PUNCT
cuesj-706	158	29	a.	a.	PROPN
cuesj-706	158	30	daryadel	daryadel	PROPN
cuesj-706	158	31	,	,	PUNCT
cuesj-706	158	32	c.	c.	PROPN
cuesj-706	158	33	a.	a.	PROPN
cuesj-706	158	34	wagner	wagner	PROPN
cuesj-706	158	35	,	,	PUNCT
cuesj-706	158	36	m.	m.	NOUN
cuesj-706	158	37	föller	föller	PROPN
cuesj-706	158	38	and	and	CCONJ
cuesj-706	158	39	f.	f.	PROPN
cuesj-706	158	40	lang	lang	PROPN
cuesj-706	158	41	.	.	PUNCT
cuesj-706	159	1	up	up	ADP
cuesj-706	159	2	-	-	PUNCT
cuesj-706	159	3	regulation	regulation	NOUN
cuesj-706	159	4	of	of	ADP
cuesj-706	159	5	fgf23	fgf23	NOUN
cuesj-706	159	6	release	release	NOUN
cuesj-706	159	7	by	by	ADP
cuesj-706	159	8	aldosterone	aldosterone	NOUN
cuesj-706	159	9	.	.	PUNCT
cuesj-706	160	1	biochemical	biochemical	ADJ
cuesj-706	160	2	and	and	CCONJ
cuesj-706	160	3	biophysical	biophysical	ADJ
cuesj-706	160	4	research	research	NOUN
cuesj-706	160	5	communications	communication	NOUN
cuesj-706	160	6	,	,	PUNCT
cuesj-706	160	7	vol	vol	NOUN
cuesj-706	160	8	.	.	PROPN
cuesj-706	160	9	470	470	NUM
cuesj-706	160	10	,	,	PUNCT
cuesj-706	160	11	no	no	INTJ
cuesj-706	160	12	.	.	NOUN
cuesj-706	160	13	2	2	NUM
cuesj-706	160	14	,	,	PUNCT
cuesj-706	160	15	pp	pp	ADJ
cuesj-706	160	16	.	.	PUNCT
cuesj-706	161	1	384	384	NUM
cuesj-706	161	2	-	-	SYM
cuesj-706	161	3	390	390	NUM
cuesj-706	161	4	,	,	PUNCT
cuesj-706	161	5	2016	2016	NUM
cuesj-706	161	6	.	.	PUNCT
cuesj-706	162	1	22	22	NUM
cuesj-706	162	2	.	.	PUNCT
cuesj-706	163	1	n.	n.	PROPN
cuesj-706	163	2	carrillo	carrillo	PROPN
cuesj-706	163	3	-	-	PUNCT
cuesj-706	163	4	lópez	lópez	PROPN
cuesj-706	163	5	,	,	PUNCT
cuesj-706	163	6	p.	p.	NOUN
cuesj-706	163	7	román	román	NOUN
cuesj-706	163	8	-	-	PUNCT
cuesj-706	163	9	garcía	garcía	ADJ
cuesj-706	163	10	,	,	PUNCT
cuesj-706	163	11	a.	a.	NOUN
cuesj-706	163	12	rodríguez	rodríguez	NOUN
cuesj-706	163	13	-	-	PUNCT
cuesj-706	163	14	rebollar	rebollar	ADJ
cuesj-706	163	15	,	,	PUNCT
cuesj-706	163	16	j.	j.	PROPN
cuesj-706	163	17	l.	l.	PROPN
cuesj-706	163	18	fernández	fernández	PROPN
cuesj-706	163	19	-	-	PUNCT
cuesj-706	163	20	martín	martín	NOUN
cuesj-706	163	21	,	,	PUNCT
cuesj-706	163	22	m.	m.	NOUN
cuesj-706	163	23	naves	nave	NOUN
cuesj-706	163	24	-	-	PUNCT
cuesj-706	163	25	díaz	díaz	NOUN
cuesj-706	163	26	and	and	CCONJ
cuesj-706	163	27	j.	j.	PROPN
cuesj-706	163	28	b.	b.	PROPN
cuesj-706	163	29	cannata	cannata	PROPN
cuesj-706	163	30	-	-	PUNCT
cuesj-706	163	31	andía	andía	NOUN
cuesj-706	163	32	.	.	PUNCT
cuesj-706	164	1	indirect	indirect	ADJ
cuesj-706	164	2	regulation	regulation	NOUN
cuesj-706	164	3	of	of	ADP
cuesj-706	164	4	pth	pth	NOUN
cuesj-706	164	5	by	by	ADP
cuesj-706	164	6	estrogens	estrogen	NOUN
cuesj-706	164	7	may	may	AUX
cuesj-706	164	8	require	require	VERB
cuesj-706	164	9	fgf23	fgf23	PROPN
cuesj-706	164	10	.	.	PUNCT
cuesj-706	165	1	journal	journal	PROPN
cuesj-706	165	2	of	of	ADP
cuesj-706	165	3	the	the	DET
cuesj-706	165	4	american	american	ADJ
cuesj-706	165	5	society	society	NOUN
cuesj-706	165	6	of	of	ADP
cuesj-706	165	7	nephrology	nephrology	NOUN
cuesj-706	165	8	,	,	PUNCT
cuesj-706	165	9	vol	vol	NOUN
cuesj-706	165	10	.	.	PROPN
cuesj-706	165	11	20	20	NUM
cuesj-706	165	12	,	,	PUNCT
cuesj-706	165	13	no	no	INTJ
cuesj-706	165	14	.	.	NOUN
cuesj-706	165	15	9	9	NUM
cuesj-706	165	16	,	,	PUNCT
cuesj-706	165	17	pp	pp	ADJ
cuesj-706	165	18	.	.	PUNCT
cuesj-706	166	1	2009	2009	NUM
cuesj-706	166	2	-	-	SYM
cuesj-706	166	3	2017	2017	NUM
cuesj-706	166	4	,	,	PUNCT
cuesj-706	166	5	2009	2009	NUM
cuesj-706	166	6	.	.	PUNCT
cuesj-706	167	1	23	23	NUM
cuesj-706	167	2	.	.	PUNCT
cuesj-706	167	3	i.	i.	PROPN
cuesj-706	167	4	zanoni	zanoni	PROPN
cuesj-706	168	1	and	and	CCONJ
cuesj-706	168	2	f.	f.	PROPN
cuesj-706	168	3	j.	j.	PROPN
cuesj-706	168	4	e.	e.	PROPN
cuesj-706	168	5	granucci	granucci	PROPN
cuesj-706	168	6	.	.	PUNCT
cuesj-706	169	1	regulation	regulation	NOUN
cuesj-706	169	2	and	and	CCONJ
cuesj-706	169	3	dysregulation	dysregulation	NOUN
cuesj-706	169	4	of	of	ADP
cuesj-706	169	5	innate	innate	ADJ
cuesj-706	169	6	immunity	immunity	NOUN
cuesj-706	169	7	by	by	ADP
cuesj-706	169	8	nfat	nfat	NOUN
cuesj-706	169	9	signaling	signal	VERB
cuesj-706	169	10	downstream	downstream	NOUN
cuesj-706	169	11	of	of	ADP
cuesj-706	169	12	pattern	pattern	NOUN
cuesj-706	169	13	recognition	recognition	NOUN
cuesj-706	169	14	receptors	receptor	NOUN
cuesj-706	169	15	(	(	PUNCT
cuesj-706	169	16	prrs	prr	NOUN
cuesj-706	169	17	)	)	PUNCT
cuesj-706	169	18	.	.	PUNCT
cuesj-706	170	1	vol	vol	NOUN
cuesj-706	170	2	.	.	PROPN
cuesj-706	171	1	42	42	NUM
cuesj-706	171	2	,	,	PUNCT
cuesj-706	171	3	no	no	INTJ
cuesj-706	171	4	.	.	NOUN
cuesj-706	171	5	8	8	NUM
cuesj-706	171	6	,	,	PUNCT
cuesj-706	171	7	pp	pp	ADJ
cuesj-706	171	8	.	.	PUNCT
cuesj-706	172	1	1924	1924	NUM
cuesj-706	172	2	-	-	SYM
cuesj-706	172	3	1931	1931	NUM
cuesj-706	172	4	,	,	PUNCT
cuesj-706	172	5	2012	2012	NUM
cuesj-706	172	6	.	.	PUNCT
cuesj-706	173	1	24	24	NUM
cuesj-706	173	2	.	.	PUNCT
cuesj-706	173	3	u.	u.	PROPN
cuesj-706	173	4	a.	a.	PROPN
cuesj-706	173	5	s.	s.	PROPN
cuesj-706	173	6	el	el	PROPN
cuesj-706	173	7	din	din	PROPN
cuesj-706	173	8	,	,	PUNCT
cuesj-706	173	9	m.	m.	NOUN
cuesj-706	173	10	m.	m.	NOUN
cuesj-706	173	11	salem	salem	PROPN
cuesj-706	173	12	and	and	CCONJ
cuesj-706	173	13	d.	d.	PROPN
cuesj-706	173	14	o.	o.	PROPN
cuesj-706	173	15	abdulazim	abdulazim	PROPN
cuesj-706	173	16	.	.	PUNCT
cuesj-706	173	17	is	be	AUX
cuesj-706	173	18	fibroblast	fibroblast	ADJ
cuesj-706	173	19	growth	growth	NOUN
cuesj-706	173	20	factor	factor	NOUN
cuesj-706	173	21	23	23	NUM
cuesj-706	173	22	the	the	DET
cuesj-706	173	23	leading	lead	VERB
cuesj-706	173	24	cause	cause	NOUN
cuesj-706	173	25	of	of	ADP
cuesj-706	173	26	increased	increase	VERB
cuesj-706	173	27	mortality	mortality	NOUN
cuesj-706	173	28	among	among	ADP
cuesj-706	173	29	chronic	chronic	ADJ
cuesj-706	173	30	kidney	kidney	NOUN
cuesj-706	173	31	disease	disease	NOUN
cuesj-706	173	32	patients	patient	NOUN
cuesj-706	173	33	?	?	PUNCT
cuesj-706	174	1	a	a	DET
cuesj-706	174	2	narrative	narrative	NOUN
cuesj-706	174	3	review	review	NOUN
cuesj-706	174	4	.	.	PUNCT
cuesj-706	175	1	journal	journal	PROPN
cuesj-706	175	2	of	of	ADP
cuesj-706	175	3	advanced	advanced	ADJ
cuesj-706	175	4	research	research	NOUN
cuesj-706	175	5	,	,	PUNCT
cuesj-706	175	6	vol	vol	NOUN
cuesj-706	175	7	.	.	PROPN
cuesj-706	175	8	8	8	NUM
cuesj-706	175	9	,	,	PUNCT
cuesj-706	175	10	no	no	INTJ
cuesj-706	175	11	.	.	NOUN
cuesj-706	175	12	3	3	NUM
cuesj-706	175	13	,	,	PUNCT
cuesj-706	175	14	pp	pp	ADJ
cuesj-706	175	15	.	.	PUNCT
cuesj-706	176	1	271	271	NUM
cuesj-706	176	2	-	-	SYM
cuesj-706	176	3	278	278	NUM
cuesj-706	176	4	,	,	PUNCT
cuesj-706	176	5	2017	2017	NUM
cuesj-706	176	6	.	.	PUNCT
cuesj-706	177	1	25	25	NUM
cuesj-706	177	2	.	.	PUNCT
cuesj-706	177	3	g.	g.	PROPN
cuesj-706	177	4	okan	okan	PROPN
cuesj-706	177	5	,	,	PUNCT
cuesj-706	177	6	a.	a.	NOUN
cuesj-706	177	7	m.	m.	PROPN
cuesj-706	177	8	baki	baki	PROPN
cuesj-706	177	9	,	,	PUNCT
cuesj-706	177	10	e.	e.	PROPN
cuesj-706	177	11	yorulmaz	yorulmaz	PROPN
cuesj-706	177	12	,	,	PUNCT
cuesj-706	177	13	s.	s.	PROPN
cuesj-706	177	14	doğru	doğru	PROPN
cuesj-706	177	15	-	-	PUNCT
cuesj-706	177	16	abbasoğlu	abbasoğlu	VERB
cuesj-706	177	17	and	and	CCONJ
cuesj-706	177	18	p.	p.	PROPN
cuesj-706	177	19	vural	vural	NOUN
cuesj-706	177	20	.	.	PUNCT
cuesj-706	178	1	fibroblast	fibroblast	ADJ
cuesj-706	178	2	growth	growth	NOUN
cuesj-706	178	3	factor	factor	NOUN
cuesj-706	178	4	23	23	NUM
cuesj-706	178	5	and	and	CCONJ
cuesj-706	178	6	placental	placental	ADJ
cuesj-706	178	7	growth	growth	NOUN
cuesj-706	178	8	factor	factor	NOUN
cuesj-706	178	9	in	in	ADP
cuesj-706	178	10	patients	patient	NOUN
cuesj-706	178	11	with	with	ADP
cuesj-706	178	12	psoriasis	psoriasis	NOUN
cuesj-706	178	13	and	and	CCONJ
cuesj-706	178	14	their	their	PRON
cuesj-706	178	15	relation	relation	NOUN
cuesj-706	178	16	to	to	PART
cuesj-706	178	17	disease	disease	NOUN
cuesj-706	178	18	severity	severity	NOUN
cuesj-706	178	19	.	.	PUNCT
cuesj-706	179	1	annals	annal	NOUN
cuesj-706	179	2	of	of	ADP
cuesj-706	179	3	clinical	clinical	ADJ
cuesj-706	179	4	laboratory	laboratory	NOUN
cuesj-706	179	5	science	science	NOUN
cuesj-706	179	6	,	,	PUNCT
cuesj-706	179	7	vol	vol	NOUN
cuesj-706	179	8	.	.	PROPN
cuesj-706	179	9	46	46	NUM
cuesj-706	179	10	,	,	PUNCT
cuesj-706	179	11	no	no	INTJ
cuesj-706	179	12	.	.	NOUN
cuesj-706	179	13	2	2	NUM
cuesj-706	179	14	,	,	PUNCT
cuesj-706	179	15	pp	pp	ADJ
cuesj-706	179	16	.	.	PUNCT
cuesj-706	179	17	174	174	NUM
cuesj-706	179	18	-	-	SYM
cuesj-706	179	19	179	179	NUM
cuesj-706	179	20	,	,	PUNCT
cuesj-706	179	21	2016	2016	NUM
cuesj-706	179	22	.	.	PUNCT
cuesj-706	180	1	26	26	NUM
cuesj-706	180	2	.	.	PUNCT
cuesj-706	180	3	e.	e.	PROPN
cuesj-706	180	4	riffat	riffat	PROPN
cuesj-706	180	5	sarhat	sarhat	PROPN
cuesj-706	180	6	,	,	PUNCT
cuesj-706	180	7	s.	s.	PROPN
cuesj-706	180	8	j.	j.	PROPN
cuesj-706	180	9	khalaf	khalaf	PROPN
cuesj-706	180	10	and	and	CCONJ
cuesj-706	180	11	m.	m.	PROPN
cuesj-706	180	12	s.	s.	PROPN
cuesj-706	180	13	hamad	hamad	PROPN
cuesj-706	180	14	.	.	PUNCT
cuesj-706	181	1	a	a	DET
cuesj-706	181	2	study	study	NOUN
cuesj-706	181	3	of	of	ADP
cuesj-706	181	4	some	some	DET
cuesj-706	181	5	biochemical	biochemical	ADJ
cuesj-706	181	6	parameters	parameter	NOUN
cuesj-706	181	7	in	in	ADP
cuesj-706	181	8	blood	blood	NOUN
cuesj-706	181	9	serum	serum	NOUN
cuesj-706	181	10	of	of	ADP
cuesj-706	181	11	patients	patient	NOUN
cuesj-706	181	12	with	with	ADP
cuesj-706	181	13	congestive	congestive	ADJ
cuesj-706	181	14	heart	heart	NOUN
cuesj-706	181	15	failure	failure	NOUN
cuesj-706	181	16	.	.	PUNCT
cuesj-706	182	1	vol	vol	NOUN
cuesj-706	182	2	.	.	PROPN
cuesj-706	183	1	10	10	NUM
cuesj-706	183	2	,	,	PUNCT
cuesj-706	183	3	no	no	INTJ
cuesj-706	183	4	.	.	NOUN
cuesj-706	183	5	5	5	NUM
cuesj-706	183	6	,	,	PUNCT
cuesj-706	183	7	p.	p.	NOUN
cuesj-706	183	8	412	412	NUM
cuesj-706	183	9	,	,	PUNCT
cuesj-706	183	10	2019	2019	NUM
cuesj-706	183	11	.	.	PUNCT
cuesj-706	184	1	27	27	NUM
cuesj-706	184	2	.	.	PUNCT
cuesj-706	185	1	p.	p.	NOUN
cuesj-706	185	2	gisondi	gisondi	PROPN
cuesj-706	185	3	,	,	PUNCT
cuesj-706	185	4	v.	v.	PROPN
cuesj-706	185	5	lora	lora	PROPN
cuesj-706	185	6	,	,	PUNCT
cuesj-706	185	7	c.	c.	PROPN
cuesj-706	185	8	bonauguri	bonauguri	PROPN
cuesj-706	185	9	,	,	PUNCT
cuesj-706	185	10	a.	a.	NOUN
cuesj-706	185	11	russo	russo	PROPN
cuesj-706	185	12	,	,	PUNCT
cuesj-706	185	13	g.	g.	PROPN
cuesj-706	185	14	lippi	lippi	PROPN
cuesj-706	185	15	and	and	CCONJ
cuesj-706	185	16	g.	g.	PROPN
cuesj-706	185	17	girolomoni	girolomoni	PROPN
cuesj-706	185	18	.	.	PUNCT
cuesj-706	186	1	serum	serum	PROPN
cuesj-706	186	2	chemerin	chemerin	PROPN
cuesj-706	186	3	is	be	AUX
cuesj-706	186	4	increased	increase	VERB
cuesj-706	186	5	in	in	ADP
cuesj-706	186	6	patients	patient	NOUN
cuesj-706	186	7	with	with	ADP
cuesj-706	186	8	chronic	chronic	ADJ
cuesj-706	186	9	plaque	plaque	NOUN
cuesj-706	186	10	psoriasis	psoriasis	NOUN
cuesj-706	186	11	and	and	CCONJ
cuesj-706	186	12	normalizes	normalize	VERB
cuesj-706	186	13	following	follow	VERB
cuesj-706	186	14	treatment	treatment	NOUN
cuesj-706	186	15	with	with	ADP
cuesj-706	186	16	infliximab	infliximab	NOUN
cuesj-706	186	17	.	.	PUNCT
cuesj-706	187	1	british	british	PROPN
cuesj-706	187	2	journal	journal	PROPN
cuesj-706	187	3	of	of	ADP
cuesj-706	187	4	dermatology	dermatology	NOUN
cuesj-706	187	5	,	,	PUNCT
cuesj-706	187	6	vol	vol	NOUN
cuesj-706	187	7	.	.	PROPN
cuesj-706	187	8	168	168	NUM
cuesj-706	187	9	,	,	PUNCT
cuesj-706	187	10	no	no	INTJ
cuesj-706	187	11	.	.	NOUN
cuesj-706	187	12	4	4	NUM
cuesj-706	187	13	,	,	PUNCT
cuesj-706	187	14	tawfeeq	tawfeeq	ADJ
cuesj-706	187	15	,	,	PUNCT
cuesj-706	187	16	et	et	PROPN
cuesj-706	187	17	al	al	PROPN
cuesj-706	187	18	.	.	PUNCT
cuesj-706	187	19	:	:	PUNCT
cuesj-706	188	1	role	role	NOUN
cuesj-706	188	2	of	of	ADP
cuesj-706	188	3	fibroblast	fibroblast	ADJ
cuesj-706	188	4	growth	growth	NOUN
cuesj-706	188	5	factors	factor	NOUN
cuesj-706	188	6	23	23	NUM
cuesj-706	188	7	,	,	PUNCT
cuesj-706	188	8	chemerin	chemerin	NOUN
cuesj-706	188	9	,	,	PUNCT
cuesj-706	188	10	and	and	CCONJ
cuesj-706	188	11	vitamin	vitamin	NOUN
cuesj-706	188	12	d	d	NOUN
cuesj-706	188	13	in	in	ADP
cuesj-706	188	14	psoriasis	psoriasis	NOUN
cuesj-706	188	15	61	61	NUM
cuesj-706	188	16	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-706	188	17	cuesj	cuesj	ADJ
cuesj-706	188	18	2022	2022	NUM
cuesj-706	188	19	,	,	PUNCT
cuesj-706	188	20	6	6	NUM
cuesj-706	188	21	(	(	PUNCT
cuesj-706	188	22	2	2	NUM
cuesj-706	188	23	):	):	PUNCT
cuesj-706	188	24	57	57	NUM
cuesj-706	188	25	-	-	SYM
cuesj-706	188	26	61	61	NUM
cuesj-706	188	27	pp	pp	NOUN
cuesj-706	188	28	.	.	PUNCT
cuesj-706	189	1	749	749	NUM
cuesj-706	189	2	-	-	SYM
cuesj-706	189	3	755	755	NUM
cuesj-706	189	4	,	,	PUNCT
cuesj-706	189	5	2013	2013	NUM
cuesj-706	189	6	.	.	PUNCT
cuesj-706	190	1	28	28	NUM
cuesj-706	190	2	.	.	PUNCT
cuesj-706	191	1	v.	v.	PROPN
cuesj-706	191	2	lora	lora	PROPN
cuesj-706	191	3	,	,	PUNCT
cuesj-706	191	4	c.	c.	PROPN
cuesj-706	191	5	bonaguri	bonaguri	PROPN
cuesj-706	191	6	,	,	PUNCT
cuesj-706	191	7	p.	p.	NOUN
cuesj-706	191	8	gisondi	gisondi	PROPN
cuesj-706	191	9	,	,	PUNCT
cuesj-706	191	10	f.	f.	PROPN
cuesj-706	191	11	sandei	sandei	PROPN
cuesj-706	191	12	,	,	PUNCT
cuesj-706	191	13	l.	l.	PROPN
cuesj-706	191	14	battistelli	battistelli	PROPN
cuesj-706	191	15	,	,	PUNCT
cuesj-706	191	16	a.	a.	NOUN
cuesj-706	191	17	russo	russo	PROPN
cuesj-706	191	18	,	,	PUNCT
cuesj-706	191	19	a.	a.	NOUN
cuesj-706	191	20	melegari	melegari	NOUN
cuesj-706	191	21	,	,	PUNCT
cuesj-706	191	22	t.	t.	PROPN
cuesj-706	191	23	trenti	trenti	PROPN
cuesj-706	191	24	and	and	CCONJ
cuesj-706	191	25	g.	g.	PROPN
cuesj-706	191	26	lippi	lippi	PROPN
cuesj-706	191	27	and	and	CCONJ
cuesj-706	191	28	g.	g.	PROPN
cuesj-706	191	29	girolomoni	girolomoni	PROPN
cuesj-706	191	30	.	.	PUNCT
cuesj-706	192	1	autoantibody	autoantibody	ADJ
cuesj-706	192	2	induction	induction	NOUN
cuesj-706	192	3	and	and	CCONJ
cuesj-706	192	4	adipokine	adipokine	ADJ
cuesj-706	192	5	levels	level	NOUN
cuesj-706	192	6	in	in	ADP
cuesj-706	192	7	patients	patient	NOUN
cuesj-706	192	8	with	with	ADP
cuesj-706	192	9	psoriasis	psoriasis	NOUN
cuesj-706	192	10	treated	treat	VERB
cuesj-706	192	11	with	with	ADP
cuesj-706	192	12	infliximab	infliximab	PROPN
cuesj-706	192	13	.	.	PUNCT
cuesj-706	192	14	journal	journal	PROPN
cuesj-706	192	15	of	of	ADP
cuesj-706	192	16	immunology	immunology	NOUN
cuesj-706	192	17	research	research	NOUN
cuesj-706	192	18	,	,	PUNCT
cuesj-706	192	19	vol	vol	NOUN
cuesj-706	192	20	.	.	PROPN
cuesj-706	192	21	56	56	NUM
cuesj-706	192	22	,	,	PUNCT
cuesj-706	192	23	no	no	INTJ
cuesj-706	192	24	.	.	NOUN
cuesj-706	192	25	2	2	NUM
cuesj-706	192	26	,	,	PUNCT
cuesj-706	192	27	pp	pp	ADJ
cuesj-706	192	28	.	.	PUNCT
cuesj-706	193	1	382	382	NUM
cuesj-706	193	2	-	-	SYM
cuesj-706	193	3	389	389	NUM
cuesj-706	193	4	,	,	PUNCT
cuesj-706	193	5	2013	2013	NUM
cuesj-706	193	6	.	.	PUNCT
cuesj-706	194	1	29	29	NUM
cuesj-706	194	2	.	.	PUNCT
cuesj-706	195	1	y.	y.	PROPN
cuesj-706	195	2	xue	xue	PROPN
cuesj-706	195	3	,	,	PUNCT
cuesj-706	195	4	l.	l.	PROPN
cuesj-706	195	5	jiang	jiang	PROPN
cuesj-706	195	6	,	,	PUNCT
cuesj-706	195	7	q.	q.	PROPN
cuesj-706	195	8	cheng	cheng	PROPN
cuesj-706	195	9	,	,	PUNCT
cuesj-706	195	10	h.	h.	PROPN
cuesj-706	195	11	chen	chen	PROPN
cuesj-706	195	12	,	,	PUNCT
cuesj-706	195	13	y.	y.	PROPN
cuesj-706	195	14	yu	yu	PROPN
cuesj-706	195	15	,	,	PUNCT
cuesj-706	195	16	y.	y.	PROPN
cuesj-706	195	17	lin	lin	PROPN
cuesj-706	195	18	,	,	PUNCT
cuesj-706	195	19	x.	x.	PROPN
cuesj-706	195	20	yang	yang	PROPN
cuesj-706	195	21	,	,	PUNCT
cuesj-706	195	22	n.	n.	PROPN
cuesj-706	195	23	kong	kong	PROPN
cuesj-706	195	24	,	,	PUNCT
cuesj-706	195	25	x.	x.	PROPN
cuesj-706	195	26	zhu	zhu	PROPN
cuesj-706	195	27	,	,	PUNCT
cuesj-706	195	28	x.	x.	PROPN
cuesj-706	195	29	xu	xu	PROPN
cuesj-706	195	30	,	,	PUNCT
cuesj-706	195	31	w.	w.	PROPN
cuesj-706	195	32	wan	wan	PROPN
cuesj-706	195	33	and	and	CCONJ
cuesj-706	195	34	h.	h.	PROPN
cuesj-706	195	35	zou	zou	PROPN
cuesj-706	195	36	.	.	PUNCT
cuesj-706	196	1	adipokines	adipokine	NOUN
cuesj-706	196	2	in	in	ADP
cuesj-706	196	3	psoriatic	psoriatic	ADJ
cuesj-706	196	4	arthritis	arthritis	NOUN
cuesj-706	196	5	patients	patient	NOUN
cuesj-706	196	6	:	:	PUNCT
cuesj-706	196	7	the	the	DET
cuesj-706	196	8	correlations	correlation	NOUN
cuesj-706	196	9	with	with	ADP
cuesj-706	196	10	osteoclast	osteoclast	ADJ
cuesj-706	196	11	precursors	precursor	NOUN
cuesj-706	196	12	and	and	CCONJ
cuesj-706	196	13	bone	bone	NOUN
cuesj-706	196	14	erosions	erosion	NOUN
cuesj-706	196	15	.	.	PUNCT
cuesj-706	197	1	plos	plos	PROPN
cuesj-706	197	2	one	one	NUM
cuesj-706	197	3	,	,	PUNCT
cuesj-706	197	4	vol	vol	NOUN
cuesj-706	197	5	.	.	PROPN
cuesj-706	197	6	7	7	NUM
cuesj-706	197	7	,	,	PUNCT
cuesj-706	197	8	no	no	INTJ
cuesj-706	197	9	.	.	NOUN
cuesj-706	197	10	10	10	NUM
cuesj-706	197	11	,	,	PUNCT
cuesj-706	197	12	pp	pp	ADJ
cuesj-706	197	13	.	.	PUNCT
cuesj-706	198	1	e46740	e46740	PRON
cuesj-706	198	2	,	,	PUNCT
cuesj-706	198	3	2012	2012	NUM
cuesj-706	198	4	.	.	PUNCT
cuesj-706	199	1	30	30	NUM
cuesj-706	199	2	.	.	PUNCT
cuesj-706	200	1	y.	y.	PROPN
cuesj-706	200	2	song	song	PROPN
cuesj-706	200	3	,	,	PUNCT
cuesj-706	200	4	x.	x.	PROPN
cuesj-706	200	5	zhu	zhu	PROPN
cuesj-706	200	6	,	,	PUNCT
cuesj-706	200	7	z.	z.	PROPN
cuesj-706	200	8	lin	lin	PROPN
cuesj-706	200	9	,	,	PUNCT
cuesj-706	200	10	l.	l.	PROPN
cuesj-706	200	11	luo	luo	PROPN
cuesj-706	200	12	and	and	CCONJ
cuesj-706	200	13	d.	d.	PROPN
cuesj-706	200	14	wen	wen	PROPN
cuesj-706	200	15	.	.	PUNCT
cuesj-706	201	1	the	the	DET
cuesj-706	201	2	potential	potential	ADJ
cuesj-706	201	3	value	value	NOUN
cuesj-706	201	4	of	of	ADP
cuesj-706	201	5	serum	serum	NOUN
cuesj-706	201	6	chemerin	chemerin	NOUN
cuesj-706	201	7	in	in	ADP
cuesj-706	201	8	patients	patient	NOUN
cuesj-706	201	9	with	with	ADP
cuesj-706	201	10	breast	breast	NOUN
cuesj-706	201	11	cancer	cancer	NOUN
cuesj-706	201	12	.	.	PUNCT
cuesj-706	202	1	scientific	scientific	ADJ
cuesj-706	202	2	reports	report	NOUN
cuesj-706	202	3	,	,	PUNCT
cuesj-706	202	4	vol	vol	NOUN
cuesj-706	202	5	.	.	PROPN
cuesj-706	202	6	11	11	NUM
cuesj-706	202	7	,	,	PUNCT
cuesj-706	202	8	no	no	INTJ
cuesj-706	202	9	.	.	NOUN
cuesj-706	202	10	1	1	NUM
cuesj-706	202	11	,	,	PUNCT
cuesj-706	202	12	pp	pp	ADJ
cuesj-706	202	13	.	.	PUNCT
cuesj-706	203	1	1	1	NUM
cuesj-706	203	2	-	-	SYM
cuesj-706	203	3	6	6	NUM
cuesj-706	203	4	,	,	PUNCT
cuesj-706	203	5	2021	2021	NUM
cuesj-706	203	6	.	.	PUNCT
cuesj-706	204	1	31	31	NUM
cuesj-706	204	2	.	.	PUNCT
cuesj-706	205	1	f.	f.	PROPN
cuesj-706	205	2	bai	bai	PROPN
cuesj-706	205	3	,	,	PUNCT
cuesj-706	205	4	w.	w.	PROPN
cuesj-706	205	5	zhen	zhen	PROPN
cuesj-706	205	6	,	,	PUNCT
cuesj-706	205	7	y.	y.	PROPN
cuesj-706	205	8	dong	dong	PROPN
cuesj-706	205	9	,	,	PUNCT
cuesj-706	205	10	j.	j.	PROPN
cuesj-706	205	11	wang	wang	PROPN
cuesj-706	205	12	,	,	PUNCT
cuesj-706	205	13	m.	m.	NOUN
cuesj-706	205	14	a.	a.	NOUN
cuesj-706	205	15	garstka	garstka	PROPN
cuesj-706	205	16	,	,	PUNCT
cuesj-706	205	17	r.	r.	PROPN
cuesj-706	205	18	li	li	PROPN
cuesj-706	205	19	,	,	PUNCT
cuesj-706	205	20	j.	j.	PROPN
cuesj-706	205	21	an	an	PROPN
cuesj-706	205	22	and	and	CCONJ
cuesj-706	205	23	h.	h.	PROPN
cuesj-706	205	24	ma	ma	PROPN
cuesj-706	205	25	.	.	PROPN
cuesj-706	206	1	serum	serum	PROPN
cuesj-706	206	2	levels	level	NOUN
cuesj-706	206	3	of	of	ADP
cuesj-706	206	4	adipokines	adipokine	NOUN
cuesj-706	206	5	and	and	CCONJ
cuesj-706	206	6	cytokines	cytokine	NOUN
cuesj-706	206	7	in	in	ADP
cuesj-706	206	8	psoriasis	psoriasis	NOUN
cuesj-706	206	9	patients	patient	NOUN
cuesj-706	206	10	:	:	PUNCT
cuesj-706	206	11	a	a	DET
cuesj-706	206	12	systematic	systematic	ADJ
cuesj-706	206	13	review	review	NOUN
cuesj-706	206	14	and	and	CCONJ
cuesj-706	206	15	meta	meta	ADJ
cuesj-706	206	16	-	-	PUNCT
cuesj-706	206	17	analysis	analysis	NOUN
cuesj-706	206	18	.	.	PUNCT
cuesj-706	207	1	oncotarget	oncotarget	NOUN
cuesj-706	207	2	,	,	PUNCT
cuesj-706	207	3	vol	vol	NOUN
cuesj-706	207	4	.	.	PROPN
cuesj-706	207	5	9	9	NUM
cuesj-706	207	6	,	,	PUNCT
cuesj-706	207	7	no	no	INTJ
cuesj-706	207	8	.	.	NOUN
cuesj-706	207	9	1	1	NUM
cuesj-706	207	10	,	,	PUNCT
cuesj-706	207	11	p.	p.	NOUN
cuesj-706	207	12	1266	1266	NUM
cuesj-706	207	13	,	,	PUNCT
cuesj-706	207	14	2018	2018	NUM
cuesj-706	207	15	.	.	PUNCT
cuesj-706	208	1	32	32	NUM
cuesj-706	208	2	.	.	PUNCT
cuesj-706	209	1	k.	k.	PROPN
cuesj-706	209	2	m.	m.	PROPN
cuesj-706	209	3	chyl	chyl	PROPN
cuesj-706	209	4	-	-	PUNCT
cuesj-706	209	5	surdacka	surdacka	PROPN
cuesj-706	209	6	,	,	PUNCT
cuesj-706	209	7	a.	a.	NOUN
cuesj-706	209	8	gerkowicz	gerkowicz	NOUN
cuesj-706	209	9	,	,	PUNCT
cuesj-706	209	10	j.	j.	PROPN
cuesj-706	209	11	bartosińska	bartosińska	PROPN
cuesj-706	209	12	,	,	PUNCT
cuesj-706	209	13	m.	m.	NOUN
cuesj-706	209	14	kowal	kowal	PROPN
cuesj-706	209	15	,	,	PUNCT
cuesj-706	209	16	j.	j.	PROPN
cuesj-706	209	17	przepiórka	przepiórka	PROPN
cuesj-706	209	18	-	-	PUNCT
cuesj-706	209	19	kosińska	kosińska	PROPN
cuesj-706	209	20	,	,	PUNCT
cuesj-706	209	21	g.	g.	PROPN
cuesj-706	209	22	surdacki	surdacki	PROPN
cuesj-706	209	23	,	,	PUNCT
cuesj-706	209	24	d.	d.	PROPN
cuesj-706	209	25	krasowska	krasowska	PROPN
cuesj-706	209	26	and	and	CCONJ
cuesj-706	209	27	g.	g.	PROPN
cuesj-706	209	28	chodorowska	chodorowska	PROPN
cuesj-706	209	29	.	.	PUNCT
cuesj-706	210	1	analysis	analysis	NOUN
cuesj-706	210	2	of	of	ADP
cuesj-706	210	3	serum	serum	NOUN
cuesj-706	210	4	chemerin	chemerin	NOUN
cuesj-706	210	5	concentrations	concentration	NOUN
cuesj-706	210	6	in	in	ADP
cuesj-706	210	7	psoriatic	psoriatic	ADJ
cuesj-706	210	8	patients	patient	NOUN
cuesj-706	210	9	in	in	ADP
cuesj-706	210	10	relation	relation	NOUN
cuesj-706	210	11	to	to	ADP
cuesj-706	210	12	metabolic	metabolic	NOUN
cuesj-706	210	13	abnormalities	abnormality	NOUN
cuesj-706	210	14	.	.	PUNCT
cuesj-706	211	1	postepy	postepy	PROPN
cuesj-706	211	2	dermolatol	dermolatol	PROPN
cuesj-706	211	3	alergol	alergol	NOUN
cuesj-706	211	4	,	,	PUNCT
cuesj-706	211	5	vol	vol	NOUN
cuesj-706	211	6	.	.	PROPN
cuesj-706	211	7	36	36	NUM
cuesj-706	211	8	,	,	PUNCT
cuesj-706	211	9	no	no	INTJ
cuesj-706	211	10	.	.	NOUN
cuesj-706	211	11	5	5	NUM
cuesj-706	211	12	,	,	PUNCT
cuesj-706	211	13	p.	p.	NOUN
cuesj-706	211	14	531	531	NUM
cuesj-706	211	15	,	,	PUNCT
cuesj-706	211	16	2019	2019	NUM
cuesj-706	211	17	.	.	PUNCT
cuesj-706	212	1	33	33	NUM
cuesj-706	212	2	.	.	PUNCT
cuesj-706	212	3	m.	m.	NOUN
cuesj-706	212	4	maleki	maleki	PROPN
cuesj-706	212	5	,	,	PUNCT
cuesj-706	212	6	y.	y.	PROPN
cuesj-706	212	7	nahidi	nahidi	PROPN
cuesj-706	212	8	,	,	PUNCT
cuesj-706	212	9	s.	s.	PROPN
cuesj-706	212	10	azizahari	azizahari	PROPN
cuesj-706	212	11	,	,	PUNCT
cuesj-706	212	12	n.	n.	PROPN
cuesj-706	212	13	t.	t.	PROPN
cuesj-706	212	14	meibodi	meibodi	PROPN
cuesj-706	212	15	and	and	CCONJ
cuesj-706	212	16	a.	a.	NOUN
cuesj-706	212	17	hadianfar	hadianfar	PROPN
cuesj-706	212	18	.	.	PUNCT
cuesj-706	213	1	serum	serum	VERB
cuesj-706	213	2	25	25	NUM
cuesj-706	213	3	-	-	PUNCT
cuesj-706	213	4	oh	oh	NUM
cuesj-706	213	5	vitamin	vitamin	NOUN
cuesj-706	213	6	d	d	NOUN
cuesj-706	213	7	level	level	NOUN
cuesj-706	213	8	in	in	ADP
cuesj-706	213	9	psoriatic	psoriatic	ADJ
cuesj-706	213	10	patients	patient	NOUN
cuesj-706	213	11	and	and	CCONJ
cuesj-706	213	12	comparison	comparison	NOUN
cuesj-706	213	13	with	with	ADP
cuesj-706	213	14	control	control	NOUN
cuesj-706	213	15	subjects	subject	NOUN
cuesj-706	213	16	,	,	PUNCT
cuesj-706	213	17	j	j	PROPN
cuesj-706	213	18	cutan	cutan	PROPN
cuesj-706	213	19	med	med	ADJ
cuesj-706	213	20	surg	surg	NOUN
cuesj-706	213	21	,	,	PUNCT
cuesj-706	213	22	vol	vol	NOUN
cuesj-706	213	23	.	.	PROPN
cuesj-706	213	24	20	20	NUM
cuesj-706	213	25	,	,	PUNCT
cuesj-706	213	26	no	no	INTJ
cuesj-706	213	27	.	.	NOUN
cuesj-706	213	28	3	3	NUM
cuesj-706	213	29	,	,	PUNCT
cuesj-706	213	30	pp	pp	ADJ
cuesj-706	213	31	.	.	PUNCT
cuesj-706	213	32	207210	207210	NUM
cuesj-706	213	33	,	,	PUNCT
cuesj-706	213	34	2016	2016	NUM
cuesj-706	213	35	.	.	PUNCT
cuesj-706	214	1	34	34	NUM
cuesj-706	214	2	.	.	PUNCT
cuesj-706	214	3	l.	l.	PROPN
cuesj-706	214	4	barrea	barrea	PROPN
cuesj-706	214	5	,	,	PUNCT
cuesj-706	214	6	m.	m.	PROPN
cuesj-706	214	7	c.	c.	PROPN
cuesj-706	214	8	savanelli	savanelli	PROPN
cuesj-706	214	9	,	,	PUNCT
cuesj-706	214	10	c.	c.	PROPN
cuesj-706	214	11	di	di	PROPN
cuesj-706	214	12	somma	somma	PROPN
cuesj-706	214	13	,	,	PUNCT
cuesj-706	214	14	m.	m.	PROPN
cuesj-706	214	15	napolitano	napolitano	PROPN
cuesj-706	214	16	,	,	PUNCT
cuesj-706	214	17	m.	m.	PROPN
cuesj-706	214	18	megna	megna	PROPN
cuesj-706	214	19	,	,	PUNCT
cuesj-706	214	20	a.	a.	NOUN
cuesj-706	214	21	colao	colao	PROPN
cuesj-706	214	22	and	and	CCONJ
cuesj-706	214	23	s.	s.	PROPN
cuesj-706	214	24	savastano	savastano	PROPN
cuesj-706	214	25	.	.	PUNCT
cuesj-706	215	1	vitamin	vitamin	NOUN
cuesj-706	215	2	d	d	NOUN
cuesj-706	215	3	and	and	CCONJ
cuesj-706	215	4	its	its	PRON
cuesj-706	215	5	role	role	NOUN
cuesj-706	215	6	in	in	ADP
cuesj-706	215	7	psoriasis	psoriasis	NOUN
cuesj-706	215	8	:	:	PUNCT
cuesj-706	215	9	an	an	DET
cuesj-706	215	10	overview	overview	NOUN
cuesj-706	215	11	of	of	ADP
cuesj-706	215	12	the	the	DET
cuesj-706	215	13	dermatologist	dermatologist	NOUN
cuesj-706	215	14	and	and	CCONJ
cuesj-706	215	15	nutritionist	nutritionist	PROPN
cuesj-706	215	16	,	,	PUNCT
cuesj-706	215	17	rev	rev	PROPN
cuesj-706	215	18	endocr	endocr	PROPN
cuesj-706	215	19	metab	metab	PROPN
cuesj-706	215	20	disord	disord	PROPN
cuesj-706	215	21	,	,	PUNCT
cuesj-706	215	22	vol	vol	NOUN
cuesj-706	215	23	.	.	PROPN
cuesj-706	215	24	18	18	NUM
cuesj-706	215	25	,	,	PUNCT
cuesj-706	215	26	no	no	INTJ
cuesj-706	215	27	.	.	NOUN
cuesj-706	215	28	2	2	NUM
cuesj-706	215	29	,	,	PUNCT
cuesj-706	215	30	pp	pp	ADJ
cuesj-706	215	31	.	.	PUNCT
cuesj-706	216	1	195	195	NUM
cuesj-706	216	2	-	-	SYM
cuesj-706	216	3	205	205	NUM
cuesj-706	216	4	,	,	PUNCT
cuesj-706	216	5	2017	2017	NUM
cuesj-706	216	6	.	.	PUNCT
cuesj-706	217	1	35	35	NUM
cuesj-706	217	2	.	.	PUNCT
cuesj-706	217	3	a.	a.	PROPN
cuesj-706	217	4	q.	q.	PROPN
cuesj-706	217	5	hamdi	hamdi	PROPN
cuesj-706	217	6	,	,	PUNCT
cuesj-706	217	7	e.	e.	PROPN
cuesj-706	217	8	r.	r.	PROPN
cuesj-706	217	9	sarhat	sarhat	PROPN
cuesj-706	217	10	,	,	PUNCT
cuesj-706	217	11	n.	n.	PROPN
cuesj-706	217	12	h.	h.	PROPN
cuesj-706	217	13	ali	ali	PROPN
cuesj-706	217	14	and	and	CCONJ
cuesj-706	217	15	t.	t.	PROPN
cuesj-706	217	16	r.	r.	PROPN
cuesj-706	217	17	sarhat	sarhat	PROPN
cuesj-706	217	18	.	.	PUNCT
cuesj-706	218	1	evaluation	evaluation	NOUN
cuesj-706	218	2	of	of	ADP
cuesj-706	218	3	lipocalin-2	lipocalin-2	X
cuesj-706	218	4	and	and	CCONJ
cuesj-706	218	5	visfatin	visfatin	NOUN
cuesj-706	218	6	,	,	PUNCT
cuesj-706	218	7	and	and	CCONJ
cuesj-706	218	8	vitamin	vitamin	NOUN
cuesj-706	218	9	(	(	PUNCT
cuesj-706	218	10	d	d	NOUN
cuesj-706	218	11	,	,	PUNCT
cuesj-706	218	12	c	c	NOUN
cuesj-706	218	13	,	,	PUNCT
cuesj-706	218	14	and	and	CCONJ
cuesj-706	218	15	e	e	X
cuesj-706	218	16	)	)	PUNCT
cuesj-706	218	17	in	in	ADP
cuesj-706	218	18	serum	serum	NOUN
cuesj-706	218	19	of	of	ADP
cuesj-706	218	20	diabetic	diabetic	ADJ
cuesj-706	218	21	patients	patient	NOUN
cuesj-706	218	22	with	with	ADP
cuesj-706	218	23	chronic	chronic	ADJ
cuesj-706	218	24	periodontitis	periodontitis	NOUN
cuesj-706	218	25	.	.	PUNCT
cuesj-706	219	1	indian	indian	PROPN
cuesj-706	219	2	journal	journal	PROPN
cuesj-706	219	3	of	of	ADP
cuesj-706	219	4	forensic	forensic	ADJ
cuesj-706	219	5	medicine	medicine	NOUN
cuesj-706	219	6	and	and	CCONJ
cuesj-706	219	7	toxicolog	toxicolog	ADJ
cuesj-706	219	8	,	,	PUNCT
cuesj-706	219	9	vol	vol	NOUN
cuesj-706	219	10	.	.	PROPN
cuesj-706	219	11	15	15	NUM
cuesj-706	219	12	,	,	PUNCT
cuesj-706	219	13	no	no	INTJ
cuesj-706	219	14	.	.	NOUN
cuesj-706	219	15	2	2	NUM
cuesj-706	219	16	,	,	PUNCT
cuesj-706	219	17	pp	pp	ADJ
cuesj-706	219	18	.	.	PUNCT
cuesj-706	220	1	1668	1668	NUM
cuesj-706	220	2	-	-	SYM
cuesj-706	220	3	1674	1674	NUM
cuesj-706	220	4	,	,	PUNCT
cuesj-706	220	5	2021	2021	NUM
cuesj-706	220	6	.	.	PUNCT
cuesj-706	221	1	36	36	NUM
cuesj-706	221	2	.	.	PUNCT
cuesj-706	221	3	a.	a.	PROPN
cuesj-706	221	4	filoni	filoni	PROPN
cuesj-706	221	5	,	,	PUNCT
cuesj-706	221	6	m.	m.	NOUN
cuesj-706	221	7	vestita	vestita	PROPN
cuesj-706	221	8	,	,	PUNCT
cuesj-706	221	9	m.	m.	NOUN
cuesj-706	221	10	congedo	congedo	PROPN
cuesj-706	221	11	,	,	PUNCT
cuesj-706	221	12	g.	g.	PROPN
cuesj-706	221	13	giudice	giudice	PROPN
cuesj-706	221	14	,	,	PUNCT
cuesj-706	221	15	s.	s.	PROPN
cuesj-706	221	16	tafuri	tafuri	PROPN
cuesj-706	221	17	and	and	CCONJ
cuesj-706	221	18	d.	d.	PROPN
cuesj-706	221	19	j.	j.	PROPN
cuesj-706	221	20	m.	m.	PROPN
cuesj-706	221	21	bonamonte	bonamonte	PROPN
cuesj-706	221	22	,	,	PUNCT
cuesj-706	221	23	association	association	NOUN
cuesj-706	221	24	between	between	ADP
cuesj-706	221	25	psoriasis	psoriasis	NOUN
cuesj-706	221	26	and	and	CCONJ
cuesj-706	221	27	vitamin	vitamin	NOUN
cuesj-706	222	1	d	d	NOUN
cuesj-706	222	2	:	:	PUNCT
cuesj-706	222	3	duration	duration	NOUN
cuesj-706	222	4	of	of	ADP
cuesj-706	222	5	disease	disease	NOUN
cuesj-706	222	6	correlates	correlate	VERB
cuesj-706	222	7	with	with	ADP
cuesj-706	222	8	decreased	decrease	VERB
cuesj-706	222	9	vitamin	vitamin	NOUN
cuesj-706	222	10	d	d	NOUN
cuesj-706	222	11	serum	serum	NOUN
cuesj-706	222	12	levels	level	NOUN
cuesj-706	222	13	:	:	PUNCT
cuesj-706	222	14	an	an	DET
cuesj-706	222	15	observational	observational	ADJ
cuesj-706	222	16	case	case	NOUN
cuesj-706	222	17	-	-	PUNCT
cuesj-706	222	18	control	control	NOUN
cuesj-706	222	19	study	study	NOUN
cuesj-706	222	20	.	.	PUNCT
cuesj-706	223	1	medicine	medicine	NOUN
cuesj-706	223	2	(	(	PUNCT
cuesj-706	223	3	baltimore	baltimore	PROPN
cuesj-706	223	4	)	)	PUNCT
cuesj-706	223	5	,	,	PUNCT
cuesj-706	223	6	vol	vol	NOUN
cuesj-706	223	7	.	.	PROPN
cuesj-706	223	8	97	97	NUM
cuesj-706	223	9	,	,	PUNCT
cuesj-706	223	10	no	no	INTJ
cuesj-706	223	11	.	.	NOUN
cuesj-706	223	12	25	25	NUM
cuesj-706	223	13	,	,	PUNCT
cuesj-706	223	14	p.	p.	NOUN
cuesj-706	223	15	e11185	e11185	PROPN
cuesj-706	223	16	,	,	PUNCT
cuesj-706	223	17	2018	2018	NUM
cuesj-706	223	18	.	.	PUNCT
cuesj-706	224	1	37	37	NUM
cuesj-706	224	2	.	.	PUNCT
cuesj-706	225	1	y.	y.	PROPN
cuesj-706	225	2	h.	h.	PROPN
cuesj-706	225	3	lee	lee	PROPN
cuesj-706	225	4	and	and	CCONJ
cuesj-706	225	5	g.	g.	PROPN
cuesj-706	225	6	g.	g.	PROPN
cuesj-706	225	7	song	song	PROPN
cuesj-706	225	8	.	.	PUNCT
cuesj-706	226	1	association	association	NOUN
cuesj-706	226	2	between	between	ADP
cuesj-706	226	3	circulating	circulate	VERB
cuesj-706	226	4	25‐	25‐	NUM
cuesj-706	226	5	hydroxyvitamin	hydroxyvitamin	NOUN
cuesj-706	226	6	d	d	NOUN
cuesj-706	226	7	levels	level	NOUN
cuesj-706	226	8	and	and	CCONJ
cuesj-706	226	9	psoriasis	psoriasis	NOUN
cuesj-706	226	10	,	,	PUNCT
cuesj-706	226	11	and	and	CCONJ
cuesj-706	226	12	correlation	correlation	NOUN
cuesj-706	226	13	with	with	ADP
cuesj-706	226	14	disease	disease	NOUN
cuesj-706	226	15	severity	severity	NOUN
cuesj-706	226	16	:	:	PUNCT
cuesj-706	226	17	a	a	DET
cuesj-706	226	18	meta	meta	ADJ
cuesj-706	226	19	-	-	PUNCT
cuesj-706	226	20	analysis	analysis	NOUN
cuesj-706	226	21	.	.	PUNCT
cuesj-706	227	1	clin	clin	PROPN
cuesj-706	227	2	exp	exp	NOUN
cuesj-706	227	3	dermatol	dermatol	NOUN
cuesj-706	227	4	,	,	PUNCT
cuesj-706	227	5	vol	vol	NOUN
cuesj-706	227	6	.	.	PROPN
cuesj-706	227	7	43	43	NUM
cuesj-706	227	8	,	,	PUNCT
cuesj-706	227	9	no	no	INTJ
cuesj-706	227	10	.	.	NOUN
cuesj-706	227	11	5	5	NUM
cuesj-706	227	12	,	,	PUNCT
cuesj-706	227	13	pp	pp	ADJ
cuesj-706	227	14	.	.	PUNCT
cuesj-706	228	1	529	529	NUM
cuesj-706	228	2	-	-	SYM
cuesj-706	228	3	535	535	NUM
cuesj-706	228	4	,	,	PUNCT
cuesj-706	228	5	2018	2018	NUM
cuesj-706	228	6	.	.	PUNCT